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Colorectal cancer
Cancers located in the colon, (recto)sigmoid, or rectum are collectively known as colorectal 
cancer (see Figure 1). Colon cancer is situated in the large intestine (i.e., colon), the lower 
part of the digestive system. The colon starts where the small bowel ends. When stretched, 
the colon is 1.5 to 1.8 meters long. The rectum forms the final 10 to 15 centimeters of the large 
intestine and connects the colon to the anus. Cancer located in this last part is, therefore, 
known as rectal cancer. The (recto)sigmoid is the transitional zone between the colon and 
the rectum. 
Incidence and prevalence
In the Netherlands, colorectal cancer is the third most common cancer for both men and 
women.1 About 13.000 new cases are diagnosed each year, of which approximately 30% are 
located in the rectum.1,2 The incidence of colorectal cancer is increasing.2,3 This rise is associated 
with an increasingly aging population. Currently, 75% of colorectal cancer patients are 65 years 
or older.4 Changes in lifestyle, such as dietary habits5,6, smoking5,6, and physical inactivity5,7, are 
also associated with the increase in incidence. Simultaneously, the prevalence of colorectal 
cancer is growing rapidly. The rising prevalence is partly due to an increased five-year survival 
rate. Nowadays, approximately 65% of patients survive the first five years after diagnosis.8 In 
2011 the Dutch government decided to implement a national population screening program 
for colorectal cancer.9,10 This screening program will be gradually introduced. In September 
2013, a pilot has started in the south-west of the Netherlands.9 When the colorectal cancer 
screening program is nationally implemented a further growth in incidence and prevalence of 
colorectal cancer may be expected. 
Colorectal cancer treatment 
The multidisciplinary colorectal cancer treatment is mostly determined by the type, location, 
and extensiveness of the tumor. For colon cancer, neoadjuvant treatment is only considered 
if an irradical resection is to be expected.11 Therefore, surgery is the first part of treatment 
for most patients with colon cancer. Surgery for colon cancer can be safely performed with 
a minimally invasive laparoscopic procedure.12 As a result, the number of patients that are 
treated with laparoscopic surgery is increasing fast.13 Surgery is aimed at removing the tumor 
en bloc with the draining lymph node basin.14 If the tumor is located in the cecum, ascending 
colon, hepatic flexure or transverse colon, a right hemicolectomy, including a dissection of the 
mesenteric lymph nodes, is generally performed. Tumors located in the splenic flexure or the 
descending colon are treated with a left hemicolectomy and tumors located in the sigmoid 
colon are operated on with a sigmoid resection. In general, an anastomosis can be formed 
between the remaining parts of the colon in order to preserve a functioning colon.15 However, 
sometimes a temporary colostomy needs to be constructed.15 Finally, adjuvant chemotherapy 
is recommended if the tumor has spread to the lymph nodes and sometimes in high risk 
tumors without lymphatic spread.14,16-18 In contrast with colon cancer treatment, neoadjuvant 
therapies are often an important part of rectal cancer treatment. In rectal cancer, neoadjuvant 




Figure 1  Early 19th century anatomical lithography demonstrating the colon, (recto)sigmoid, and rectum 
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increases the probability to perform a radical resection and sometimes even allows more 
limited surgery.19 Therefore, the Dutch national guidelines advice that only patients with a 
small, superficially growing, well or moderately differentiated tumor, without positive lymph 
nodes are not treated with neoadjuvant therapy.20 Neoadjuvant short-term radiotherapy (5x5 
Gray) is considered standard for resectable tumors with three or less involved lymph nodes 
but without an expected positive Circumferential Resection Margin (CRM).20 For patients 
who are expected to have a positive CRM or four or more positive lymph nodes, long-term 
neoadjuvant radiotherapy (25x2 Gray) may be applied combined with chemotherapy.20 Due to 
the challenging anatomy and location in the pelvic area (i.e., below the peritoneal fraction), 
complex surgical approaches are needed for rectal cancer. In line with colon cancer treatment, 
laparoscopic rectal cancer surgery is increasingly performed.12,13 The surgical approach is based 
on the location of the tumor in combination with the response to neoadjuvant treatment. If 
the tumor is small, superficially growing, and well or moderately differentiated than the tumor 
can be dissected with radical surgery or local excision, preferably using transanal endoscopic 
microsurgery.14 A (low) anterior resection, with preservation of the sphincter function, is 
performed for tumors located in the rectosigmoid or the upper or middle part of the rectum, 
provided that at least 4 to 5 centimeters of the mesorectum is removed distally from the tumor.19 
For very low tumors (at the anorectal junction or below), an abdominoperineal resection is 
performed.19 In this procedure some parts of the pelvic floor muscles and external sphincter 
are removed en bloc with the rectum, hereby necessitating the formation of a permanent 
colostomy.19,21 In general, rectal cancer surgery that includes the autonomous nerve-sparing 
total mesorectal excision procedure offers the best oncologic results.14,19,22 
Quality of (sexual) life 
Traditional oncological research focuses on developing treatments that increase overall and 
disease-free survival. For colorectal cancer, the introduction of the total mesorectal excision 
procedure in the early 1980’s and the development of suitable (neo)adjuvant treatments are 
important contributions in this regard.14,19 Due to the increased life expectancy for patients 
with colorectal cancer, more awareness arose for the potential side-effects of treatments. 
Therefore, studies started to evaluate functional results after treatment, such as fecal 
incontinence, urinary function, and Sexual Function (SF).23 In addition, the impact of colorectal 
cancer treatment on patients’ Quality of Life (QoL) became a key outcome of interventions.24 
QoL is a multi-dimensional construct, incorporating at least physical, psychological, and 
social well-being.25 Sexuality is considered central to a person’s well-being and is, as such, 
an important aspect of QoL.26 However, sexuality itself is a broad concept which can mean 
different things to different people at different stages of their lives.27 This is also reflected in 
the World Health Organization’s definition of sexuality: “…a central aspect of being human 
throughout life encompasses sex, gender identities and roles, sexual orientation, eroticism, 
pleasure, intimacy and reproduction. Sexuality is experienced and expressed in thoughts, 
fantasies, desires, beliefs, attitudes, values, behaviours, practices, roles and relationships. 
While sexuality can include all of these dimensions, not all of them are always experienced 
or expressed. Sexuality is influenced by the interaction of biological, psychological, social, 
economic, political, cultural, legal, historical, religious and spiritual factors.”28 This definition 
establishes two important things. First, it shows that sexuality is more than sexual intercourse 
alone. Therefore, in this dissertation a distinction is made between sexual (dys)function and 
the Quality of Sexual Life (QoSL). SF refers to the normal performance standards of the sexual 
response cycle (i.e., desire, excitement, orgasm, and resolution).29,30 A sexual dysfunction 
is characterized by a disturbance in this sexual response cycle or by pain associated with 
intercourse.31 QoSL takes into account the person’s subjective evaluation of his/her sexual 
life and, thus, concerns the extent to which someone is (dis)satisfied with their sexual life. 
Moreover, the definition of sexuality shows that sexuality can be influenced by different factors, 
which warrants the need to evaluate sexual (dys)function and QoSL from a biopsychosocial 
perspective. 
A biopsychosocial approach
Several authors have emphasized that SF and QoSL may be best understood from an integrative 
biopsychosocial approach.29,30,32 Treatment-related factors (e.g., surgery-related autonomic 
nerve injury33, temporary ileostomy or permanent colostomy34-36), demographic factors (e.g., 
age37, sex34), symptoms (e.g., fatigue38), psychological issues (e.g., mood39, body image40), and 
social aspects (e.g., patients’ and/or partners’ relationship function38) may have a mutual direct 
or indirect effect on SF and QoSL. Until now, the abovementioned factors have been mostly 
evaluated in separate studies. To our knowledge, only one cross-sectional study incorporated 
a biopsychosocial approach to evaluate the SF of patients with colorectal cancer. In this 
study, a higher age, having received an adbominoperineal resection, and poor social support 
were associated with low SF in men, while low SF in women was associated with higher age 
and a poor global QoL.37 No study has yet evaluated QoSL from a biopsychosocial approach. 
Therefore, future prospective research examining SF and QoSL from a biopsychosocial 
perspective is warranted. 
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Stress-spillover 
Stress-spillover may exist between QoSL, quality of the partner relationship, and QoL. 
QoSL can influence the quality of the partner relationship, while the quality of the partner 
relationship may influence quality of life. However, the reversed direction may also be true. In 
addition, QoSL can influence QoL and vice versa. Research evaluating stress-spillover between 
QoSL, the quality of the partner relationship, and QoL in patients with cancer is scarce. QoL 
was associated with the quality of the partner relationship in one study41 and with SF in another 
study37. However, these cross-sectional studies do not allow making causal interferences. In 
addition, previous research has not yet evaluated all three aspects in one integrative model. 
Therefore, it remains interesting to prospectively evaluate the bidirectional influence of these 
three constructs on one another. 
A dyadic perspective
For a long time, cancer has been viewed as a disease that mainly affects patients. In this 
perspective, patient’s individual stress demands patient’s individual coping efforts. However, 
since the 1990’s researchers have started to consider stress and coping as interpersonal 
processes.42-44 This interpersonal approach is well reflected in the definition ‘dyadic stress’.45 
Dyadic stress implies that a stressful event or encounter concerns both partners directly or 
indirectly. Directly if both partners are confronted by the same stressor or when the stress 
originates inside the relationship and indirectly when the stress of one partner spills over to 
the relationship and in that way affects both partners. Cancer can be seen as a dyadic stressor 
since both partners have to incorporate ongoing cancer-related experiences and concerns into 
their daily lives. Therefore, an individualistic view, focused solely on patients, seems outdated. 
Instead, cancer may be best considered as a stressor concerning both partners simultaneously 
(i.e., cancer as a ‘we-disease’).46 Several literature reviews have shown that a number of studies 
evaluated and reported interdependence between patients’ and partners’ psychosocial 
outcomes.47,48 This interdependence can be depicted in an Actor–Partner Interdependence 
Model (APIM, see Figure 2).49 In this model, each person’s score is an independent variable 
that can influence not only his/her own score on the outcome variable (Actor effect) but 
also the partner’s score (Partner effect). Methodologically, this entails that the dyad should 
be the unit of analysis. The interdependence between patients and partners is also seen in 
the way patients and partners cope with dyadic stressors, such as cancer. Above and beyond 
individual coping, couples may engage in an additional form of stress management.50,51 This 
form of coping is defined as dyadic coping and entails the attempt of one member of the dyad 
to help reduce stress perceived by the other member of the dyad and as a common endeavor 
to cope with stress that originates inside the relationship.42 However, as the field of dyadic 
research (e.g., dyadic stress, dyadic coping) is relatively new, few studies have incorporated a 
couple-based perspective (i.e., dyadic-perspective) to evaluate the consequences of colorectal 
cancer.52-54 While these studies showed that adequate dyadic coping is important in order to 
maintain a satisfying relationship, a dyadic approach to SF and QoSL has not yet been taken 
into account. Therefore, future research in this area is needed.
Studies in this thesis
The general aim of this dissertation was to evaluate the consequences of colorectal cancer 
on SF and quality of (sexual) life for patients and their partners. Data from three studies were 
used to achieve this goal.
Figure 2  Actor-Partner Interdependence Model
Note: E represents the unique residuals.
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The (sexual) consequences of colorectal  
cancer for patients and partners 
Data on the (sexual) consequences of colorectal cancer for patients and their partners was 
analyzed in chapter 4,5,7, and 8. Before surgical treatment, patients diagnosed with colorectal 
cancer and their partners were asked to participate. Patients were recruited between 
September 2010 and March 2014 from six Dutch hospitals: St. Elisabeth hospital (Tilburg), 
TweeSteden Hospital (Tilburg and Waalwĳk), Catharina Hospital (Eindhoven), Jeroen Bosch 
Hospital (‘s Hertogenbosch), Amphia Hospital (Breda), and Maxima Medical Centre (Eindhoven 
and Veldhoven). Patients and partners older than 18 years were eligible for participation. The 
following exclusion criteria were applied: (i) elderly age (older than 75 years), (ii) not curatively 
treated metastases at baseline, (iii) poor expression of the Dutch language, (iv) dementia, 
and/or (v) a history of psychiatric illness. When patients declined participation, the partners 
were still invited to participate (and vice versa) in order to prevent selection bias. If patients 
and/or their partners agreed to participate they were asked to complete a set of standardized 
surveys at home preoperatively (Time-0) and three (Time-1), six (Time-2) and 12 months (Time-
3) postoperatively. A detailed overview of the study process is presented in Figure 3. 
The sexual health care needs 
Patients’ and partners’ sexual health care needs were evaluated qualitatively in chapter 9. For 
this study, participants were recruited from three Dutch hospitals: the St. Elisabeth Hospital 
(Tilburg), TweeSteden Hospital (Tilburg and Waalwĳk), and Catharina Hospital (Eindhoven). 
Eligible participants had to be (i) diagnosed with colorectal cancer between January 2010 
and February 2012 or be the partner of an eligible patient diagnosed with colorectal cancer 
within this time frame and (ii) aged between 18 and 75 years. Persons were excluded if they (i) 
had metastatic colorectal cancer or their partner had metastatic colorectal cancer, (ii) were 
physically not fit enough to attend the focus group, (iii) had a history of mental disease or 
cognitive problems, or (iv) had insufficient knowledge of the Dutch language. In order to 
ensure a wide variety of experiences to be represented, potential participants were informed 
that having sexual health care needs and/or being sexually active was not a prerequisite to 
participate. Patients and partners were selected based on their age, sex, and tumor type (if 
applicable) in order to attain a fair representation of the colorectal cancer patient population 
and their partners. To rule out selection bias, the partners were still invited to participate when 
patients declined participation and vice versa. A purposive sampling method was applied. In 
this study, the perspective of the health care professionals was also taken into account. Health 
care professionals were selected based on their level of expertise and working experience with 
the colorectal cancer patient population. 
Figure 3  Overview of the study process
Abbreviations: BIS: Body Image scale, EORTC-QLQ-CR38: European Organization for Research and Treatment 
of Cancer Quality of Life Questionnaire disease specific ColoRectal 38, FAS: Fatigue Assessment Scale, FSFI: 
Female Sexual Function Index, GRISS: Golombok-Rust Inventory of Sexual Satisfaction, IIEF: International 
Index of Erectile Function, MMQ: Maudsley Marital Questionnaire, NEO-FFI: Neuroticism-Extraversion-
Openness-Five Factor Inventory SCQ: Self-administered Comorbidity Questionnaire, STAI-state: Spielberger 
State Anxiety Inventory – state anxiety scale, STAI-trait: Spielberger State Anxiety Inventory – trait 
anxiety scale, WHOQOL-Bref: World Health Organization Quality of Life assessment abbreviated version, 
WHOQOL-100: WHOQOL-100 item version. 
Note: *Only patients completed these questionnaires.
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Background
To determine (i) the prevalence of sexual (dys)function in patients with colorectal cancer and 
(ii) treatment-related and sociodemographic aspects in relation to sexual (dys)function and 
the quality of sexual life (QoSL). Recommendations for future studies are provided.
Method
A systematic search was conducted for the period January 1990 to July 2010 that used the 
databases PubMed, PsycINFO, the Cochrane Library, EMBASE, and OVID Medline.
Results
Eighty-two studies were included. The mean quality score was 7.2. The percentage of 
preoperatively potent men that experienced Sexual Dysfunction (SD) postoperatively varied 
from 5% to 88%. Approximately half of the women reported SD. Preoperative radiotherapy, 
a stoma, complications during or after surgery, and a higher age predicted more SD with a 
strong level of evidence. Type of surgery and a lower tumor location predicted more SD with 
a moderate level of evidence. Insufficient evidence existed for predictors of QoSL. Current 
studies mainly focused on biological aspects of sexual (dys)function. Furthermore, existing 
studies suffer from methodological shortcomings such as a cross-sectional design, a small 
sample size, and the use of non-standardized measurements.
Conclusion
Sexuality should be investigated prospectively from a biopsychosocial model, hereby 
including QoSL.
Background
Worldwide colorectal cancer is the third most common cancer in men (10%), after lung cancer 
(17%) and prostate cancer (14%) and the second most common cancer in women (9%) after 
breast cancer (22%) (www.globocan.iarc.fr). Despite improvements in the multimodality 
treatment of colorectal cancer, surgery remains the only treatment offering a chance of cure. 
For colon cancer, surgery is aimed at total resection of the tumor with adequate margins 
and lymphadenectomy (i.e., colectomy).1 In general, the remaining parts of the colon are 
anastomosed together to create a functioning colon; however, sometimes a temporary 
colostomy may be constructed.2 For rectal cancer, different surgical approaches are warranted. 
An Anterior Resection (AR), with preservation of the sphincter function, is carried out for 
tumors located in the middle or upper part of the rectum. For very low tumors an Abdominal 
Perineal Resection (APR) is carried out, hereby resecting the anal sphincter and forming a 
permanent colostomy.1 In general, surgery that includes Total Mesorectal Excision (TME) 
offers the best results.3 Colon cancer can be safely treated by open or laparoscopic surgery4; 
however, laparoscopic rectal cancer surgery is in the experimental phase.5 Preoperative 
Radiation Therapy (PRT) or Preoperative Chemo Radiation Therapy (PCRT) leads to an 
additional reduction of local recurrence rates.6,7
Although oncologic cure and overall survival are the main goals of treatment, functional 
results such as faecal incontinence, urinary function, and sexual function (SF) are also 
important. Furthermore, patient-reported outcomes, such as quality of life, are regarded as key 
measurements in assessing outcomes of interventions.8 Quality of life is a multi-dimensional 
construct, incorporating at least physical, psychological, and social well-being.9 Sexuality and 
intimacy are considered central to a person’s well-being and are, as such, important aspects 
of quality of life.10 Poor SF and a lower sexual satisfaction are risk factors for a worse quality 
of life.11 SF refers to the normal performance standards of the sexual response cycle12, which 
consists of four phases; desire, excitement, orgasm, and resolution13. A Sexual Dysfunction 
(SD) is characterized by a disturbance in this sexual response cycle or by pain associated with 
intercourse.14 In line with the distinction between health status (i.e., the impact of disease on 
functioning) and quality of life (i.e., the subjective evaluation of this functioning)15-17, a similar 
distinction can be made between sexual (dys)function and the Quality of Sexual Life (QoSL). 
Sexual (dys)function refers mainly to the biological aspects of sexuality (e.g., “When you had 
sexual stimulation or intercourse, how often did you reach orgasm?”), while QoSL takes into 
account the person’s subjective evaluation of his/her SF (e.g., “How satisfied were you with 
your ability to reach orgasm during sexual activity or intercourse?”). Several authors have 
emphasized the assessment of sexual (dys)function from a biopsychosocial perspective.12,18 
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(neo)adjuvant treatments), but also psychosocial factors (e.g., mood, the partner relationship, 
and the subjective evaluation of the current functioning). These factors may have a direct 
or indirect effect on sexual (dys)function or QoSL. For instance, SF can not only be directly 
affected by surgical treatment19 or by PRT or PCRT20-22, but can also be indirectly affected due 
to the potential loss of sphincter function, accompanied with a stoma20,23.
Published research focussed on several aspects associated with sexual (dys)function in 
patients with colorectal cancer. To our knowledge, an overview of these studies has not yet 
been published. Knowledge of how colorectal cancer and its treatment affect patients will give 
health professionals opportunities to adequately support this patient group. 
The objective of this systematic review was to provide an overview of studies that addressed 
sexual (dys)function and/or QoSL in colorectal cancer with regard to (i) the prevalence of 
sexual (dys)function and (ii) treatment-related and sociodemographic aspects in relation to 
sexual (dys)function and/or QoSL.
Methods
Search strategy
A search of the literature was performed in Pubmed (196 hits), Ovid Medline (328 hits), 
PsycINFO (7 hits), The Cochrane Library (67 hits), and Embase (534 hits). The databases were 
searched with combinations of colonic neoplasms, colon cancer*, colonic cancer*, rectal 
cancer*, colorectal cancer*, rectum cancer*, colon tumo*, colonic tumo*, rectal tumo*, 
colorectal tumo*, rectum tumo*, colon neoplas*, colonic neoplas*, rectal neoplas*, colorectal 
neoplas*, rectum neoplas*, and combinations of sexual behaviour, sexual behav*, sex behav*, 
sexual funct*, sex funct*, “sexual and gender disorders”, sexual disorder*, sex disorder*, sexual 
dysfunct*, sex dysfunct*, dyspareun*, erect*, coit*, “quality of sexual life”, “sexual quality of 
life”. The search was restricted to studies published from 1990 to July 2010 in English or Dutch 
journals. Only original reports were included. Subsequently, the reference lists of included 
studies were checked in order to identify studies which were not found in the computerized 
database searches.
Selection criteria
Studies that met the following criteria were included: (i) the studies investigated sexual (dys)
function and/or QoSL as a primary or secondary objective, (ii) the study population exclusively 
concerned patients with colon and/or rectal cancer, (iii) sexual (dys)function and/or QoSL were 
measured by self-report or an interview, (iv) the studies were original full-reports published 
in English or Dutch, (v) studies were published in peer-reviewed journals, and (vi) studies 
reported on patient populations recruited after 1989 since in the past two decades substantial 
improvements in surgical techniques have taken place, such as the introduction of TME24.
Data extraction
Combining the search results and removing duplicates resulted in 698 hits. Two authors (MJT 
and BLDO) applied the described inclusion criteria independently in a standardized manner. 
Disagreements between the two reviewers (<5%) were resolved in a consensus meeting. 
Altogether, 590 articles were excluded based on title and abstract. Hard copies were obtained 
of 108 studies, of which 81 met the selection criteria. With regard to multiple reports on the 
same study, only one article was included based on the highest quality score. If studies were 
of equal quality, only the most recent study was included. Six articles were excluded based 
on the multiple reports criterion. Through a hand search seven additional articles were found 
which met the selection criteria. Thus, a total of 82 articles remained. The flow chart of study 
selection is shown in Figure 1.
Quality assessment
The methodological quality of the selected studies was independently assessed by two 
reviewers (MJT and BLDO) using a criteria list (Table 1). This checklist was based on established 
criteria lists for systematic reviews, that have been previously published.25,26 The maximum 
attainable score is 15. If a criterion is not sufficiently fulfilled or not explicitly mentioned, a zero 
is scored. Studies scoring 70% or more of the maximum attainable score (i.e., ≥ 11 points) were 
considered to be of a ‘high quality’. Studies of a ‘moderate quality’ scored between 50% and 
70%, while studies scoring lower than 50% (i.e., ≤ 7 points) were considered as ‘low quality’.
Levels of evidence
After the individual quality of the studies was assessed, the level of evidence was determined 
for predictors of SD and QoSL. Findings were considered consistent if ≥75% of the studies that 
investigated a particular predictor showed the same direction of association. Table 2 provides 
an overview of the four levels of evidence.
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Table 1. List of criteria for assessing the methodological quality of studies on sexual (dys)function and/or 
QoSL in patients with colorectal cancer
Positive if
Sexual (dys)function and/or QoSL assessment
A. a psychometrically sound questionnaire is used
B. examining sexual (dys)function and/or QoSL was a primary objective of the study
Study population concerning sexual (dys)function and/or QoSL
C. examining both men and women
D. description is included of at least two socio-demographic variables (e.g., age, sex, employment status, 
educational status, etc.)
E. a description is present of at least two clinical variables (e.g., TNM or Dukes classification, type of 
surgery, tumor location etc.)
F. inclusion and/or exclusion criteria are provided
G. the study describes potential prognostic factors by using multivariate analyses or structural equation 
modelling
H. participation rates for patient groups are described (defined as the percentage of eligible patients who 
gave their informed consent) and these rates are exceeding 75%
I. the ratio non-responders versus responders is given (defined as the ratio of patients who withdrew 
their initial informed consent) including reasons for withdrawal
Study design concerning sexual (dys)function and/or QoSL
J. the study size is at least consisting of 75 patients (arbitrarily chosen)
K. the collection of data is prospectively gathered with at least two assessment points
L. the design is longitudinal (more than 1-year)
M. the process of data collection is described (e.g., interview or self-report, etc.)
N. the loss to follow-up is described and is less than < 20%
Results
O. the results are compared between two groups or more (e.g., healthy population, groups with different 
disease stages or treatment types)
Abbreviations: QoSL = Quality of Sexual Life, TNM = Tumor Nodes Metastasis.
Figure 1. Study selection process
Table 2. Levels of evidence
Level of evidence Criteria
Strong Consistent findings (≥ 75%) in at least two high-quality studies or one 
high-quality study and at least three moderate studies
Moderate Consistent findings (≥ 75%) in one high-quality study and at least one 
low-quality study or at least three moderate studies
Weak Findings of two moderate studies or consistent findings (≥ 75%) in at 
least three or more low-quality studies
Inconclusive Inconsistent findings irrespective of study quality, or less than three 
low-quality studies available
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The included studies investigated diverse outcomes (i.e., different phases and aspects of the 
sexual response cycle) in various patient populations, using different study designs. Therefore, 
a quantitative approach (i.e., a meta-analysis) was not possible. The information extracted 
from the individual reports is summarized in Table 3, page 40. As said, various biopsychosocial 
factors may have an effect on sexual (dys)function and QoSL. Unfortunately, most of the current 
studies focus on treatment related or sociodemographic aspects of sexual (dys)function 
hereby neglecting psychosocial factors that may influence sexual (dys)function and/or QoSL. 
In addition, in the current studies, it is difficult to identify the contribution of each aspect in 
the development of SD or changes in QoSL. In this review, the prevalence of SD is described 
for both men and women. Subsequently, treatment-related predictors and sociodemographic 
predictors of SD and QoSL are discussed. The main results of the prospective and cross-
sectional studies are presented, which were specified for men and women when applicable
Results
Methodological quality
There was <5% disagreement between the two reviewers when scoring the articles. These 
disagreements were mainly due to differences in applying criterion I. The disagreements 
were solved through discussion in a consensus meeting. The quality scores ranged from 3 
(low quality)27-31 to 12 (high quality)20,32. The mean quality score was 7.2 (range 3-12; standard 
deviation=2.2). Methodological shortcomings mainly concerned the following items: 
describing potential prognostic factors by using multivariate analyses or structural equation 
modelling (criterion G; 81%), participation rates for patient groups are described and these 
rates are exceeding 75% (criterion H; 73%), information is given about the ratio non-responders 
versus responders (criterion I; 95%), the design is longitudinal (criterion L; 82%), and the loss 
to follow-up is described and is < 20% (criterion N; 90%).
Study characteristics 
Sample sizes ranged from 433 to 143734. In total, 39 (48%) studies investigated sexual (dys)
function as a secondary objective (as part of clinical outcome studies, or as part of studies 
on health-related quality of life/health status).23,29,34-70 The majority of studies were cross-
sectional, except for 36 (44%) studies.5,20,21,23,27,30-32,36,38,39,42,45,47,49,51,55,58,61,62,67,68,71-80 Of the prospective 
studies, seven studies failed to define the exact postoperative measurement point.31,49,72,74,77,81,82 
Six studies investigated the results of a randomized trial.20,36,38,45,47,67 The study duration ranged 
from three months30,55 up to five years21. Four studies used a healthy population as a control 
group33,43,64,74 and one study investigated both patients and their caregivers65. Postoperative 
sexual (dys)function in men was investigated in 28 (34%) studies5,22,27,29-31,36,46,55,63,68,71-73,75-77,80,83-92, 
seven (9%) studies investigated women21,28,33,93-96, and 47 (57%) studies investigated both men 
and women20,23,32,34,35,37-45,47,49-54,56-62,64-67,69,70,74,78,79,81,82,97-103. The results were mainly presented for 
sexually active patients; however, not all patients were sexually active or willing to answer 
questions concerning sexual (dys)function and/or QoSL.
Six different standardized self-report instruments were applied. The colorectal cancer specific 
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 
(EORTC QLQ-CR38)104 was most used in 23 (28%) studies23,34-37,40-44,48,49,51-53,58,59,64-67,99. Regarding 
sexual (dys)function and QoSL the EORTC QLQ-CR38 measures SF, Sexual Enjoyment, Male SF, 
and Female SF with five questions. For men, the International Index of Erectile Function (IIEF)105 
was most assessed in 13 (16%) studies5,22,46,67,69,71,74,75,77,87,98-100. The IIEF is a 15-item questionnaire, 
which evaluates men’s SF, including Erectile Function, Orgasmic Function, Sexual Function, 
Desire, Intercourse Satisfaction, and Overall Satisfaction. The most used female counterpart 
was the Female Sexual Function Index (FSFI)106, which was used in three (4%) studies67,69,95,99. 
The FSFI is a 19-item questionnaire addressing six domains of women’s SF: Arousal, Lubrication, 
Orgasmic Function, Sexual Desire, Intercourse Satisfaction, and Sexual Pain.
Several studies used a combination of instruments; however, 43 (52%) studies used 
non-standardized assessments.20,21,27-32,38,39,45,47,50,54-57,61-63,68,70,73,76,78-83,85,86,88-94,96,97,101-103 One study 
investigated sexual (dys)function based on a single question: “Did your health status and/or 
treatment cause your sexual life to decline?”.47 Most studies described at least two demographic 
and clinical variables of interest. The most reported demographic variables were age and 
sex; frequently represented clinical variables were type of surgery, tumor-node-metastasis 
stage, distance of the tumor from the anal verge, and (neo)adjuvant therapies. Patients with 
rectal cancer were investigated in 66 (81%) studies5,20-22,27,29-32,35-55,58-63,71,72,74-81,83,85,87-89,91,93,96-100,102,103, 
two (2%) studies concerned patients with colon cancer69,70, and 14 (17%) studies investigated 
patients with colon or rectal cancer23,28,34,64-68,82,84,86,92,94,95. Therefore, results presented will 
concern patients with rectal cancer unless explicitly mentioned.
3635 Quality of sexual life and colorectal cancer  Towards a dyadic approach Chapter 2   Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review
22 The prevalence of sexual  
(dys)function in patients with colorectal cancer
Preoperatively, the percentage of sexually active man varied from 37%79 to 79%20 across studies. 
The percentage of preoperatively potent men that experienced SD postoperatively varied 
from 5%98 to 88%88. Compared with preoperative scores, a postoperative increase in erectile 
dysfunction5,20,27,30,72,73,79,80,82,98 and/or ejaculatory dysfunction20,22,30,55,79,80 was most reported. In 
addition, sexual desire decreased postoperative.5,22,77 The percentage preoperatively sexually 
active women ranged from 27%79 to 78%69. Women who were sexually active preoperatively 
remained sexually active postoperative.48,96 Women reported SD such as dyspareunia20,21,82 
and vaginal dryness20,99. Twelve months after treatment, sexual desire remained unchanged in 
women.48 For both men and women, the prevalence’s of sexual (dys)function found in cross-
sectional studies did not deviate from the results of the above-mentioned prospective studies.
Treatment-related aspects  
in relation to sexual (dys)function
(P)RT predicted SD with a strong level of evidence.20-22,76,99 RT predicted less sexual activity 
in both men and women76,99 and erectile and orgasmic dysfunction in men76. PRT predicted 
ejaculatory dysfunction in men20,76 and dyspareunia in women21. (P)RCT predicted erectile 
dysfunction22 and sexual desire77 in men. Compared with scores before PRT, SD was higher at 
12 months follow-up.20,51,72 Cross-sectional studies revealed the same direction of association; 
more sexual (dys)function was reported by patients who received PRT.53,54,90
Having a stoma was a predictor of SD with a strong level of evidence.20,23 SD was more 
often present in patients with a stoma compared with patients without a stoma up to 24 
months after surgery.20,23,64,87 Perioperative or postoperative complications predicted SD with 
a strong level of evidence.20,21,67 Excessive perioperative blood loss (>1500 ml) and anastomotic 
leakage predicted erectile dysfunction, while anastomotic leakage also predicted ejaculatory 
problems.20 Patients with intra-abdominal sepsis had decreased ability to achieve arousal 
postoperatively.21 Conversion from laparoscopic to open surgery predicted postoperative SD 
in men.67
Type of surgery predicted SD with a moderate level of evidence.21,22,67,97,99,102 Patients in a 
colonic resection group reported more sexual desire and sexual activity at three months 
follow-up compared with a rectal resection group, although levels were similar at six months.67 
Cross-sectional studies also found less SD after colonic versus rectal cancer surgery.66,95 In 
rectal cancer surgery, APR predicted less sexual activity99, more erectile dysfunction in 
men97, and more dyspareunia in women97. Less SD was reported in patients who underwent 
AR compared with patients who underwent APR up to 12 months after surgery.5,21,22,42,102 In 
concordance, cross-sectional studies ruled in favor of AR.35,52,53,97,99 Mixed results were found 
regarding laparoscopic versus open surgery for rectal cancer; some studies rule in favor of 
laparoscopic surgery85,98, others for open surgery22,100, and some remain inconclusive5,42. Finally, 
Pelvic Autonomic Nerve Preservation (PANP) yielded good results in terms of sexual (dys)
function69,71,78. The degree of SD depended on the degree of PANP.73 Cross-sectional studies 
confirm these results.63,83 A lower tumor location predicted SD with a moderate level of 
evidence.22,77,84 A lower distance between the tumor and the anal verge predicted erectile 
dysfunction22,77,84, intercourse satisfaction77, and orgasmic functioning77. Inconclusive evidence 
was found for tumor stage76 and time since surgery76,77.
Sociodemographic aspects in relation to SD
An elderly age predicted SD with a strong level of evidence.20,21,76,77,81,97,99 Cross-sectional 
studies revealed a similar association.29,84,93,97,99,103,107 An increasing age predicted a loss of 
sexual activity20,21,76,81,97,99 and worse orgasmic functioning21,76,81. For women, an increasing age 
predicted worse arousal, less dyspareunia, and less intercourse per month.21 For men, a higher 
age predicted lower sexual desire77 and worse erectile functioning76,84. 
If being a man or women influences sexual (dys)function remains unclear. Women were 
found to be less sexually active.20 Although both sexually active men and women suffered 
from SD, a trend revealed more SD in men compared with women up to 24 months after 
surgery.20,70
Treatment-related and  
sociodemographic aspects in relation to QoSL
Insufficient evidence was found for the predictive value of treatment-related or 
sociodemographic factors on QoSL. Type of operation (APR versus AR or a transanal excision) 
and RT predicted a positive answer on the statement ‘surgery made my sexual life worse’.99 
Limited changes were seen for sexual enjoyment in the first year after surgery.49,51,58 Patients 
in the colonic resection group reported more sexual enjoyment compared with patients in a 
rectal resection group.67 Compared with healthy controls, patients with rectal cancer reported 
lower scores on sexual enjoyment.64 A worse QoSL was found for patients with a stoma 
patients compared with patients without a stoma.65
For men, sexual satisfaction decreased after surgery.5,39,77 Cross-sectional studies revealed 
the same association.75,86 At a median follow-up period of five years, 64% of men reported to be 
unsatisfied with their current SF.88 Few studies have examined sexual satisfaction/experiences 
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their ideas of sexuality.94 Some women did not present long-term challenges and were able to 
have intercourse with their husbands, while other women had to find other erotic activities, 
such as oral sex.94 However, these women were thus able to maintain a sexual relationship. 
Other women chose not to be sexual active anymore due to their age or because they were 
unable to reconcile their own experience of disgust or the potential reactions of a sexual 
partner to their ostomy.94 This study concluded that neither sexual nor intimate acts where 
essential to the well-being these women.94 Sexual satisfaction was lower for patients with a 
stoma than for patients without a stoma in one study86, but not in another one93. No studies 
reported on the association between sociodemographic factors and QoSL.
Discussion
The objective of this systematic review was to provide an overview of studies that addressed 
sexual (dys)function and/or QoSL in colorectal cancer, with regard to (i) the prevalence of 
sexual (dys)function and (ii) treatment-related and sociodemographic aspects in relation to 
sexual (dys)function and QoSL.
This review included 82 studies. However, measuring sexual (dys)function and/or QoSL 
was a secondary objective in 39 (48%) studies. Since the selected studies differed regarding 
the targeted study population, study design, and outcome measures, definite conclusions 
regarding the prevalence of sexual (dys)function and clinical and sociodemographic factors 
associated with sexual (dys)function and QoSL cannot be made.
Methodologically, there is room for improvement. Approximately half of the studies were 
cross-sectional. In order to detect short-term and long-term effects it is necessary to use a 
prospective design with an assessment point prior to surgical treatment and measurement 
points up to at least one year postoperative. In addition, sample sizes of most studies were 
rather small. Besides, more data was collected for men, perhaps partially due to the fact 
that women were more reluctant to answer questions concerning sexuality.44,49,101 To draw 
meaningful conclusions on differences between men and women future large sample studies 
should focus on both sexes.
Furthermore, most studies used non-standardized measurements, which hampered 
comparisons across studies. Most studies measured sexual (dys)function and/or QoSL 
with a limited number of questions. Also, in several instruments (e.g., EORTC QLQ-CR38) 
questions are only completed if the person indicated to be sexually active. Furthermore, most 
questionnaires did not provide definitions for the concepts used, such as ‘sexual activity’. 
Some patients will interpret sexual activity as sexual intercourse, while others might feel 
that intimacy, touching, and kissing constitutes as sexual activity. It is therefore difficult to 
draw meaningful conclusions from the current data. In future studies, an explicit definition 
of the concept of interest is warranted. The selection of instruments should be based on 
systematic reasoning and will depend on how the objectives and the concepts of interest are 
conceptualized.25 If the study objective is to measure sexual (dys)function after a colorectal 
cancer treatment, the use of more biomedical instruments (e.g., the FSFI for women, the IIEF 
for men, or physiological measurements) is satisfactory. If the objective is to describe the 
subjective evaluation of a patient’s sexual (dys)function then instruments measuring QoSL 
are needed, such as the Golombok Rust Inventory of Sexual Satisfaction.108 However, as 
pointed out by Arrington et al. (2004) the best way to measure SF remains uncertain.109 To 
our knowledge there are still no questionnaires available which are suitable for both sexes of 
all sexual preferences in both healthy and cancer populations. In this perspective, qualitative 
methodologies may be a good starting point in order to examine the experience and meaning 
of sexuality.
The reviewed studies mostly evaluated sexual intercourse and/or the presence of a SD while 
other aspects of sexuality (e.g. oral sex, hugging or kissing, and QoSL) were often omitted. 
Moreover, having a SD may lead to a diminished QoSL, though this is not a necessity. Patients 
may have a SD (e.g., erectile dysfunction) without being bothered by it; in turn, they may also 
experience a diminished QoSL (e.g., due to a low body image) without having an apparent SD.12 
Furthermore, the current heteronormative vision of sexuality (i.e., the vision that sexual and 
marital relations are between a man and a woman) limits the way we think about sexuality 
and/or capturing its experience and meaning. For instance, the current questionnaires 
assessing sexuality can only be filled in by persons in a heterosexual relationship (e.g., “Do 
you find your vagina is so tight that your partner’s penis can’t enter it?” for women and “How 
often were you able to penetrate (enter) your partner?” for men). In addition, sexuality should 
be seen from a biopsychosocial perspective, hereby taken into account QoSL. Moreover, 
the relationship between psychosocial factors (e.g., self-esteem, body image, fatigue, loss of 
independence, depressive symptoms, personality characteristics, and the partners’ feelings 
about the patients’ disease or appearance) and sexual (dys)function and/or QoSL in patients 
with colorectal cancer should be investigated more extensively. Also, though patients with 
colon cancer may have better functional results, it can be expected that they suffer from 
psychosocial problems to the same extent as patients with rectal cancer.
Additionally, little is known on how partners of patients with colorectal cancer cope with 
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known that a SD and the lack of affection are some of the most commonly identified marital 
problems in couples with an ill partner.110 In addition, it would be interesting to investigate if 
there are non-sexual forms of intimacy which may replace sexual activity but still enable a 
couple to experience companionship and maintain a satisfactory relationship. Relationship 
satisfaction is an important aspect of psychological well-being and thus quality of life. A 
diminished marital satisfaction may therefore diminish quality of life. Overall, knowledge 
on these topics is a prerequisite for providing adequate support for patients with colorectal 
cancer and their partners.
Finally, colorectal cancer is a disease which mostly affects the elderly. There has been an on 
going debate on whether or not SD in a higher age is normal or pathological.111 A recent cross-
sectional study reported lower SF for patients with colorectal cancer compared with an age-
matched general population.112 This may indicate that colorectal cancer causes an additional 
negative effect on SF. Future research should investigate the effect of sociodemographic 
variables, such as age and sex, more extensively. There is an important task for researchers to 
provide more information on the potential effects of a colorectal cancer diagnosis and/or the 
effects of treatment to health care professionals so they in turn can inform patients on the 
possible outcomes of multimodality treatment. Information about the nature of treatment, 
including the side effects (both biological and psychosocial) that can occur, provides patients 
the opportunity to include sexual issues in the decision-making process.113 However, only 1 
out of 10 patients remembered discussing sexual effects of treatment prior to surgery.99 If the 
health care professional initiates such a discussion this may act in an empowering way to give 
license to patients to discuss these issues.
Conclusion
Most studies on sexual (dys)function following colorectal cancer surgery suffer from 
methodological problems, such as a cross-sectional design, a small sample size, and the use 
of non-standardized measurements. In future research, sexuality should be investigated 
prospectively from a biopsychosocial model. In this biopsychosocial model the subjective 
evaluation of sexual (dys)function, hence QoSL, and psychological factors associated with or 
predictive of sexual (dys)function and QoSL should be taken into account.
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RC V RT for rectal 
cancer (n=172)
CS - + - - + + + - - + - - + - + 7 NS Sexual interest was equally impaired in the 
RT+ compared with the RT- group. RT+ women 
reported more vaginal dryness, dyspareunia, and 
reduced vaginal dimension, they did not have 
more worries about their sex life.
Celentano et 
al. 201071
RC B Rectal cancer 
(n=20)
P 24 + + - - + + - - - - + + + - - 7 IIEF Erectile function was not different at 2 year 
follow-up. In the group with no nerve damage 
13% developed erectile dysfunction. All patients 




RC VB Coloanal 
anastomosis 
(n=85) versus 
APR ( n =83)
CS + - + + + - - - - + - - + - + 7 EORTC QLQ-
CR38
SF scores in men and women were lower for APR 
patients compared with patients with a coloanal 
anastomosis.
Song et al. 
201072







+ + - - + + - - - + + + + - + 9 IIEF-5 In both groups the total IIEF-5 score decreased 
postoperatively, the decline was worse for the 
PRT+ group compared with the surgery alone 
group. For the PRT+ group, APR and a lower 
cancer resulted in a lower total score compared 
with LAR and upper rectal cancer groups.
Stephens et 
al. 201036
RC B PRT versus 
PCRT (n=353)
RCT 36 + - - - + + - - - + + + + - + 8 EORTC QLQ-
CR38
Male SD increased from 6 to 24 months 
postoperative, which was larger for the PRT 
group compared with the PCRT group. 
Akasu et al. 
200973
RC B TME with or 
without PANP 
and ELD (n=55)
P 12 - + - - + - - - - - + - + - + 5 NS The degree of erectile function at one year 
follow-up depended on the extent of both PANP 
and ELD.
Asoglu et al. 
200998
RC VB LTME versus 
TME (n=63)
CS + + + + + + - - - - - - - + - 7 IIEF Preoperatively 92% of women and 95% of men 
were sexually active. Overall SD was higher in 
LTME versus TME with regard to the ability to 
ejaculate for men and with regard to vaginal 
secretion and dyspareunia for women. Both men 




RC VB Stoma (n=51) 
versus non-
stoma (n=70)
CS + - + + + + - - - + - - + - + 8 EORTC QLQ-
CR38
The men had a higher median score on sexual 
problems and a lower median score on SF. Only 
33% of women answered questions regarding SF.
Ellis et al. 
200984





CS + + - + + + + - - + - - + - + 9 IIEF-5 One third was sexually active in the past 6 
months. Erectile problems were reported by 
75%. Erectile dysfunction was associated with 
increased age, having a malignancy below the 
recto-sigmoid junction, radiotherapy, and having 
a stoma.
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Jones et al. 
200985
RC B LTME (n=101) CS - + - - + + - - - + - - - - - 4 NS SD was present in 11% in the APR group 
versus 5% in the (ultra)LAR group. Few men 
experienced retrograde ejaculation (n=4) or 
erectile dysfunction (n=2).
Lange et al. 
200920
RC VB TME with or 
without PRT 
(n=757)
RCT 24 - + + + + + + - - + + + + + + 12 NS Of men, >70% reported an increased general SD, 
erectile dysfunction, and ejaculatory problems. 
Risk factors were nerve damage, blood loss, 
anastomotic leakage, PRT, and the presence of 
a stoma. Women also reported SD (62%), i.e., 
dyspareunia and vaginal dryness. SD in women 
was associated with PRT and the presence of a 
stoma.
Morino et al. 
200922
RC B LTME (n=45) CS + + - - + + + - - - - - + + + 8 IIEF Sexual desire was maintained by 56% of 
men. The ability to engage in intercourse was 
maintained by 58%. Ejaculation and orgasm were 
maintained by 37%. Distance of the tumor from 
the anal verge and (neo)adjuvant treatments 
were predicted poor postoperative SF.
Parc et al. 
200938
RC VB AR with or 
without PRT 
(n=297)
RCT 24 - - + - + + - + + + + + + - + 10 NS PRT+ men had worse SF compared PRT- men at 
24 months follow-up. No significant differences 
were observed for women. 
Pietrangeli 
et al. 200974




P ? + + + + - + - - - - + - + + + 9 IIEF SD was reported by 60% of patients. Impotence 




CRC V Ostomy group 
(n=30)
CS - + - + - + - - - - - - + - - 4 NS Three women reported that sexual intercourse 
was no longer important to maintain a 
harmonious marital relationship. Seven women 
experienced long term sexual difficulties 




RC B TME versus 
LTME (n=56)
P 12 - + - - + + - - - - + - - - + 5 IIEF The groups did not differ regarding SF. For the 
total group, sexual desire, erectile function, and 
the ability to achieve orgasm was worse at 12 
months. Sexual desire was better at baseline, 3, 
and 6 months for the LAR group versus the APR 
group. 
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Tekkis et al. 
200921
RC V AR versus APR 
(n=295)
P 60 - + - - + + + - - + + - + - + 8 NS The APR group had worse results: At one year 
follow-up they were less sexually active. Those 
who were active had a lower frequency of 
intercourse, which improved over time. At 8 
and 12 months they were less likely to achieve 
arousal. Dyspareunia increased during the four 
years follow-up. At 8 months they were less 
likely to achieve orgasm, which improved over 
time. For the AR group dyspareunia became 
worse after 5 years. APR, PRT, intra-abdominal 
sepsis, and age ≥65 years were associated with 
significant impairments in female SF.
Trninic et al. 
200964
CRC VB Stoma (n=25), 




CS + - + + - + - + - + - - + - + 8 EORTC QLQ-
CR38
Sexual enjoyment was less in the colostomy 
and the non-colostomy group compared with 
the healthy population. Female SD was worse 
in the stoma group compared with the healthy 
population. 
Varpe et al. 
200939
RC VB Rectal cancer 
(n=56)
P 12 - - + + + - - - - - + - + - + 6 NS SD did not cause a significant worsening of 
quality of life. Of men, 67% reported satisfactory 
preoperative sex life, compared with 37% 
postoperatively. 
Bohm et al. 
200895
CRC V TME (n=6) 
versus colonic 
resection (n=6)




RC V PRT and TME 
(n=4) versus 
controls (n=18) 
CS - + - - + - - - - - - - + - + 4 QSD The changes in genital and subjective sexual 
excitement after erotic stimuli between 




RC B LTME (n=9) P 15 + + - - + + - - - - + + + - + 8 IIEF Intercourse satisfaction was the only IIEF domain 
which decreased significantly postoperative. 
Cotrim et al. 
200865




CS + - + + + + - - - + - - + - + 8 EORTC QLQ-
CR38, ISS
Only sexual satisfaction was lower for patients 
with a stoma than patients without a stoma.
Di Fabio et 
al. 200866
CRC VB CRC group 
(n=62)
CS + - + + + + - + - - - - + - + 8 EORTC QLQ-
CR38
Of patients with colon cancer 61% reported ‘no 
sexual problems’ versus 24% of those with rectal 
cancer. 
Gervaz et al. 
200840
RC VB APR (n=20) P 12 + - + + + + - - - - + - + - + 8 EORTC QLQ-
CR38
Twelve months after surgery no improvements in 
SF were found. 
Liang et al. 
200869




P 6 + - + + + + - - - + + - + - + 9 IIEF, FSFI No significant changes before and after PANP 
were found regarding SF in both men and 
women.
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Nitori et al. 
200886
CRC B TME (n=39) 
versus LTME 
(n=29)
CS - + - - + + - - - - - - + - + 5 NS Arousal, erectile function, ejaculation, and 
satisfaction decreased both after LTME and TME, 
but there were no differences between groups 
in terms of change. The only significant factor 
affecting SF was tumor location.
Perera et al. 
200882








- + + + - + - - - - + + + - + 8 NS Compared with women, men reported more 
SD. In men, 50% reported erectile dysfunction 
after rectal excision, compared with 33% in 
the colectomy group. In women, 6% reported 
dyspareunia and 19% reported reduced orgasm 
after rectal excision compared with none of the 
patients having had a colectomy.
Phipps et al. 
200870
CC VB Long-term 
survivors (n=20)
CS + - + + + + + - - - - - + - + 8 NS Of survivors, 67% attributed their problems 
with SF to having had colon cancer. Of those 
problems attributed to colon cancer, SF was 
given one of the highest severity rankings by 
survivors.
Segalla et al. 
200834




P ? + - + + - + + + - + + - + - - 9 EORTC QLQ-
CR38
Women’s perception of sexual enjoyment 
worsened during follow-up. For men, worsening 
of their perception of SF and sexual enjoyment 
was observed.
Zajac et al. 
200841
RC VB Stoma patients 
(n=50)
CS + - + + - - - - - - - - + - - 4 EORTC QLQ-
CR38
A negative influence of stoma on SF in men was 




RC VB LTME and LAR 
(n=38) versus
LTME and APR 
(n=13) 
P 12 + - + + + + - + - - + - + - + 9 EORTC QLQ-
CR38
SF, male and female SD were worse from 
3 months until 12 months after surgery. 
Postoperative sexual enjoyment was the worst 
at 3 months and the best at 6 months follow-up. 
Patients who underwent LAR experienced less 
SD than patients after APR. 
Doorne- 
bosch et al. 
200743





CS + - + + + + - + - - - - + - + 8 EORTC QLQ-
CR38
Between TEM and TME no significant differences 
were found for SF, sexual satisfaction, male and 
female SD.
Farroni et al. 
200744







CS + - + + - + - + - - - - + - + 7 EORTC QLQ-
CR38
Patients with abdominal colostomy or a perineal 
colostomy with appedictostomy did not differ on 
SF, sexual enjoyment, and male SD. Females did 
not answer questions concerning female SD. 
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Fazio et al. 
200745 
RC VB Coloanal 
anastomosis 
with or without 
a reservoir 
(n=297) 
P 24 - - + + + + - + + + + + + - + 11 NS Compared with baseline, male SF declined in 
both groups with low scores at 24 months. At 
12 and 24 months more women were sexually 
active in the Coloplasty compared with the 
J-Pouch group. 
Kneist et al. 
200746
RC B ANP + TME 
(n=26)
CS + - - - + + - - - - - - + - + 5 IIEF Postoperative erectile dysfunction (27%) was 
associated with micturition disturbance in 57%. 
Men with negative results on intraoperative 




RC VB PRT (n=58), 
versus PCRT 
(n= 60)
RCT 7 - - + + + - - - + + + - + - + 8 NS SF did not differ between patients receiving PRT 
and those receiving PCRT. However, patients 
indicated that their treatment worsened their SF.
Pocard et al. 
200748







CS + - + - + + - - - - - - + - + 6 EORTC QLQ-
CR38
Patients with coloanal anastomosis reported 
equivalent results with regard to SF, sexual 
enjoyment, and male and female SD compared 
with patients with a perineal colostomy.
Ross et al. 
200723





P 24 + - + + + + + - - + + + + - + 11 EORTC QLQ-
CR38
Only male SD was significantly worse for men 
with a stoma compared with men without a 
stoma. Having a stoma formed during follow-up 




RC VB Preoperative 
chemotherapy 
(n=81)
P ? + - - + + + - + - + + - + - - 8 EORTC QLQ-
CR38
Of patients, 63% reported to have no sexual 
desire nor had sexual activity 4 weeks previous 
to treatment. Moderate limitations were seen for 
SF and sexual enjoyment. None of the women 
answered questions regarding female SD. Male 
SD increased during the follow-up period.
Col et al. 
200687
RC B Resection 
(n=78) versus 
resection + ELD 
(n=13)
CS + + - - + + - - - + - - + - + 7 IIEF All IIEF domains decreased after surgical 
treatment. No differences were found between 
the treatment groups. Patients with a colostomy 
reported worse scores on all IIEF domains 
compared with patients without a colostomy.
Daniels et al. 
200696
RC V TME (n = 18) CS - + - - + - - + - - - - + - + 5 NS Preoperatively, 28% of women were sexually 
active. Postoperatively these women remained 
sexually active, although all described some 
discomfort with penetration. Two women 
described that their sexual desire was reduced 
due to the presence of a stoma.
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Kyo et al. 
200629
RC B PANP with ELD 
(n=37)
CS - - - - + - - - - - - - + - + 3 NS Among sexually active men 90% with ELD and 
50% without ELD maintained sexual activity, 
ejaculation was maintained by 90% and 70% 
respectively. Reduced sexual satisfaction was 
reported by 50% of patients who underwent 
LAR or Hartman procedure without LND and all 
patients with APR or LND.
Vironen et 
al. 200650 
RC VB HAR (n=15), 
versus LAR 
(n=39) or APR 
(n=28)
CS - - + + + - + + - + - - + - + 8 NS SD was more common after APR than after LAR 
or HAR. Overall, 63% of men and 50% women 
who had been sexually active before surgery 
reported changes in SF. 
Ameda et al. 
200588
RC B AR (n=15) 
versus APR 
(n=13)
CS - + - + + - - + - - - - - - + 5 NS Of men, 88% had some deterioration in erectile 
function, regardless of surgical treatment. 
Overall, 64% of men were unsatisfied with their 
current SF.
Allal et al. 
200551
RC VB PRT and surgery 
for LARC (n=53)
P 12 + - + + + + - + - - + + + + + 11 EORTC QLQ-
CR38
Only male SD increased postoperative, to a 








CS + - + + + + - + - + - - + - + 9 EORTC QLQ-
CR38
Less SD was seen after a colo-anal J-pouch 
anastomosis (CPA) compared with a low colo-
rectal anastomosis (LRA) and APR. Retrograde 
ejaculation occurred in 10% of men, and 
impotence in 22%. Women reported dyspareunia 
in 12%.
Guren et al. 
200553
RC VB AR (n=229) or 
APR (n=90)
CS + - + + + + - + - + - - + - + 9 EORTC QLQ-
CR38
Only male SD increased after APR compared 
with AR or AR, 84% reported to have been 
sexually active the last 4 weeks compared with 
26% of APR patients. 
Hendren et 
al. 200599
RC VB Curative 
surgery (n=180)
CS + + + + + + + + - + - - + - + 11 FSFI, IIEF, 
EORTC QLQ-
CR38
Surgical treatment deteriorated SF. Of women, 
61% had a total score more than 1 SD below 
the normal population. 67% of men had an 
abnormal total IIEF score. Current age, surgical 
procedure, and preoperative sexual activity were 
independently associated with current sexual 
activity. Sex, surgical procedure, and RT were 
associated with a deteriorated SF. 
Heriot et al. 
200576
RC B PRT+ (n=101) 
versus PRT- 
(n=100)
P 48 - + - - + + + - - + + + - - + 8 NS The patient’s age, adjuvant RT, T-stage, and time 
of measurement predicted SF. A significant 
variability in SF was present among the 7 time 
points with a maximal deterioration at 8 months. 
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Jayne et al. 
200567






RCT 18 + - + + + + + - - + + + + - + 11 FSFI , IIEF, 
EORTC QLQ-
CR38
No significant differences were found on the 
IIEF and the FSFI domain scores between the 
laparoscopic versus open rectal surgery. Male SD 








CS + - + + + + - - - - - - + - + 7 NS Patients who received PRT with TME had a 
higher male SD compared with the TME alone 
group. Female SD was not statistically different 
between the two treatment groups. 
Schmidt et 
al. 200532





P 24 + + + + + + - - + + + + + - + 12 NS APR and AR with Pouch affected SF more than 
AR and resection of the lower sigmoid. Men 
scored lower on sexual enjoyment than women. 
Patients aged ≤ 69 years experienced more 
stress through deterioration in SF than older 
patients.
Sterk et al. 
200530
RC B  TME (n=29) P 3 - + - + - - - - - - + - - - - 3 NS Of the preoperatively potent men, 30% had SD 
postoperatively. No associations were found 
between postoperative impotence (n=8) and the 
age of patients at the time of surgery. Two men 
reported retrograde ejaculation.
Platell et al. 
200428
CRC V RC (n=22) 
versus 
CC (n=19)
CS - + - - - + - - - - - - - - + 3 NS The rectal cancer group experienced more SD 
compared with the colonic surgery control 
group. They felt that their vagina was to short or 
less elastic and experienced more pain or fecal 
soiling during intercourse. 
Shirouzu et 
al. 200455
RC B TME + PANP 
(n=49) versus 
TME (n=80)
P 3 - - - - + + - - - + + + - + + 7 NS After TME with PANP the majority of men 
preserved erectile and ejaculatory functions 
(79% and 65%, respectively). Permanent damage 
was seen after TME without PANP. 
Maeda et al. 
200389
RC B TME (n=5) 
versus
TME + ELD 
(n=37)
CS - + - - + + - - - - - - + - + 5 NS Of the preoperative sexually active men 27% 
in the TME + ELD group and 20% in the TME 
alone group had partial or total impotency after 
surgery. Retrograde ejaculation occurred in 11% 
and 25%, respectively.
Bonnel et al. 
200290
RC B AR + TME with 
PRT (n=15) or 
without PRT 
(n=24)
CS - + - - + + - - - - - - + - + 5 NS Preoperatively sexually active men who received 
PRT were less sexually active postoperative. No 
differences were found for diminished libido, 
erectile and ejaculatory problems.
Chatwin et 
al. 200256
RC VB LAR +PRT 
(n=16) versus 
LAR (n=27)
CS - - + + + - - - - - - - + - + 5 NS SD was reported by 5/84 sexually active men 
and 1/4 sexually active women in the surgery 
alone group and by 4/5 sexually active men and 
1/7 sexually active women in the PRT group.
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Kim et al. 
200277
RC B TME with PANP 
(n=68)
P 8.7 ± 
4.8
+ + - - + + + - - - + - + - + 8 IIEF The average IIEF score, intercourse satisfaction, 
orgasmic functioning, sexual desire, and overall 
satisfaction decreased postoperatively. An 
age ≥60 years predicted sexual desire, within 
6 months after surgery predicted intercourse 
satisfaction and orgasmic function, and lower 
rectal cancer predicted erectile function, 
intercourse satisfaction, and orgasmic 
functioning.
Kuzu et al. 
200257
RC VB APR (n=75), LAR 
(n=51), 
AR (n=52)
CS + - + + + + - - - + - - + - + 8 NS After APR patients were less sexually active and 
for those who were sexually active had a lower 
frequency of intercourse, compared with AR and 
LAR.
Pocard et al. 
200278
RC VB AR without PRT 
(n=20)
P 12 - + + + + + - + - - + - + - + 9 NS Of women, 69% were sexually active before 
surgery. Sexual activity, sexual desire, and the 
ability to achieve orgasm was unchanged in 
these women. No dyspareunia was reported. 
Of men, 69% were sexually potent in the 
preoperative period. Sexual activity, the ability to 
achieve orgasm, and potency were unchanged in 
these men.
Quah et al. 
2002100
RC VB LTME versus 
(n=21)
TME (n=28)
CS + + + + + - - - - + - - + - + 8 IIEF LTME was associated with a higher rate erectile, 
ejaculatory, and overall SD in men, compared 
with open surgery. One woman in the TME group 
became sexually inactive after surgery. Another 
woman reported dyspareunia after LTME, but 




RC VB TME (n=65) P 12 + - + + + + - + - - + - + + - 9 EORTC QLQ-
CR38
Compared with baseline, sexual enjoyment and 
male SD were worse up to one year follow-up. SF 
was only worse at 3 months follow-up.
Guren et al. 
200159





CS + - + + + + - + - - - - + - + 8 EORTC QLQ-
CR38
The two groups did not differ with regard to any 
evaluable scale or single items of the EORTC 
QLQ-CR38. 
Maurer et al. 
2001101




CS - + + + + + - - - - - - + - + 7 NS Compared with conventional surgery, TME 
preserved the ability to achieve orgasm and to 
ejaculate. Preserved erectile function and less 
functional deterioration (sexual activity and 
interest in sex) was more common in the TME 
group. Few women answered the SF questions.
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Mannaerts 
et al. 200181




CS - + + + + + + + - + - - + - + 10 NS Patients were asked about current and 
preoperative functioning. Sexual desire 
decreased in men from 80% to 37% and in 
women from 63% to 26%. Both preoperative 
and postoperative SD was higher in women. The 
preoperative ability to achieve an orgasm had 
disappeared in 45% of patients after treatment 
for locally advanced primary and 57% of patients 
after treatment for locally recurrent rectal 
cancer. An age >60 years significantly reduced 
the ability to have an orgasm postoperatively, as 
well as the ability to have sexual intercourse.
Shah et al. 
200168
CRC B Recectable RC 
(n=31)
P 6 - - - - + + - - - - + - + - + 5 NS All men, except one, were sexually active. 
Postoperative impotence was reported by 13% 
of men.
Allal et al. 
200060
RC VB AR with PRT 
(n=11) versus
APR with PRT 
(n=11) 
CS + - + + + + - - - - - - + - + 7 EORTC QLQ-
CR38
SF was low in both the APR and the AR group. 
In men, SD was higher in the APR group, though 
this result was not significant. None of the 




RC VB Curative 
procedures 
(n=52)
CS - + + + + + + - - - - - + - - 7 NS After local excision SD was not reported. After 
LAR one patient reported SD. After APR 33% 
reported SD, whereas 75% treated with APR and 




RC VB RC patients 
with PANP 
(n=36)




RC VB TME (n = 39) 
or partial TME 
(n=10)
P 6 - + + + + - - - - - + - + - + 7 NS Men reported some reduction in erectile 
function (6/27) and one became impotent. Two 
men reported retrograde ejaculation. Women 
reported a reduction in sexual desire and sexual 
activity. 
Maas et al. 
199862
RC VB Patients after 
PANP (n=41)
P 6 - - + + + - - - - - + - + - + 6 NS 3/11 women and 19/30 men were sexually 
active. Postoperative, dyspareunia was 




RC VB TME + PANP 
(n=81)
CS - + + + + + + - - + - - + - + 9 NS The ability to have intercourse was maintained 
by 86% of patients <60 years and by 67% of 
patients aged ≥60 years. Age <60 years was 
associated with more sexual activity, while type 
of surgery (APR versus LAR) was related with the 
ability to have an erection. For women sexual 
activity declined with age. 
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Masui et al. 
199683
RC B PANP (n=134) CS - + - - + + - - - + - - - - + 5 NS Patients undergoing complete PANP showed 
higher rates of erectile function (93%), 
ejaculatory function (83%), sexual intercourse 
(90%), and orgasm (94%) compared with 
patients undergoing hemilateral PANP (for 
which rates were 83%, 47%, 53%, and 65%, 
respectively) or partial pelvic plexus-preserving 
operation (62%, 0%, 26%, and 22%, respectively).
Sugihara et 
al. 199663
RC B PANP (n= 64) CS  - - - - + - - + - + - - + - + 5 NS For men, complete SF was maintained by 33% 
while 37% were not able to perform sexual 
intercourse. The degree of SD (erection, sexual 




RC B Rectal cancer 
group (n=16)
P 4 - + - - + - - - - - + - - - - 3 NS Normal SF was reported by 7 men. Two men had 
erections but were not sexually active, 2 had 
partial erections and were not sexually active, 
and 2 were having intercourse despite only 
partial erections. Three men became impotent.
Cosimelli et 
al. 1994103
RC VB Rectosigmoid 
cancer (n=246)
CS 12 - + + + + - - - - + - - + + + 8 NS Overall, 47% of patients maintained satisfactory 
sexual activity. Erectile en ejaculation capacity 
was retained by 26% and 39% of men. A higher 
age and a colostomy were associated with less 
sexual activity.
Filiberti et al. 
199491




CS - + - - - + - + - - - - + - + 5 NS Sphincter preserving surgery might prevent 
neurogenic impotency at a higher rate. 
Impotency was reported by 10% of patients, 
ejaculation was also widely affected (90%).
Enker et al. 
199231
RC B LAR (n=38) P 19.6 
(4-85)
- + - - + + - - - - - - - - - 3 NS Most men remained potent (88%) and 88% of 
men remained normal ejaculation.
Hojo et al. 
199180
RC B Rectal cancer 
group (n=78)
P 12 - + + + + - - - - + + - + - - 7 NS In men aged <60 30% recovered erectile function 
and 19% recovered ejaculatory function at 




CRC B Colorectal 
cancer group 
(n=60)
CS - + - - + + - - - - - - + - + 5 NS Sexual activity was suppressed in 32%. Of these, 
25% had no ejaculation and penetration and 25% 
had no erection.
A higher incidence of SD after APR (54%) 
compared with AR (15%) was found.
Abbreviations: CR = Rectal Cancer, CC = Colon Cancer, CRC = ColoRectal Cancer, V = Women, B = Men, 
P = Prospective study, CS = Cross-Sectional study, NS = Not Standardized, SD = Sexual Dysfunction, SF = 
Sexual Functioning, LTME = Laparoscopic Total Mesorectal Excision, TME = Total Mesorectal Excision, TEM 
= Transanal Endoscopic Microsurgery, AR = Anterior Resection, LAR = Low Anterior Resection, HAR = High 
Anterior Resection, APR = Abdominal Perineal Resection, PANP = Pelvic Autonomic Nerve Preservation, PRT 
= Preoperative Radiation Therapy, PRT+ = Patients who underwent preoperative radiotherapy, PRT- = Patients 
who did not underwent preoperative radiotherapy, PCRT = Preoperative Chemo Radiation Therapy, ELD = 
Extended Lateral pelvic lymph node Dissection, EORTC QLQ-CR38 = European Organization for Research on 
Treatment of Cancer Quality of Life Questionnaire ColoRectal Cancer specific, IIEF = International Index of 
Erectile Function, IIEF-5 = International Index of Erectile Function abbreviated version, FSFI = Female Sexual 
Function Index, QSD = Questionnaire for Screening Sexual Dysfunction, ISS = Index of Sexual Satisfaction.
Note: * Only the design, instruments and study population used to measure sexual (dys)function are 
mentioned. In case of a prospective study, the follow-up time in months is presented. If the follow-up 
measurement is not standardized, the median follow-up time and range are reported.
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To compare colorectal cancer survivors with a normative population regarding erectile 
dysfunction, ejaculation problems, dyspareunia, dry vagina, sexual functioning (SF), and sexual 
enjoyment (SE). In addition, the sociodemographic, clinical, and psychological correlates of 
(dys)function in survivors are examined.
Methods
Sexuality subscales of the European Organization for Research and Treatment of Cancer 
(EORTC) module Quality of Life Questionnaire – Colorectal 38 (QLQ-CR38) were completed 
by survivors (n=1371; response rate 82%), of which 1359 received surgical treatment and were 
included in analysis. The normative population consisted of 400 participants (response rate 
78%). 
Results
Erectile problems were more often present in rectal cancer (54%) than colon cancer survivors 
(25%) and the normative population (27%; p<.001). They also had more ejaculation problems 
(68%) than colon cancer survivors (47%; p<.001). Dry vagina was common in colon (28%) and 
rectal cancer survivors (35%), while the normative population scored lower (5%; p=.003). 
In addition, colon (9%) and rectal cancer survivors (30%) experienced more pain during 
intercourse than the normative population (0%; p=.001). SE for men was similar across groups, 
while women with colorectal cancer reported lower scores than the normative population. 
Higher age, being a woman, not having a partner, a low educational level, rectal cancer, 
depressive symptoms, and fatigue were associated with lower SF. Lower SE was associated 
with higher age, being a woman, depressive symptoms, and cardiovascular disease.
Conclusion
SF was deteriorated in both sexes after cancer, which affected women’s SE negatively. Attention 
towards sexual (dys)function in colorectal cancer survivors is needed.
Introduction
Colorectal cancer is the third most common cancer in men (10%), and the second most 
common cancer in women.1 Due to medical advances about 62% of the patients will become 
long-term survivors2,3, especially in younger cohorts.4
Conventionally, outcomes assessment in colorectal cancer included mortality, morbidity, 
disease recurrence, and long-term survival. However, patient-reported outcomes (e.g., quality 
of life) are now also regarded as key measurements in assessing outcomes of interventions.5 
Sexuality and intimacy are considered to be important aspects of quality of life.6 The majority 
of colorectal cancer survivors remain sexually active.7 However, survivors do experience 
sexual dysfunction, which may be caused by surgical treatment, radiochemotherapy7-9, or the 
presence of a stoma.7 In addition, sexual functioning and sexual satisfaction are influenced by 
the presence of depressive symptoms, anxiety, and fatigue.10-12
In a recent literature review (n=82), about half of the studies had small samples sizes (n<75) 
and presented data for both men and women.7 In addition, only four studies have used a 
healthy population as a control group.13-16 Since, the majority of studies did not include an 
age-matched normative population, it is often unclear whether sexual dysfunction is purely 
related to age or comorbidities. Therefore, the aim of this large population-based study was to 
examine (i) the prevalence of erectile dysfunction, ejaculation problems, dyspareunia, and dry 
vagina in colon and rectal cancer survivors and a normative population, (ii) to compare sexual 
(dys)function between these three groups, and (iii) to describe the sociodemographic, clinical 
and psychological correlates of sexual (dys)function in survivors.
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Figure 1  Flow-chart of the data collection process in colorectal cancer survivorsMethods
Participants
The Eindhoven Cancer Registry (ECR) records data of all newly diagnosed individuals with 
cancer in the southern part of the Netherlands, an area with 2.3 million inhabitants, 10 hospitals 
with 18 locations and two large radiotherapy institutes.17 Registered individuals diagnosed 
with colorectal cancer between 1998 and 2007 were eligible for participation (n=5580). From 
these survivors, a weighted random selection of 2400 survivors based on tumor, sex, and year 
of diagnosis was made (Figure 1). These weights were derived from the distribution of colon 
and rectal cancer survivors in the normative population. Survivors with shorter duration since 
diagnosis were oversampled for inclusion in future follow-up assessments. After excluding 
survivors who had cognitive impairment or who had died, data collection started in January 
2009. Survivors were informed of the study via a letter from their (ex)attending surgeon. A 
Medical Ethics Committee approved this study. Participants provided informed consent.
The normative sample was derived from CentERdata (an online household panel). In total, 
1731 (81%) members of this panel completed questionnaires.18 The description of the data 
collection is given elsewhere.18 For this analysis, an age-matched normative population (n=400), 
in which a similar distribution of ages as in the survivor sample was obtained, was included. The 
data will be available for non-commercial scientific research, subject to study question, privacy 
and confidentiality restrictions, and registration (www.profilesregistry.nl).19
Measures
Survivors’ sociodemographic and clinical information (i.e., date of diagnosis, Tumor-Node-
Metastasis classification20, clinical stage20, treatment) was available from the ECR. Living 
situation, education, work situation, length and weight, and life style factors were completed 
in the questionnaire. An adapted Self-administered Comorbidity Questionnaire (SCQ) was 
completed.21 Disease-specific issues were assessed with the European Organization for Research 
and Treatment of Cancer (EORTC) module Quality of Life Questionnaire – Colorectal 38 (QLQ-
CR38).22 The QLQ-CR38 comprises 38 questions, of which 19 are completed by all survivors and 
the remaining by subsets of survivors (men or women; survivors with/without a stoma). The 
QLQ-CR38 assesses both functioning (Weight loss, Body Image, Sexual Functioning (SF), Sexual 
Enjoyment (SE), Future Perspective) and symptom burden (Micturition Problems, Defecation 
Problems, Gastrointestinal Symptoms, Stoma-related Problems, Chemotherapy Side effects, 
Male SF, Female SF). The items have a 4-point rating scale ranging from 1 (not at all) to 4 (very 
much). Scales were linearly converted to a 0-100 scale. Higher scores on functional items/
scales indicate better functioning, while higher scores on symptom item/scale indicate higher 
symptom burden. In this study, SF, SE, and male SF or female SF were analyzed. 
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The Fatigue Assessment Scale (FAS)23 is a 10-item questionnaire assessing perceived fatigue 
and exhaustion. Five questions of the FAS reflect physical fatigue and five assess mental 
fatigue. The response scale is a 5-point rating scale ranging from 1 (never) to 5 (always). Scores 
on the FAS range from 10 to 50. The psychometric properties are good.24-27 
Symptoms of anxiety and depression were evaluated with the 14-item Hospital Anxiety and 
Depression Scale (HADS).28 This self-report questionnaire contains two 7-item subscales 
designed to measure symptoms of anxiety and depression. The scale was developed for use in 
patients suffering from bodily disease and therefore, symptoms of somatic reference such as 
pain and fatigue were excluded. The psychometric properties are good. 29,30
The normative sample completed a sociodemographic questionnaire, the SCQ, and the 
EORTC QLQ-CR38 sexuality questions, except for the item on ejaculation difficulties since 
the CentERpanel strongly advised not to include this specific item due to practical and ethical 
considerations. 
Statistical analyses
Chi-square tests and independent student t-tests were used to compare both sexes on 
sociodemographic and clinical characteristics (for colon-, rectal cancer survivors, and the 
normative population separately) and sexually active survivors with survivors who were not 
sexually active. To determine the prevalence of sexual problems, the scores on the subscales 
were dichotomized. Participants who reported no problems or minor problems (not at all 
– a little bit) were categorized as not having sexual problems, while patients who reported 
quite some problems or severe problems (quite some–very much) were categorized as having 
sexual problems. Analyses of Variance (ANOVA)’s compared the sexuality subscales, for 
men and women separately. Post-hoc tests were corrected with the Bonferonni method. 
Finally, multivariate linear regression models (method: Enter) investigated whether a priori 
determined sociodemographic characteristics (age, sex, having a partner, educational level, 
Body Mass Index (BMI), being a smoker), clinical and psychological characteristics (site of 
cancer, type of treatment, years since diagnosis, disease progression, having a stoma, having 
cardiovascular disease, having diabetes mellitus, fatigue, anxiety, and depression) were 
associated with SF, SE, male SF and female SF. Assumptions were checked. SF was analyzed for 
the entire group, while the other scales were only examined for the sexually active survivors. 
Means and standard deviations are provided as (M±SD). Statistical differences were indicated 
if p<.05 (two-sided). A difference of >0.5 SD was considered indicative of clinical meaningful 
differences between groups.31 All statistical analyses were performed using SPSS17.0.
Results
In total, 1371 (82%) survivors completed the questionnaire. Eventually, 1359 survivors treated 
with surgery (with or without (neo)adjuvant therapy) were included. Non-respondents were 
significantly older (72±10) and more often women (55%) than respondents (70±10, 43% female) 
and those with non-verified addresses (69±11, 44% female). These groups did not differ on 
clinical aspects.
Male participants were more often partnered and more highly educated, while they less 
often had arthrosis and back pain than women (Table 1). In addition, female colon cancer 
survivors were more often depressed and less sexually active than men. Male rectal cancer 
survivors were more often smokers than their female counterparts.
Sexually active participants were significantly younger, more often partnered, and had a 
higher educational level than participants who were not sexually active. In addition, sexually 
active men less often had a stoma and sexually active women less often reported comorbidities 
(Table 2). 
The normative sample consisted of 224 men and 156 women (response rate 78%). Men 
were older (70±10) than women (67±11, p=.009), were more often partnered (80% versus 65%, 
p=.001), and were more often sexually active (64% versus 45%, p<.001). Further information is 
published elsewhere.32 33
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Mean±SD Mean±SD Mean±SD Mean±SD
Age at time of survey 70.4 ± 9.2 69.9 
±10.1
.486 68.6 ± 9.4 67.6 ± 
10.1
.298
Years since initial 
diagnosis
3.9 ± 2.4 3.9 ± 2.5 .701 3.9 ± 2.5 4.2 ± 2.6 .168
BMI 27.0 ± 3.9 27.0 ± 5.5 .961 26.4 ± 4.2 26.0 ± 4.7 .491
N (%) N (%) N (%) N (%)
Having a partner
Yes 382 (82) 238 (55) <.001 248 (84) 107 (67) <.001
Missing 15 (3) 19 (4) 7 (2) 7 (4)
Sexually active
Yes 243 (52) 136 (31) <.001 140 (47) 59 (37) .063
Missing 47 (10) 78 (18) 24 (8) 22 (14)
Educational levela <.001 <.001
Low 114 (24) 45 (10) 79 (27) 15 (9)
Medium 251 (54) 246 (57) 168 (57) 102 (64)
High 82 (18) 116 (27) 41 (14) 35 (22)
Missing 21 (5) 27 (6) 9 (3) 8 (5)
Currently smoking 53 (11) 35 (8) .099 43 (15) 12 (8) .029
Stage of cancer .076 .731
1 119 (25) 82 (19) 123 (41) 63 (39)
2 198 (42) 195 (45) 88 (30) 46 (29)
3 124 (27) 136 (31) 77 (26) 48 (30)











N (%) N (%) N (%) N (%)
Type of treatment .790 .102
Surgery only 334 (71) 297 (68) 67 (23) 33 (21)
Surgery + RT 3 (1) 4 (1) 175 (59) 89 (56)
Surgery + CT 127 (27) 129 (30) 21 (7) 7 (4)
Surgery + RC + CT 4 (1) 4 (1) 34 (11) 31 (19)
Disease progression 32 (7) 30 (7) .965 26 (9) 9 (6) .230
Stoma status .986 .568
Stoma at time of 
surgery
20 (4) 21 (5) 97 (33) 62 (39)




199 (43) 175 (40) .503 127 (43) 76 (48) .331
Lung disease 45 (10) 46 (11) .624 30 (10) 11 (7) .250
Diabetes mellitus 64 (14) 58 (13) .891 35 (12) 21 (13) .677
Arthrosis 90 (19) 148 (34) <.001 57 (19) 55 (34) <.001
Back pain 92 (20) 124 (29) .002 60 (20) 51 (32) .006
Depression 12 (3) 34 (8) <.001 29 (6) 13 (8) .490
Abbreviations: SD = standard deviation, BMI = Body Mass Index, RT = Radiotherapy, CT = Chemotherapy
Note: a Educational level: Low (no or primary school); Medium (lower general secondary education or 
vocational training); High (pre-university education, high vocational training, university). A p-value of <.05 is 
considered significant.
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Mean±SD Mean±SD Mean±SD Mean±SD









Years since initial diagnosis 3.8 ± 2.4 3.9 ± 2.4 .480 3.9 ± 2.5 3.9 ± 2.5 .729









N (%) N (%) N (%) N (%)
Having a partner
Yes 239 (77) 348 (91) <.001 148 (51) 168 (87) <.001
Missing 6 (2) 4 (1) 11 (4) 1 (1)
Educational levela <.001 <.001
Low 65 (22) 38 (10) 99 (35) 26 (14)
Medium 167 (56) 223 (59) 158 (55) 142 (74)
High 69 (23) 115 (31) 28 (10) 24 (13)
Missing 10 (3) 7 (2) 14 (5) 3 (2)
Currently smoking 36 (12) 57 (15) .203 24 (8) 19 (10) .508
Rectal cancer 133 (43) 140 (37) .096 79 (26) 59 (30) .353
Stage of cancer .595 .711
1 105 (34) 112 (29) 67 (22) 47 (24)
2 113 (36) 145 (38) 127 (43) 73 (37)
3 77 (25) 107 (28) 92 (31) 67 (34)
4 16 (5) 19 (5) 13 (4) 8 (4)
Type of treatment .055 .188
Surgery only 157 (51) 195 (51) 169 (57) 91 (47)
Surgery + RT 86 (28) 77 (20) 46 (15) 34 (17)
Surgery + CT 55 (18) 88 (23) 66 (22) 55 (28)

















N (%) N (%) N (%) N (%)
Disease progression 28 (9) 26 (7) .279 20 (7) 14 (7) .833
Stoma status .037 .997
Stoma at time of surgery 60 (25) 53 (17) 43 (17) 31 (17)
Missing 68 (22) 79 (21) 44 (15) 11 (6)
Comorbidity
Cardiovascular disease 147 (48) 158 (41) .112 142 (48) 70 (36) .011
Lung disease 37(12) 30 (8) .071 35 (12) 14 (7) .100
Diabetes mellitus 49 (16) 42 (11) .063 54 (18) 14 (7) .001
Arthrosis 69 (22) 72 (19) .270 118 (40) 57 (29) .020
Back pain 67 (22) 79 (21) .768 92 (31) 63 (32) .719
Depression 14 (5) 15 (4) .702 28 (9) 15 (8) .519
Abbreviations: SD = standard deviation, BMI = Body Mass Index, RT = Radiotherapy, CT = Chemotherapy. 
Note: aEducational level: Low (no or primary school); Medium (lower general secondary education or 
vocational training); High (pre-university education, high vocational training, university). A p-value of <.05 is 
considered significant.
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Figure 2  Comparison of sexual problems (mean scores) in men between (i) colon cancer survivors compared 
with the normative population, (ii) rectal cancer survivors compared with the normative population, 
and (iii) colon versus rectal cancer survivors
* The contrast is significant between patients with colon cancer and the normative population.
† The contrast is significant between patients with rectal cancer and the normative population.
± The contrast is significant between patients with colon cancer and patients with rectal cancer.
Sexual dysfunction 
Male colon (58%) and rectal cancer survivors (51%) were less sexually active than men from the 
normative population (64%, p=.018). For women, 54% of colon cancer survivors were sexually 
active compared with 23% for both rectum cancer survivors and the normative population 
(p=.345). Male rectal cancer survivors had more problems with erectile functioning (54%) than 
colon cancer survivors (25%) and the normative population (27%, p<.001). Furthermore, male 
rectal cancer survivors reported more ejaculation problems (68%) than colon cancer survivors 
(47%, p<.001). Lubrication problems were more common in female colon (28%) and rectal 
cancer survivors (35%) than the normative population (5%, p=.003). In addition, female colon 
(9%) and rectal cancer survivors (30%) experienced more dyspareunia than the normative 
population (0%, p<.001). 
Compared with male colon (29±25) and rectal cancer survivors (26±23), men from the 
normative population had higher scores on SF (38±24, p<.001; Figure 2a). However, SE was 
similar in these groups. Finally, rectal cancer survivors (52±39) reported more problems with 
erectile functioning than colon cancer survivors (31±35, p<.001) and the normative population 
(29±34, p<.001). Female colon (15±19) and rectal cancer survivors (15±18), reported lower SF 
than the normative population (22±24) (p=.020 and p=.010 respectively; Figure 2B), as well as 
lower SE than the normative population (51±29, 49±26 and 66±28, respectively). Female colon 
(23±26) and rectal cancer (30±33) survivors reported significantly more problems with female 
SF than the normative population (11±17; p=.002). The differences in SF and SE in both sexes 
were clinically meaningful.
Correlates of SF in colorectal cancer survivors
Lower SF was significantly associated with higher age, female sex, not having a partner, low 
educational level, rectal cancer, depressive symptoms, and fatigue, explaining 32% of the 
variance (R2; p<.001) (Table 3). Lower SE was associated with higher age, female sex, depressive 
symptoms, and cardiovascular disease (R2=23%; p<.001). A lower male SF was associated with 
a higher age and having a stoma (R2=28%; p<.001) Fatigue was associated with a lower SF for 
women (R2=24%; p<.001).
Secondary analyses, stratified by sex, were conducted in order to determine the sex-
specific correlates of SF and SE. For men, the results remained comparable; however, a higher 
BMI was also related with a lower SF (R2=32%, p<.001). For women, only a higher age and 
having a partner remained significantly associated with SF (R2=29%; p<.001). For men, lower 
SE was associated with a higher age and depressive symptoms (R2=20%; p<.001). For women, 
lower SE was associated with having cardiovascular disease and surgery in combination with 
radiotherapy and chemotherapy (R2=26%; p=.05).




Male colon- and rectal cancer survivors were less sexually active and reported worse SF 
compared with the normative population. These differences were clinically meaningful. 
The findings on the prevalence of sexual dysfunction fall within the range of previous 
studies.34 However, it is not clear how to define the presence of sexual dysfunction, sexual 
problems, and sexual disorders.35,36 In line with the recent literature35,37, we have excluded the 
score ‘a little bit’ from the definition of a sexual problem. As a consequence, sexual dysfunction 
is only present when dysfunction is severe. Moreover, it is important to know to which extent 
patients are bothered by their sexual problems (i.e., their quality of sexual life). Having a sexual 
dysfunction may lead to a diminished quality of sexual life, though this is not a necessity. In 
this light, the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) formulated 
two separate categories to describe sexual disorders.37 The A category focuses on defining 
sexual disorders per se, with the common denominator being: “persistent or recurrent”, while 
the B category adds a distress dimension to all dysfunctions “the disturbance causes marked 
distress or interpersonal difficulty”.36,37 These definitions are a prerequisite to distinguish a 
dysfunction from its emotional impact.36 The current research focussed on the A category 
(defining sexual disorders per se). However, future research should also include the B category 
in order to provide a complete picture.
Consistent with previous studies, this study showed a strong relationship between male 
SF and age38,39 and the presence of a stoma.7 ,40 Rather unexpected were the findings that 
radiotherapy, chemotherapy, and having a stoma were not significantly associated with SF. 
Especially, since the role of radiotherapy is one of the most robust findings in the literature.41 
Perhaps, the QLQ-C38 is not the most appropriate instrument to assess this theme (see below). 
This study also examined the relationship between psychological factors and SF and SE, since 
it has been suggested that depression may be a more important factor in sexual dysfunction 
than clinical factors.41 ,42 However, only a few studies have included this aspect.10-12 We showed 
that depression was negatively associated with SF and SE. Moreover, fatigue was negatively 
associated with SF and female SF. These findings show that the existence of sexual problems in 
colorectal cancer patients should not merely be attributed to treatment damage, since sexual 
dysfunction is often multifactorial with biological, psychological, and/or social causes. 
Strengths of the current study are the fact that a normative population with a similar age 
distribution is included. Up to date, no large population-based studies comparing sexual 
(dys)function in colorectal cancer survivors and a normative population are available. This 
study contributes to the debate on whether sexual dysfunction in a higher age is normal or 
pathological. The current study achieved a high response rate for both men (76%) and women 
Table 3  Multivariate regression analyses of sexual functioning, sexual enjoyment, and male/female sexual 













β-value p-value β-value p-value β-value p-value β-value p-value
Age at time of survey -.274 <.001 -.175 .001 .316 <.001 .003 .975
Men (vs women) .242 <.001 .286 <.001 NA NA NA NA
Years since diagnosis .038 .197 .048 .321 .047 .426 .063 .473
Having a partner .148 <.001 NA NA NA NA NA NA
Educational level
Low* -.110 .004 -.053 .341 -.066 .294 .046 .670
Middle* -.070 .057 -.021 .697 -.027 .653 .110 .269
BMI -.051 .087 -.020 .693 -.042 .474 -.082 .373
Smoker .037 .218 -.028 .586 .095 .118 .046 .609
Rectum (vs colon) -.133 .006 -.054 .483 .088 .322 .028 .844
Type of treatment
Surgery + RT † .042 .364 -.029 .695 .133 .129 .224 .095
Surgery + CT † .008 .792 .036 .490 -.045 .483 .163 .070
Surgery + RT + CT † -.005 .891 .053 .404 .102 .163 .084 .475
Disease progression -.027 .369 -.014 .771 .060 .300 -.060 .483
Stoma -.016 .628 -.022 .677 .232 <.001 .146 .137
Cardiovascular disease -.006 .856 .141 .005 -.043 .472 -.090 .295
Diabetes mellitus -.046 .128 -.002 .966 .062 .282 -.089 .305
Anxiety .066 .087 .064 .316 -.118 .089 .157 .185
Depression -.132 .001 -.271 <.001 .058 .450 -.200 .095
Fatigue -.175 <.001 -.030 .639 .067 .362 .257 .048
Abbreviations: BMI = Body Mass Index, RT = Radiotherapy, CT = Chemotherapy, NA = not applicable.
Note: A p-value of <.05 is considered significant. For the sexual functioning and enjoyment scale a positive 
β-value indicates better functioning, while for the male and female sexual functioning scales a positive β-value 
indicates more problems. *The middle and low educational level were compared with a high educational level. 
†These treatments were compared with surgery only.




This study showed that male colorectal cancer survivors were less sexually active and reported 
worse SF compared with the normative population. These results imply that attention towards 
sexual (dys)function in colorectal cancer survivors, in both research and clinical practice is 
needed. 
(70%). Moreover, most studies on sexual function focus on rectal cancer survivors34, since it 
is expected that especially they will report more functional problems due to surgery and/or 
radio(chemo)therapy. This study consisted of both rectal- and colon cancer survivors. We have 
shown that colon cancer survivors and women also need attention for their potential sexual 
problems. Finally, this study had few missing data on sexual questions compared with other 
studies.43 ,44 For instance, Bloemen et al.43 reported that 33% of the women did not complete 
the sexuality items, while another study reported a even higher percentage (58%).44 In our 
study, less than 10% of the men did not complete the items on sexuality, with exception of 
item on SE (17% was missing). Missing data in women ranged from 12% (dry vagina) to 17% 
(sexually active). 
There are also some limitations that need to be acknowledged. First, this study is cross-
sectional. As a consequence, this design does not allow making causal inferences or displaying 
short-term and long-term changes in SF over time. However, knowledge about the course 
of sexual (dys)function will help health care professionals informing their patients in what 
to expect during and after treatment. Second, no information was known about sexual (dys)
function before diagnosis/treatment of cancer, which limits the determination of the effect 
of a cancer diagnosis and treatment on functioning or being able to correct for baseline 
functioning. Prospective studies with an assessment point prior to surgical treatment are 
warranted. Third, even though the EORTC QLQ-CR38 is one of the most commonly used 
questionnaire to assess SF, it provides only limited information. The question ‘Did you 
experience difficulties ejaculating?’ for men may be inadequate, since some men with colon or 
rectal cancer end up with nerve damage or changes from surgery, pelvic (chemo)radiotherapy 
or a combination so that they essentially have ‘dry orgasms’, with pleasurable sensation and 
muscle contractions but no semen. As a consequence, it is unknown if men had dry orgasms 
or were not been able to reach orgasm. Finally, men from the normative population did not 
complete the question regarding ejaculation. Therefore, comparison with survivors was not 
possible on male SF. 
Future prospective studies should investigate sexuality from a biopsychosocial model, in 
which the subjective evaluation of sexual (dys)function is taken into account. Thus, it would 
be interesting to assess the extent to which patients are bothered by sexual problems, since 
the presence of dysfunction may lead to a diminished quality of sexual life, though this is not 
a necessity.34 
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Even though the body of literature on Sexual Function (SF) is growing, information on the 
preoperative SF and the Quality of Sexual Life (QoSL) after colorectal cancer is lacking. 
Research focusing on female patients and on partners is also rather scarce.
Aim
This cross-sectional study aimed to describe the preoperative SF, QoSL, and relationship 
functioning for male and female patients with colorectal cancer and their partners. In addition, 
the mean scores of the patients and partners were compared with mean norm scores.
Methods
Patients diagnosed with colorectal cancer (n=136) and their partners (n=106) were recruited 
before surgical treatment in six Dutch hospitals. 
Main outcome measures
Men completed the International Index of Erectile Functioning, while women completed 
the Female Sexual Function Index. All partnered participants completed the Golombok-Rust 
Inventory of Sexual Satisfaction and the Maudsley Marital Questionnaire. The mean scores 
were compared with mean norm scores derived from the manuals of the questionnaires. 
Results
All participants were in a heterosexual relationship. Female patients reported a lower QoSL 
compared with male patients. Male partners reported a lower SF and a lower QoSL compared 
with male patients. Patients with colorectal cancer and partners (both sexes) reported a lower 
SF and a lower QoSL compared with norm populations, but scored similar on relationship 
functioning. 
Conclusion
A lower SF and a lower QoSL are already reported preoperatively; however, relationship 
functioning was comparable with a norm population. Therefore, all the impairment seen after 
treatment should not be solely attributed to the effects of treatment. 
Introduction
Worldwide, colorectal cancer is the third most common cancer in men and the second most 
common cancer in women.1 Fortunately, the improved multidisciplinary treatment has led to a 
substantial improvement in prognosis.2,3 An increasing incidence combined with an improving 
prognosis will result in a significant incline in the prevalence of colorectal cancer. 
Over the past three decades, research on colorectal cancer showed a negative effect of 
colorectal treatment on Sexual Function (SF).4 A recent review reported that the current studies 
predominantly investigated the sexual response cycle. These studies found a high percentage 
erectile and/or ejaculatory dysfunction in men (range 5-88%) and that approximately half of 
the women reported pain during intercourse and/or dyspareunia.4 Sexual (dys)function is 
often investigated as part of clinical outcome studies (in combination with urological and/
or bowel functioning) or as part of studies on health-related quality of life/health status.4 
Currently, less is known about to which extent patients are bothered by their sexual problems 
(i.e., their Quality of Sexual Life – QoSL). However, it is important to evaluate the level of SF 
and QoSL, since having a sexual dysfunction does not necessarily lead to a diminished QoSL.5 
Less than half of the men and women with a sexual dysfunction were actually bothered by this 
dysfunction.6 Furthermore, a cancer diagnosis and its subsequent treatment not only affect 
patients but also partners. Moreover, there may be interdependence between both members 
of the couple.7,8 In general, the existing studies paid little attention to the preoperative SF and/
or QoSL.
Therefore, the aim of the current study was to describe the preoperative SF, QoSL, and 
relationship functioning for male and female patients with colorectal cancer and their partners. 
In addition, the mean scores of patients and partners were compared with mean norm scores 
derived from the manuals of the questionnaires.
Methods
Patients
Before surgical treatment, patients diagnosed with colorectal cancer and their partners 
were asked to participate in this study. However, according to the Dutch guidelines, patients 
with rectal cancer received neoadjuvant treatments (i.e., radio(chemo)therapy) that may 
already started by the time the participants completed the questionnaire.9 Patients were 
recruited between September 2010 and December 2011 from six Dutch hospitals: the St. 
Elisabeth hospital (Tilburg), TweeSteden Hospital (Tilburg and Waalwĳk), Catharina Hospital 
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(Eindhoven), the Jeroen Bosch Hospital (‘s Hertogenbosch), Amphia Hospital (Breda), and 
Maxima Medical Centre (Eindhoven and Veldhoven). Patients and partners older than 18 years 
were eligible for participation. The following exclusion criteria were applied: (i) elderly age 
(older than 75 years), (ii) not curatively treated metastases at baseline, (iii) poor expression 
of the Dutch language, (iv) dementia, and (v) a history of psychiatric illness. When patients 
declined participation, the partners were still invited to participate (and vice versa) in order to 
prevent selection bias. Patients and partners were asked by their treating physician during a 
preoperative visit if they could be approached by a member of the research group who would 
explain the study design and purpose of the study. Subsequently, a member of the research 
group contacted the participants and explained the study details. If patients and/or their 
partners agreed to participate they were asked to complete the set of standardized surveys at 
home, prior to the patients’ surgery. Participants returned the surveys in sealed postage-paid 
envelopes. Participants who consented but who did not return the surveys within two weeks 
after consenting received a reminder (a phone call or a reminder letter). The institutional 
review board approved the study. All participants gave written informed consent. 
Measures
Questions assessing socio-demographic factors (age, sex, marital status, length of the 
relationship, number of children, paid work, and educational level) and an adapted Self-
administered Comorbidity Questionnaire10, which evaluates comorbidity at the time of 
questionnaire completion, were completed by all participants. 
All male patients and male partners completed the International Index of Erectile Function 
(IIEF).11 The IIEF is a well-validated 15-item instrument with good psychometric properties.12 
The IIEF consists of five domains and a total score. The domains Erectile Function, Orgasmic 
Function and Sexual Desire evaluate sexual (dys)function, while the domains Intercourse 
Satisfaction and Overall Satisfaction measure QoSL. Higher scores indicate fewer problems 
with SF and a better QoSL. Men scoring less than or equal to 25 were classified as having 
erectile dysfunction.12 
All female patients and female partners completed the Female Sexual Function Index 
(FSFI).13,14 The FSFI14, Dutch version13 is a 19-item validated questionnaire that addresses five 
domains of women’s sexual (dys)function: Arousal, Lubrication, Orgasmic Function, Sexual 
Desire, and Sexual Pain. In addition, the sixth domain Intercourse Satisfaction evaluates the 
women’s QoSL. All responses were summed to provide a total score. Higher scores indicate 
fewer problems with SF and a better QoSL. The psychometric properties of the FSFI were 
found satisfactory to good.13,14
The participants with a partner (both men and women) completed the Golombok-Rust 
Inventory of Sexual Satisfaction (GRISS)15, since most of the GRISS questions are intercourse 
orientated. The GRISS has separate versions for men and women, each consisting of 28 items. 
The GRISS assesses seven domains. Four domains which evaluate the QoSL: Avoidance (i.e., the 
extent to which the person is actively avoiding having sex), Satisfaction, Non-Communication 
(i.e., the extent to which a couple is able to talk about their sexual problems), Non-Sensuality 
(i.e, the extent to which a person gains pleasure from touching and caressing), and the sexual 
(dys)function domain Infrequency of Intercourse. In addition, women completed the sexual 
(dys)function domains Vaginismus and Anorgasmia, while men completed the sexual (dys)
function domains Premature Ejaculation and Impotence. Finally, for both sexes all responses 
were summed to obtain a total score. Items were answered on a 5-point Likert scale ranging 
from 1 (never) to 5 (every time). High scores indicate more problems with SF and lower QoSL. 
The psychometric qualities of the Dutch version of the GRISS are good.16,17 
Finally, the participants with a partner (both men and women) completed the Maudsley 
Marital Questionnaire (MMQ).18-20 The MMQ evaluates the relationship in general, the sexual 
relationship, and life in general. The MMQ consists of 20 items with a 9-point response 
scale (0–8). The items in each subscale were summed. Scores on the Marital Maladjustment 
subscale could range from 0 to 80, while the Sexual Maladjustment subscale and General 
Life Maladjustment could range from 0 to 40. For all subscales, a higher score indicates more 
maladjustment. A cutoff score of ≥20 on the Marital Maladjustment subscale was used to 
identify individuals who experienced marital maladjustment.21,22 The MMQ has good reliability 
and validity. The psychometric qualities of the Dutch version of the MMQ were also found to 
be satisfactory.18,20
Medical records 
Data concerning type of tumor (colon or rectum) was obtained from the medical records of 
the patients.
Statistical analysis
Frequencies were used to present the available sociodemographic and clinical data. First, it 
was determined whether patients with colon and rectal cancer differed in their SF and QoSL. 
Independent samples t-tests were used to compare patients with colon and rectal cancer on 
the IIEF (men) and the FSFI (women). Analyses of variance (ANOVAs) compared the mean 
scores on the GRISS and MMQ for the partnered participants (four subgroups: male patients 
with colon cancer, male patients with rectal cancer, female patients with colon cancer, and 
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female patients with rectal cancer). Next, the total group of patients with colorectal cancer 
(thus patients with colon and rectal cancer combined) and their partners were compared on 
the IIEF (men), and the FSFI (women) with independent samples t-tests. For the participants 
with a partner the mean scores on the GRISS and MMQ were compared with ANOVA’s (four 
subgroups: male patients, male partners, female patients, female partners). Post-hoc tests 
were corrected with the Bonferroni method; missing data was excluded from the analysis. The 
mean scores obtained in the present study were compared with the mean scores from norm 
populations as described in the questionnaire manuals of the GRISS16, the IIEF11, the FSFI14, and 
the MMQ18, with the one-samples t-test. In the text, mean scores and standard deviations are 
provided as (mean ± standard deviation). Statistical differences were indicated if p<.05 and 
reported p-values were two-sided. All statistical analyses were performed using the Statistical 
Package for the Social Sciences (version 17.0, SPSS Chicago, IL, USA).
Results 
In total, 259 eligible participants agreed to be contacted by a member of the research 
group, who subsequently informed them about the study. Of this group, 136 (54%) patients 
agreed to participate and completed the preoperative set of questionnaires. In addition, 123 
patients had a partner of which 106 (86%) participated in this study. There were no partners 
who participated if the patient did not. Although not a prerequisite, all participants were in 
a heterosexual relationship. Several couples declined participation for various reasons. The 
most reported reasons for non-participation were (i) the intimate nature of the questionnaires, 
(ii) the length of the questionnaires, and (iii) the amount of experienced stress at that time. 
The demographic and clinical characteristics of the participants are reported in Table 1. No 
differences were found between patients with colon patients and patients with rectal cancer 
on the mean scores on the IIEF (men), FSFI (women), and the GRISS and MMQ (partnered 
men and women) (p>.05). Therefore, the colon and rectal cancer groups were combined in 
the subsequent analyses. The mean scores of the patients with colorectal cancer and their 
partners on the IIEF (for men), the FSFI (for women), and the GRISS and MMQ (for partnered 
men and women) are reported in Table 2. 











Age at time of survey 64.3±11.3 65.4±10.5 64.1±13.6 60.3±12.7
BMI 82.3±13.6 84.2±10.5 69.0±10.3 71.5±11.8
Relationship in years 33.8±13.5 39.9±9.5 39.0±10.0 34.2±13.9
N (%) N (%)
Educational level
Low 5 (5.5%) 3 (9.4%) 6 (13.3%) 6 (8.1%)
Medium 49 (35.8%) 15 (46.9%) 26 (57.8%) 53 (67.1%)
High 32 (35.2%) 12 (37.5%) 7 (15.6%) 9 (12.2%)
Missing 5 (5.5%) 2 (6.3%) 6 (13.3%) 6 (8.1%)
Marital status
Partnered 84 (92.3%) - 39 (86.7%) - 
Widow/no partner 7 (7.7%) - 6 (13.3 %) - 
Missing 0 (0.0 %) - 0 (0.0%) - 
Type of cancer
Colon 26 (28.6%) - 10 (26.3%) - 
Rectum 65 (71.4%) - 28 (73.7%) - 
Comorbidity 
Cardiovascular disease 11 (12.1%) 7 (21.9%) 5 (11.1%) 6 (8.1%)
Lung disease 6 (6.6%) 0 (0.0%) 2 (4.4%) 8 (10.8%)
Diabetes mellitus 7 (7.7%) 6 (18.8%) 2 (4.4%) 7 (9.5%)
Artrose 11(12.1%) 6 (18.8%) 7 (15.6%) 18 (24.3%)
Back pain 17 (18.7%) 8 (25.9%) 6 (13.3%) 7 (9.5%)
Note: Low = up to ten years of education; middle = 10-14 years of education; high = more than 14 years of 
education.
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 IIEF (B only; higher scores indicate better SF/better QoSL)
Erectile 
functioning
8.6±5.6 7.6±6.3 ns - - - - 
Orgasmic 
functioning
1.8±2.7 1.1±2.5 ns - - - -
Sexual desire 7.2±2.1 7.4±2.3 ns - - - -
Intercourse 
satisfaction
2.0±2.7 1.7±2.9 ns - - - -
Overall 
satisfaction
5.8±2.4 6.0±2.7 ns - - - -
 FSFI ( V only, higher scores indicate better SF/QoSL)
Total - - - 14.7±6.5 14.8±5.2 ns -
Desire - - - 5.4±1.0 4.4±1.1 <.001 -
Arousal - - - 2.5±2.8 1.9±2.1 ns -
Lubrication - - - 1.3±1.5 2.0±1.4 .040 -
Orgasm - - - 1.2±1.5 1.6±1.3 ns -
Pain - - - 1.7±2.2 2.3±2.4 ns -
Satisfaction - - - 2.6±1.4 2.2±1.1 ns -
GRISS (higher scores indicate lower SF/ QoSL)
Total 64.0±71.6 15.3±19.5 ns 72.7±20.9 62.9±15.8 ns ns
Infrequency of 
intercourse
7.3±1.5 8.4±1.7 .023 7.7±1.8 7.2±1.7 ns ns
Impotence 10.1±4.2 11.0±4.8 ns - - - -
Premature 
ejaculation
10.2±2.5 10.7±3.0 ns - - - -
Vaginismus - - - 8.9±4.5 7.3±4.0 ns -
Anorgasmia - - - 12.1±2.6 10.8±2.9 .035 -
Non-sensuality 6.6±2.8 7.3±3.8 ns 8.7±4.4 6.7±2.6 ns <.001











GRISS (higher scores indicate lower SF/ QoSL)
Dissatisfaction 10.0±3.6 10.9±3.2 ns 9.6±3.8 8.6±3.9 ns <.001
 Non-
communication
4.8±1.7 6.0±2.4 .038 6.0±2.2 5.6±1.9 ns .026
MMQ (higher scores indicate more maladjustment)
Marital  
maladjustment
10.8±10.5 9.6±9.0 ns 11.4±11.3 11.8±10.0 ns ns
Sexual  
maladjustment
16.5±9.6 21.6±9.3 ns 17.8±9.5 16.4±9.4 ns ns
General life 
maladjustment
7.7±5.0 7.8±5.2 ns 7.7±5.0 7.2±4.5 ns ns
Abbreviations: GRISS=Golombok-Rust Inventory of Sexual Satisfaction, IIEF=International Index of Erectile 
Function, FSFI=Female Sexual Function Index, MMQ=Maudsley Marital Questionnaire, QoSL=Quality of 
Sexual Life, SF=Sexual Function. 
Note: A p-value <.05 was reported statistically significant. ns = not statistically significant. The quality of life 
subscales are marked in bold. For the GRISS and the MMQ the post hoc Bonferroni corrected p-values are 
reported. For each question, more than 75% of the participants completed the question.*p-value represents 
the comparison between male and female patients.
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Comparison of patients with colorectal and their 
partners with previous described normative populations
Comparing the abovementioned results with norm scores revealed that both male patients 
and male partners reported significantly lower scores on the IIEF (p’s<.05), with exception 
of the subscale Sexual Desire for both male patients and male partners (p=.436 and p=409, 
respectively). In addition, female patients and female partners reported significantly lower 
scores on all subscales of the FSFI (p’s<.05). The GRISS norm scores were lower for all subscales 
for the four groups except for the subscale Avoidance for male patients (p=.251) and male 
partners (p=.414). Finally, for the MMQ, no significant differences were reported between the 
four groups and the norm scores with regard to Marital Maladjustment (p’s>.05). However, all 
four groups differed significantly on Sexual Maladjustment (p’s<.05). Male patients and female 
partners reported more General Life Maladjustment (p=.017, and p=.001, respectively). 
Discussion 
Even though the negative effect of colorectal cancer treatment on the SF of patients is a robust 
finding in the literature, this study points out that both patients with colon and rectal cancer 
may already experience a lower SF and QoSL before surgical treatment. Therefore, surgical 
interventions may not be solely responsible for the high percentage of sexual dysfunction after 
colorectal cancer. No differences were found between patients with colon cancer (who did not 
receive neoadjuvant treatment) and patients with rectal cancer (who received neoadjuvant 
treatment). Compared with previously described populations, patients with colorectal cancer 
reported significantly lower scores on SF and the QoSL, regardless of gender. In addition, 
female patients reported a lower SF and a lower QoSL compared with male patients. Another 
important finding is the fact that not only patients but also their partners (men and women) 
reported a lower SF and QoSL compared with formerly described populations. In addition, male 
partners reported a lower SF and a lower QoSL compared with male patients. These findings 
may be partially explained by the low scores on SF for the female patients, as interdependence 
between the female patients and their male partners may play a role. 
Earlier studies have already reported high levels of psychological distress in patients 
awaiting a possible cancer diagnosis23 and recently diagnosed cancer patients24-26. Moreover, 
psychological distress, such as anxiety and depression, is found to be negatively associated 
with SF27-29. In this study, psychosocial factors may also provide the main explanation for the 
low levels of functioning and QoSL, especially since there was a lack of differences between 
colon and rectal cancer survivors.
Sexual functioning
Male patients and male partners did not differ on the IIEF SF domains (p’s>.05). However, 
male patients reported less problems with Infrequency of Intercourse compared with male 
partners, (GRISS subscale, p=.023). Female patients reported a lower SF on the FSFI subscale 
Lubrication p=.040), but a higher score on the subscale Desire (p<.001) compared with female 
partners. Furthermore, female patients reported more Anorgasmia compared with the female 
partners (GRISS subscale, p=.035). 
Quality of Sexual Life
Both patients and partners scored similar on the Satisfaction subscale of the IIEF (men) and 
FSFI (women)(p’s>.05). Female patients had more problems with Non-sensuality (p<.001), 
Avoidance (p<.001), and Non-communication (p=.026) compared with male patients. Male 
patients reported more Dissatisfaction than female patients (p<.001). However, male patients 
reported less problems with Non-communication (p=.021) and with Infrequency of intercourse 
(p=.003) compared with male partners. The four groups did not differ on Sexual Maladjustment 
(MMQ, p>.05).
Relationship Maladjustment  
and General Life Maladjustment
For the MMQ, no significant differences were found between the four subgroups on Martial 
Maladjustment and General Life Maladjustment (p’s>.05). When marital maladjustment was 
dichotomized, 10 (13%) male patients, 10 (29%) female patients, 5 (17%) male partners, and 11 
(17%) female partners reported martial maladjustment (p=.253). In four cases both members of 
the dyad reported marital maladjustment.
108107 Quality of sexual life and colorectal cancer  Towards a dyadic approach Chapter 4   The preoperative sexual functioning and quality of sexual life in colorectal cancer: a study among patients and their partners
44
However, even though both patients and their partners reported a lower SF and a lower 
QoSL, the levels of relationship functioning found in this population did not deviate from the 
levels reported by the norm population. This study therefore potentially shows that a lower SF 
and a lower QoSL do not necessarily influence the relationship as a whole. 
All in all, this study provides an in depth view of the preoperative SF, QoSL, and relationship 
functioning in both patients and partners of both sexes. To our knowledge, this has not been 
done before. In addition, the objectives were assessed with standardized, psychometrically 
sound questionnaires. Adequate quantitative measures, such as those used in this study, make 
the results more objective, more reliable, and more replicable.30 Furthermore, 54% of eligible 
patients agreed to participate which is a good response rate compared with other studies. 31-33 
There are also some limitations that need to be acknowledged. Patients completed the 
questionnaires after diagnosis; therefore, we cannot make any statements about the SF or 
QoSL prior to diagnosis. Moreover, as part of the standard care, patients with rectal cancer 
may already started with neoadjuvant treatments, since not all participants completed 
the questionnaire immediately after receiving it. Since the time between diagnosis and 
completing the questionnaires varied, we cannot determine the additional effect of 
neoadjuvant radio(chemo)therapy on the results of the patients with rectal cancer. However, 
as mentioned above no difference between patients with colon and rectal cancer was found, 
therefore, we expect that the specific effect of radio(chemo)therapy on the results was not 
substantial. Furthermore, important reasons for declining participation were the high levels 
of experienced stress and the intimate nature of the questions. It is plausible that participants 
who experienced impairments were inclined to decline participation, which may lead to an 
underestimation of the current problems. Since the objective was to examine both SF and 
QoSL, multiple sexuality questionnaires had to be completed. The IIEF and the FSFI were 
assessed as they focus predominantly on functioning. The GRISS was added since this 
questionnaire focuses more broadly and gives more weight to the subjective evaluation of the 
reported functioning. To our knowledge, there is no questionnaire available that adequately 
measures both SF and QoSL in one questionnaire. Furthermore, the questionnaires lacked 
clear cutoff scores (for both the different domains as for the total score) which prohibited 
the stratification of scores in terms of severity. There were only cut-off scores available for 
the Erectile Functioning scale of the IIEF and the Marital Maladjustment scale of the MMQ. 
However, there has been a debate on whether or not the cutoff score of ≥25 for the IIEF is 
optimal.34 In order to get some impression of the severity of the impairments, the results were 
compared with previously described populations. However, these comparison groups were 
relatively young while colorectal cancer mostly affects the elderly. Satisfactorily assessing 
whether colorectal cancer causes an additional negative effect on sexuality requires age- and 
sex- matched normative data for the questionnaires used; unfortunately, this data is not yet 
available. However, a recent cross-sectional study analysed the sexuality questions of the 
European Organization for Research and Treatment of Cancer (EORTC) module Quality of Life 
Questionnaire – Colorectal 38 (QLQ-CR38) and reported lower SF for colon and rectal cancer 
survivors compared with an age-matched normative population.28 Based on these results 
it may be expected that age does not fully explain the lower levels of SF and QoSL in our 
population compared with the comparison groups. 
Future research is needed to make the results obtained in this study more valid (e.g., through 
the availability of clear cutoff scores and good normative data). In addition, prospective 
research with a pretreatment or even pre-diagnosis baseline assessment is needed to address 
the course of SF, relationship functioning, and QoSL over time and to assess the biopsychosocial 
determinants of impairments. Finally, this study shows that couples experience problems 
prior to surgery. More information provision and/or psychosexual guidance may be needed 
preoperatively in order to give license to couples to discuss sexual problems and to search for 
adequate professional support during any point in treatment. Especially, since the majority 
of patients do not take the initiative to discuss the treatment options for possible sexual 
dysfunction.35 In this perspective, qualitative methodologies may also provide helpful insights 
in the experience and meaning of sexuality during the sequelae of cancer.
Conclusion
A lower SF and a lower QoSL are already reported preoperatively. However, relationship 
functioning was comparable with a norm population. Consequently, all the impairment 
seen after surgery should not be solely attributed to the effects of surgery. Therefore, it is a 
prerequisite that health professionals already address this topic with both the patients and 
their partners before initiating treatment.
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To evaluate (i) relatedness between Sexual Function (SF) and the Quality of Sexual Life (QoSL), 
(ii) the course of SF and QoSL, and (iii) biopsychosocial predictors of SF and QoSL.
Methods
Patients completed questionnaires assessing sociodemographic factors and personality 
characteristics before surgery. Questionnaires assessing psychosocial aspects were measured 
preoperative and three, six, and 12 months after surgery. Clinical characteristics were obtained 
from the Eindhoven Cancer Registry. Linear mixed-effects models were examined.
Results
SF and QoSL are related constructs (r=.206 to r=.642). Compared to preoperative scores, SF 
did not change over time (p>.05). Overall, patients’ QoSL decreased postoperatively (p=.001). 
A higher age (β=-.02), fatigue (β=-.02), not being sexually active (β=-.081), and having a stoma 
(β=.37) contributed to a lower SF (p’s<.05). Having rectal cancer (β=-1.64), depressive symptoms 
(β=-.09), lower SF (β=1.05), and more relationship maladjustment (β=-.05) contributed to a 
lower QoSL (p’s<.05). In addition, partners’ SF (β=.24) and QoSL (β=.30) were predictive for 
patients’ SF and QoSL, respectively. A significant interaction between time and gender was 
reported for both outcomes (p’s=.002).
Conclusion
SF and QoSL are related but distinctive constructs. The course of SF and QoSL differed. Different 
biopsychosocial predictors were found for SF and QoSL. The contribution of partner-related 
variables to patients’ outcomes suggests interdependence between patients and partners. 
Men and women showed different SF and QoSL trajectories. We recommend that health care 
professionals pay attention to both SF and QoSL. More in depth research of gender effects and 
interdependence between patients and partners is needed.
Introduction
Multidisciplinary colorectal cancer treatment may influence patients’ SF (e.g., erectile or 
ejaculatory dysfunction in men and dyspareunia and lubrication problems in women).1 
However, demographic factors (e.g., age, sex), psychological issues (e.g., mood, body image), 
and social aspects (e.g., patients’ and partners’ relationship adjustment) may also have a direct 
or indirect effect on patients’ Sexual Function (SF). Therefore, SF may be best understood from 
an integrative biopsychosocial model.2,3 
One may assume that if patients experience sexual dysfunction after colorectal cancer 
treatment they would also report a lower Quality of Sexual Life (QoSL), since these concepts 
are related. However, this is not necessarily true. Sexual (dys)function refers to (dys)function 
in a part of the sexual response cycle3 (i.e., desire, excitement, orgasm, and resolution)4,5 or 
pain associated with intercourse5, while the QoSL takes the person’s subjective evaluation of 
this functioning into account.1,3 Patients may not be bothered with sexual dysfunction if they 
employ other ways to establish a satisfactory sexual relationship.2-4 For instance, intimacy 
(e.g., hugging/kissing) has been reported as more important than being able to have sexual 
intercourse.6 On the other hand, patients may report a low QoSL without an apparent sexual 
dysfunction.2-4 
To our knowledge, no study has yet evaluated to what extent SF and QoSL are related. 
Furthermore, only one cross-sectional study examined SF using a biopsychosocial approach.7 In 
this study, older age, having received an abdominoperineal resection, and poor social support 
were associated with low SF in men, while low SF in women was associated with higher age 
and poor global quality of life.7 Finally, while treatment-related factors were related to sexual 
satisfaction and/or sexual enjoyment1, no study has evaluated biopsychosocial predictors of 
QoSL.1 
Therefore, this study aimed to evaluate (i) relatedness between SF and QoSL, (ii) the course 
of SF and QoSL, and (iii) biopsychosocial predictors of SF and QoSL during the first year after 
colorectal cancer surgery. 




Data were drawn from a larger study examining the (sexual) consequences of colorectal 
cancer for patients and their partners (NCT01234246). For this study, patients were recruited 
from six Dutch hospitals: St. Elisabeth hospital (Tilburg), TweeSteden Hospital (Tilburg and 
Waalwĳk), Catharina Hospital (Eindhoven), Jeroen Bosch Hospital (‘s Hertogenbosch), Amphia 
Hospital (Breda), and Maxima Medical Centre (Eindhoven and Veldhoven). To be eligible for 
participation, patients and partners had to be older than 18 years. Patients were excluded 
if one or more of the following criteria was applicable: (i) elderly age (>75 years), (ii) non-
curatively treated metastases at baseline, (iii) poor expression of the Dutch language, (iv) 
dementia, and/or (v) a history of psychiatric illness. In order to prevent a selection bias, all 
partners with sufficient knowledge of the Dutch language and without dementia or a history 
of psychiatric illness were still invited to participate even if patients declined participation 
(and vice versa). During a preoperative visit eligible patients and partners were asked, by their 
treating physician, if they gave permission to be approached by a member of the research 
team. Subsequently, this member contacted the potential participants by phone to explain the 
design and purpose of the study. If patients and/or partners agreed to participate they were 
asked to complete a set of questionnaires at home before surgery (Time-0) and three (Time-1), 
six (Time-2), and 12 months (Time-3) postoperative. However, the Dutch guidelines recommend 
that rectal cancer patients, except those with a clinical T1 stage without positive lymph nodes, 
receive neoadjuvant treatments (i.e., radio(chemo)therapy; www.oncoline.nl). Therefore, a 
subset of patients completed the first set of questionnaires prior to surgery, but potentially 
during or after the time patients received neoadjuvant therapy. Participants returned the 
surveys in sealed postage-paid envelopes. Participants who did not return the questionnaires 
within two weeks received reminders (phone call(s) and/or a reminder letter). This study was 
approved by the institutional review board. All participants gave written informed consent. 
Measures
The patient’s clinical information was retrieved from the Eindhoven Cancer Registry (ECR). 
The ECR routinely collects data on tumor characteristics and treatment. If needed, additional 
clinical information was retrieved from the patient’s medical records. Patients also completed 
questions regarding their age, sex, and length of the relationship with their partner.
Two aspects of the patients’ personality were assessed. Neuroticism was assessed with 
the Neuroticism facet of the Neuroticism-Extraversion-Openness-Five Factor Inventory 
(NEO-FFI).8-10 This factor assesses six aspects belonging to neuroticism (i.e., anxiety, hostility, 
depression, self-consciousness, impulsiveness, vulnerability to stress). Trait anxiety was 
evaluated with the Dutch short form trait scale of the Spielberger State-Trait Anxiety Inventory 
(STAI).11 The trait anxiety scale describes how persons generally feel and conceives anxiety as 
a personality disposition. 
Patients’ psychological function was assessed with four constructs, specifically, body 
image, state anxiety, depressive symptoms, and fatigue. Body image was evaluated with the 
Body Image scale.12,13 Depressive symptoms were evaluated with the 16-item version of the 
Center for Epidemiological Studies- Depression Scale (CES-D).14 State anxiety was assessed 
with the short form (6-items) of the STAI state anxiety scale.15 State anxiety is a momentary 
emotional condition characterized by subjective feelings of apprehension and tension, and 
heightened autonomic nervous system activity and may thus vary in intensity and fluctuate 
over time.16 Fatigue was evaluated with the Fatigue Assessment Scale (FAS).17 The FAS assessing 
perceived fatigue and exhaustion. NB: Fatigue was in this study for clarity purposes seen as 
a psychological factor, even though we know that fatigue is a multidimensional construct 
encompassing both physical and psychological aspects.
Social characteristics (i.e., sexual activity, SF, non-sensuality, avoidance, non-
communication, relationship adjustment,) were completed by both patients and partners, 
except for sexual activity, which was only completed by patients due to redundancy. Patients’ 
sexual activity was assessed with the question ‘To what extent where you sexually active (with/
without sexual intercourse)?’ from the European Organization for Research and Treatment 
of Cancer (EORTC) disease specific ColoRectal 38 (QLQ-CR38).18 QoSL was evaluated with 
the Sexual Activity facet of the World Health Organization Quality of Life assessment 
(WHOQOL-100).19,20 This facet contains the following items: ‘How would you rate your sex 
life?’, ‘How well are your sexual needs fulfilled?’, ‘How satisfied are you with your sex life?’, 
and ‘Are you bothered by any difficulties in your sex life?’ SF was evaluated with two sex-
specific questionnaires. Men completed the Erectile Function, Orgasmic Function, and Sexual 
Desire domains of the International Index of Erectile Function (IIEF).21 Women completed 
the Arousal, Lubrication, Orgasmic Function, Sexual Desire, and Sexual Pain domains of the 
Female SF Index (FSFI).22,23 If needed, patients could indicate that an item was not applicable. 
For the IIEF the total score was computed as the sum of at least five items and, thus, up to 
five items were person-mean imputed. For the FSFI, domain scores were obtained following 
the standard scoring instruction. The IIEF and FSFI total scores were transformed into 
standardized z-scores. The z-scores were subsequently combined to obtain one SF score. Next, 
patients and partners completed the Avoidance, Non-Communication, and Non-Sensuality 
domains of the Golombok-Rust Inventory of Sexual Satisfaction (GRISS).24 The GRISS has 
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separate versions for men and women; however, the Avoidance, Non-Communication, and 
Non-Sensuality domains are comparable for both sexes. Finally, relationship (mal)adjustment 
was assessed with the Marital (Mal)adjustment scale of the Maudsley Marital Questionnaire 
(MMQ).25-27 Sociodemographic factors and personality characteristics were assessed only at 
Time-0, while all other questionnaires were completed at each time point (Time-0 – Time-3). 
The psychometric properties of all questionnaires were satisfactory. 
Statistical Analyses
An independent t-test and Chi-square tests were used to examine potential differences in age, 
sex, and type of tumor for participants and non-participants. Bivariate correlations between 
SF and QoSL were at each time point assessed with the Pearson correlation coefficient. 
Correlations were grouped into small (r=<.30), moderate (r=.30-.49), or high (r>.49).28 Linear 
mixed-effects models with an unspecified covariance pattern model were used to examine 
(i) the course of SF and QoSL and (ii) identify predictors for both constructs. Linear mixed-
effects models has a comparable purpose as repeated measures (multivariate) analysis of 
variance ((M)ANOVA) and can be seen as a linear regression analysis that takes into account 
the correlational structure of repeated measures.29 However, mixed-effects models uses all 
complete time points whereas in repeated measures (M)ANOVA patients with any missing 
observation are omitted from the analysis entirely.29 Therefore, mixed-effects models are 
more efficient and more robust to missing data.29 Time was analysed as a categorical predictor 
with four levels (i.e., Time-0, Time-1, Time-2, and Time-3). The fixed-effects parameters of the 
models were estimated with maximum likelihood. Sociodemographic variables (i.e., age, sex), 
clinical variables (i.e., tumor type, type of surgery, type of radiotherapy, chemoradiation (yes/
no), type of chemotherapy, stoma status), and personality characteristics (i.e., trait anxiety and 
neuroticism) were analysed as time-invariant predictors as they were only assessed at baseline. 
Psychological variables and symptoms (i.e., anxiety, depressive symptoms, body image, and 
fatigue), patient-related social variables (i.e., sexual activity, relationship adjustment, SF, 
non-sensuality, avoidance, non-communication), and partner-related social variables (i.e., 
SF, relationship adjustment, QoSL, non-sensuality, avoidance, non-communication), were 
measured at each time point and thus analysed as time-varying predictors.29 
Analyses proceeded in three steps. In order to obtain an acceptable number of variables 
entered in the final model a selection procedure was performed first. This selection procedure 
entailed that a basic set of predictors (i.e., age, sex, and type of tumor, Block 1) was formed to 
which, in separate analyses, a specific block of predictors was added. Thus, a forward selection 
method was chosen. The following sets were formed: basic set of predictors (Block 1), basic set 
+ personality characteristics (Block 2), basic set + psychological variables (Block 3), basic set 
+ patient-related social factors (Block 4), basic set + partner-related social factors (Block 5), 
and basic set + clinical characteristics (Block 6). These sets were formed based on content. To 
minimize data-driven choices and to identify a parsimonious model, a p<.10 was used during 
the selection procedure. Significant predictors were subsequently evaluated in a final model. If 
the effect of time-varying predictors was significant in the final model, then the effect was split 
into two effects in the second part of the analysis: between-subjects effects (e.g., the degree 
to which patients’ SF/QoSL is related to their average level on a predictor) and within-subjects 
effects (e.g., the degree to which variation in patients’ SF/QoSL over time is associated with 
a change in their levels on a predictor). Finally, in the third part of analyses, the interaction 
between time and gender and time and type of tumor was evaluated for both outcomes. 
In order to correctly interpret all model parameters, all time-varying variables have been 
grand-mean centered. Analyses were performed in IBM SPSS 19.0, using a significance level of 
p≤.05 (with exception of the selection procedure).
Results
Participants
In total, 672 eligible patients agreed to be contacted by a member of the research group, 
who informed them about the study. Of them, 313 (47%) patients agreed to participate; 
64% of patients with rectal cancer participated and 50% of the patients with colon cancer 
participated (p=.001). Fewer women (38%) than men (62%) were approached for this study. 
In addition, women less often participated (43%) than men (66%). Of the 313 patients, 279 
(89%) had a partner of which 205 (74%) participated. Since partner-related variables were 
taken into account in this paper, only couples were included in the analyses (n=205). Of these 
205 couples, 42 patients and 40 partners did not complete Time-0 since the time between 
study recruitment and surgery was too short. At Time-1, 148 patients and 141 partners 
participated (missing: 10/10; dropout: 23/28; not yet completed Time-1: 25/27, respectively). 
At Time-2, 123 patients and 114 partners participated (missing: 14/14; dropout: 35/35; ongoing: 
35/35, respectively). Finally, at Time-3, 104 patients and 89 partners participated (missing: 3/7; 
dropout: 49/60; ongoing: 49/49, respectively). For patients, time-invariant characteristics are 
presented in Table 1 while time-varying factors are presented in Table 2. 
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Age at time of survey 62.0±8.6









Low anterior resection 84 (41.0%)
Abdominoperineal resection 35 (17.1%)
Hemicolectomy/ileocecal resection 29 (14.1%)
Sigmoid resection 27 (13.2%)
Other 27 (13.2%)
Unknown type of surgery 3 (1.5%)
Type of radiotherapy (RT)
No RT 135 (65.9%)
Preoperative RT 42 (20.5%)
Intra-Operative RT 19 (9.3%)









Type of chemotherapy (CT)
No CT 145 (70.7%)
Postoperative CT 50 (24.4%)






Note: Neuroticism range = 12-60. Trait anxiety range = 10-40.
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Table 2  Descriptives for the time-varying predictors 
Time-0 Time-1 Time-2 Time-3
Mean±SD (M±SD) (M±SD) (M±SD)
QoSL (WHOQOL-100)
patients 13.4±3.6 12.1±3.6 12.1±6.0 12.5±3.9
partners 13.6±3.4 12.1±3.2 12.1±3.3 12.4±3.4
Relationship (mal)adjustment (MMQ)
patients 13.3±7.2 13.7±9.2 14.7±8.4 14.9±8.4
partners 14.5±8.2 15.7±8.5 16.0±8.9 15.8±10.3
SF (z-score)
patients -2.5±1.0 -2.1±1.0 -1.3±1.0 -1.4±1.0
partners -2.4±1.0 -1.7±1.0 -1.3±1.0 -1.3±1.0
Non-sensuality (GRISS)
 patients 6.4±2.9 7.1±2.8 7.3±3.2 7.1±3.1
Avoidance (GRISS)
 patients 5.3±2.6 5.8±2.8 5.8±2.5 5.7±2.7
Non-Communication (GRISS)
 patients 5.1±1.8 5.6±2.8 5.2±1.8 5.2±1.9
Depressive symptoms (CES-D)
 patients 5.9±6.7 5.64±5.6 5.8±6.5 4.8±6.1
Body Image (BIS)
patients 24.5±13.4 18.7±8.3 17.8±7.2 18.5±8.0
Fatigue (FAS)
patients 19.5±5.7 22.2±6.6 21.8±7.1 20.3±6.3
Abbreviations: Time-0: Preoperative measurement, Time-1: 3 months follow-up, Time-2: 6 months follow-up, 
Time-3: 12 months follow-up. BIS: Body Image Scale [range 10-40], CES-D: Center for Epidemiological Studies- 
Depression Scale [range 0-48], FAS: Fatigue Assessment Scale [range 10-50], GRISS: Golombok-Rust Inventory 
of Sexual Satisfaction, MMQ: Maudsley Marital Questionnaire [range 0-80], QoSL: Quality of Sexual Life, SF: 
Sexual Function, STAI: Spielberger State-Trait Anxiety Inventory [range 4-24], WHOQOL-100: World Health 
Organization Quality of Life assessment [range 4-20]. 
Note: Higher scores indicate more problems, except for the QoSL and SF domains. For these domains higher 
scores indicate a higher QoSL or SF, respectively.
Relationship between SF and QoSL
At each time point a significant association was reported between SF and QoSL. At Time-0 a 
moderate correlation was reported (r=.47, p=.01), while at Time-1 a high association was noted 
(r=.64, p=.01). The correlation decreased at Time-2 (r=.21, p=.05), but subsequently increased to 
the baseline level at Time-3 (r=.45, p=.01).
Course and predictors of patients’ SF 
The selection procedure showed that a higher age (p=.002, Block 1), having rectal cancer 
(p=.001, Block 1), more anxiety (p=.009, Block 3), more depressive symptoms (p=.004, Block 
3), more fatigue (p=.001, Block 3), not being sexually active (p=<.001, Block 4), more non-
sensuality (p=.006, Block 4), higher levels of partners’ SF (p=<.001, Block 5), and not having 
a stoma (p=.011, Block 6) predicted the course and level of patients’ SF and were, therefore, 
included in the final model (Table 3, Part I). 
In this final model the Estimated Marginal Means (EMM) showed a non-significant change 
in SF over time (p>.05). A higher age (β=-.02), more fatigue (β=-.02), no sexual activity (β=-.81), 
higher partners’ SF (β=.24), and having a stoma (β=.24) contributed significantly to patients’ 
lower SF (p<.05). For the significant time-varying predictors, the between- and within-subject 
analyses showed that patients who on average reported not to be sexually active had on 
average lower levels of SF (between-subjects effect, β=1.03, p<.001, Table 3, Part II). Moreover, 
patients that showed a positive change in sexual activity on a time point also showed a positive 
change in SF (within-subjects effect, β=.62, p=.001). Patients that on average were more tired 
scored on average lower on SF (between-subjects effect, β=-03, p=.012). Finally, if the partners 
reported on average higher SF this predicted on average better SF for the patients (between-
subjects effect, β=.32, p=.001). 
Finally, there was a significant interaction effect between time and gender (p=.002, see 
Figure 1a and Table 3, Part III). Overall, the scores on SF fluctuated across time, but the 
difference between men and women was only significant at Time-1. At this time point women 
reported significantly higher SF (EMM=.24) than men (EMM=-.37, p=.005). The interaction 
between time and type of tumor was not significant (results not shown). 
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Table 3  Estimates of fixed effects for SF
95% CI






Timeb     .093    
Time-0 (intercept) 0.05 0.23 .838 -0.41 0.50
Time-1 – Time-0 -0.04 0.16 .815 -0.36 0.28
Time-2 – Time-0 0.22 0.15 .164 -0.09 0.52
Time-3 – Time-0 0.29 0.16 .070 -0.02 0.59
Age -0.02 0.01 .006 -0.04 -0.01
Male sex -0.05 0.13 .731 -0.31 0.22
Having rectal cancer -0.12 0.17 .474 -0.46 0.22
Anxiety -0.01 0.02 .626 -0.05 0.03
Depressive symptoms 0.01 0.01 .505 -0.01 0.03
Fatigue -0.02 0.01 .034 -0.04 0.00
Not being sexual active -0.81 0.15 <.001 -1.11 -0.51
Non-sensuality -0.04 0.02 .065 -0.08 0.00
Not having a stoma 0.37 0.17 .035 0.03 0.71
Partners SF 0.24 0.07 <.001 0.10 0.38
Part II
1. Fatigue: between -0.03 0.01 .012 -0.06 -0.01
Fatigue: within -0.01 0.01 .548 -0.03 0.02
2. Not being sexual active: between 1.03 0.22 <.001 0.60 1.46
Not being sexual active: within 0.62 0.18 .001 0.25 0.98
3. Partners’ SF: between 0.32 0.09 .001 0.14 0.49
Partners’ SF: within 0.16 0.09 .099 -0.03 0.34
Part III
Interaction effect Sex*Timeb     .002    
Sex at Time-0 0.53  0.27 .054 -0.01  1.06
Sex at Time-1c  -0.61 0.22 .005 -1.04 -0.19
Sex at Time-2c  0.11 0.17 .519 -0.23 0.46 
Sex at Time-3c -.157  0.19  .427 -0.52 0.22
Note: Time-0: Preoperative measurement, Time-1: 3 months follow-up, Time-2: 6 months follow-up, Time-3: 12 
months follow-up. Statistically significant results (p< .05) are shown in bold. a All predictors (except Time) are 
grand-mean centered. b Analysis of Variance (ANOVA) type III test.c Post-hoc test of simple effects.
Figure 1  Interaction effects for time and gender
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Course and predictors of patients’ QoSL
The selection procedure showed that having rectal cancer (p<.001, Block 1), higher levels of 
neuroticism (p=.037, Block 2), more depressive symptoms (p=.003, Block 3), lower body image 
(p=.019, Block 3), better SF (p<.001, Block 4), better relationship adjustment (p=.001, Block 4), 
more avoidance (p=.009, Block 4), better partners’ SF (p=.005, Block 5), higher partners’ QoSL 
(p<.001, Block 5), and not having a stoma (p=.020, Block 6) predicted the course and levels of 
QoSL. 
The EMM of the final model showed that QoSL at Time-0 was 15.8 which decreased 1.4 
points to 14.4 at Time-1, then decreased a little further to 13.4 at Time-2, and finally increased 
slightly to an EMM of 14.4 at Time-3 (p<.001, Table 4, Part I). In this model, having rectal cancer 
(β=-1.64), more depressive symptoms (β=-.09), lower SF (β=1.05), more relationship (mal)
adjustment (β=-.05), and lower partners’ QoSL (β=.30) contributed significantly to a lower 
QoSL for the patients (p<.05). 
The between- and within-subjects analyses (Table 4, Part II), showed that patients with 
more depressive symptoms or higher relationship maladjustment on a time point also 
reported a negative change in QoSL on that time point (within-subject effects, β=-.11 (p=.009) 
and β=-.07 (p=.047), respectively). Patients who on average reported a lower SF had on average 
lower levels of QoSL (between-subjects effect, β=1.36, p<.001). Moreover, patients who showed 
change in SF on a time point also showed a change in the QoSL (within-subjects effect, β=.67, 
p=.039). If partners on average reported higher QoSL then patients, on average, also scored 
higher on QoSL (between-subjects effect, β=0.30, p=.001). Also, if partners changed in their 
QoSL, then patients’ QoSL also changed (within-subjects effect, β=.30, p=.001). 
The interaction between time and gender was significant (p=.002, see Figure 1b and Table 
4, Part III). Compared with Time-1, women showed lower but comparable QoSL scores at the 
subsequent time points. However, the pattern for men differed. Men’s QoSL decreased at 
Time-1 and continued to drop at Time-2, but finally increased somewhat at Time-3. At Time-0, 
women had a significantly higher QoSL then men (p=.002, EMM=16.3 and 13.9, respectively). 
In addition, men scored significantly lower (EMM=11.7) than women (EMM=13.1) at Time-2 
(p=.035). Again, the interaction between time and type of tumor was not significant (results 
not shown).
Table 4  Estimates of fixed effects for QoSL
95% CI







Time-0 (intercept) 15.78 0.68 <.001 14.42 17.13
Time-1 – Time-0 -1.44 0.43 .003 -2.31 -0.56
Time-2 – Time-0 -2.38 0.50 <.001 -3.38 -1.37
Time-3 – Time-0 -1.41 0.45 .002 -2.32 -0.49
Age 0.02 0.02 .377 -0.03 0.07
Male sex -0.78 0.42 .066 -1.61 0.05
Having rectal cancer -1.64 0.53 .003 -2.70 -0.58
Neuroticism -0.03 0.03 .391 -0.09 0.04
Depressive symptoms -0.09 0.03 .001 -0.15 -0.04
Body image -0.05 0.03 .081 -0.11 0.01
SF 1.05 0.22 <.000 0.61 1.48
Relationship maladjustment -0.05 0.02 .027 -0.09 -0.01
Avoidance -0.04 0.08 .670 -0.20 0.13
Partners’ SF 0.20 0.24 .392 -0.26 0.67
Partners’ QoSL 0.30 0.06 <.001 0.17 0.43
Not having a stoma -0.12 0.53 .815 -1.17 0.93
Part II
1. Depressive symptoms: between -0.08 0.04 .073 -0.02 0.01
Depressive symptoms: within -0.11 0.04 .009 -0.18 -0.03
2. SF: between 1.36 0.28 <.001 0.79 1.92
SF: within 0.67 0.31 .039 0.03 1.28
3. Relationship maladjustment: 
between
-.03 0.03 .232 -0.09 0.02
Relationship maladjustment: within -0.07 0.04 .047 -0.14 -0.00
4. Partners’ QoSL: between 0.30 0.08 .001 0.13 0.47
Partners’ QoSL: within 0.30 0.09 .001 0.12 0.49
Part III
Interaction effect Sex*Timeb     .002     
Sex at Time-0 -2.37  0.69 .002 -3.78 -0.95
Sex at Time-1c  0.63 0.61 .301  -0.59 1.85
Sex at Time-2c  -1.36 0.63 .035 -2.62 -0.10
Sex at Time-3c  0.73 0.89 .411 -1.03 2.48
Note: Time-0: Preoperative measurement, Time-1: 3 months follow-up, Time-2: 6 months follow-up, Time-3: 12 
months follow-up. Statistically significant results (p < 0.05) are shown in bold. QoSL: Quality of Sexual Life. a 
All continuous predictors (except Time) are grand-mean centered. b Analysis of Variance (ANOVA) type III test 
c Post-hoc test of simple effects
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Few clinical variables were significant predictors of patients’ SF and QoSL. Not having a 
stoma was predictive for better SF while having rectal cancer predicted a lower QoSL. The lack 
of other significant clinical predictors may seem remarkable as earlier studies have shown that 
radiotherapy36-38, but especially surgical nerve damage (which can be roughly estimated based 
on type of surgery) seems to play an important role in the occurrence of sexual dysfunction.38 
However, type and location of the tumor leads to a protocolled treatment schedule. The 
presence of inherent multicollineartiy between the treatment related variables makes it 
difficult to find significant unique effects of each variable separately, especially since the 
number of patients included in the analyses was limited. 
An important methodological consideration that needs to be acknowledged concerns the 
questionnaires used in the current study. While validated and reliable questionnaires were 
used, a difficulty lied in obtaining one SF score (regardless of gender). For men, aspects such 
as erectile and ejaculatory (dys)function were measured while women answered questions 
regarding problems with lubrication or pain during intercourse. Therefore, sex-specific sum 
scores were transformed into z-scores and combined in one SF score. This resulted in a loss 
of information. Unfortunately, it was not possible to evaluate the specific effects of each SF 
domain on the QoSL for men and women separately, due to a limited sample size. However, 
the significant interaction between time and gender showed that the SF and QoSL trajectories 
are different for men and women. Therefore, future more in-depth studies in this area are still 
warranted. 
Conclusion
This study shows that SF and QoSL are related but distinctive constructs, for which different 
biopsychosocial predictors were identified. SF did not change significantly over time, while 
the QoSL decreased from Time-0 to Time-1 and Time-2 and finally increased somewhat at 
Time-3. Therefore, it is important that health care professional not only pay attention to the 
patient’s SF, but also to his/her QoSL. The significant contribution of partners’ SF and QoSL 
to patients’ SF and QoSL suggests interdependence between patients and partners. Finally, 
the significant interaction between time and gender suggest that SF and QoSL trajectories 
differ for men and women. Future research is needed in order to evaluate gender effects and 
interdependence between patients and partners more in depth. 
Discussion
Compared to the preoperative scores, patients’ SF did not change significantly during the 
first year after surgery. However, the course of patients’ QoSL did change. Compared to the 
preoperative assessment, patients’ QoSL was significantly lower at three, six, and 12 months 
postoperative. Evaluating biopsychosocial predictors of patients’ SF and QoSL revealed that 
a higher age and having a stoma contributed to lower scores on SF, but did not contribute to 
QoSL. The association between sexual dysfunction and a higher age1,2 and having a stoma1,30,31 
has been previously reported. Furthermore, patients who on average were more tired scored on 
average lower on SF, but this association was not found for the QoSL. This result is in line with a 
previous cross-sectional among colorectal cancer survivors.32 Moreover, mood (i.e., anxiety and 
depressive symptoms) did not predict SF, but depressive symptoms on a time point did predict 
a negative change in QoSL on that time point. In previous research, results are mixed. Milbury 
et al., 20137 did not find a significant association between depressive symptoms and SF, while 
depressive symptoms were associated with both SF and sexual enjoyment in the study of Den 
Oudsten et al., 201232. Therefore, more research examining the relationship between fatigue 
and SF and QoSL is still needed. 
Several observations regarding the relatedness between SF and QoSL can be made. Patients 
that on average reported a lower SF had on average lower levels of QoSL and a change in SF on 
a time point also predicted a change in QoSL at the that time point. This finding supports the 
idea that the constructs SF and QoSL are inter-related. However, a high correlation between 
SF and QoSL was only reported at Time-1. Thus, even though these concepts are related, 
they may be best viewed as separate constructs. The distinction between both constructs is 
further supported by the fact that different predictors were found for the QoSL and SF (see 
above). Finally, this study indicates that SF, relationship (mal)adjustment, and QoSL can be 
conceptualized as constructs ranging from narrow to broad: Being sexually active (with or 
without sexual intercourse) was both between- and within-subjects associated with SF, but 
not with the QoSL. Additionally, higher relationship maladjustment on a time point predicted a 
negative change in QoSL on that time point, but relationship maladjustment did not predict SF. 
Another interesting finding is that partners’ SF and QoSL were predictive for patients’ SF and 
QoSL, respectively. Therefore, interdependence between patients and partners seems present. 
While previous research has already addressed the importance of evaluating and addressing 
the consequences of cancer from a couple-based perspective33-35, this is the first study that 
incorporated partner-related variables as predictors for patients’ SF and QoSL. Future studies 
are required to more specifically evaluate interdependence between patients’ and partners’ SF 
and QoSL. 
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Cancer not only affects the patient but also the partner. In fact, couples may react as a unit 
rather than as individuals while coping with cancer (i.e., dyadic coping). We assessed (i) the 
relationship between dyadic coping and Relationship Function (RF) in couples coping with 
cancer and (ii) whether intervention studies aimed at improving dyadic coping were able to 
enhance the RF of these couples. Recommendations for future studies are provided.
Method
A systematic search was conducted to identify all eligible papers between January 1990 and 
September 2012. The databases PubMed, PsycINFO, the Cochrane Library, and EMBASE were 
screened.
Results
Most studies (n=33) used an appropriate study design, adequate measurements, adequate 
analytical techniques, and a sufficient number of included participants to answer addressed 
research questions. However, the definition and assessment of dyadic coping strategies 
differed, which hampered comparison. Coping styles characterized by open and constructive 
(cancer-related) communication, supportive behaviors, positive dyadic coping, and joint 
problem solving were related with higher RF, whereas dysfunctional communication patterns 
(e.g., protective buffering, demand-withdraw communication), unsupportive behaviors, and 
negative dyadic coping were related with RF. The results of the intervention studies were 
inconsistent: while some studies reported a beneficial effect on RF, other studies report 
no such effect, or only found a positive effect in couples with fewer personal relationship 
resources. 
Conclusions
This review showed that adequate dyadic coping may improve RF, while dysfunctional dyadic 
coping may impede RF. In order to increase the comparability of the reported findings, a more 
uniformly conceptualized perspective on dyadic coping is needed. A better understanding of 
the dyadic challenges couples coping with cancer may face and more insight on how to expand 
the dyadic coping of these coupes may facilitate improvements in the quality of cancer care. 
Couple-based intervention studies may increase the couples’ RF. However, future research is 
needed to examine more specifically which couples may benefit from such interventions.
Statement of contribution 
‘What is already known on this subject?’ 
Dyadic coping may influence the distress experienced by both members of the couple and 
their Relationship Function (RF). Several reviews already reported on the potential of couple-
based interventions to improve the dyadic coping of couples coping with cancer and on 
the beneficial effects of this coping on the psychosocial adjustment and RF of patients and 
partners.1-3 However, even though we now know that couple-based intervention might be 
useful, no systematic review has been conducted that focuses specifically on the mechanisms 
of dyadic coping itself. 
‘What does this study add?’
This review showed the importance of stress communication, supportive behaviors, and 
positive dyadic coping for the maintenance or enhancement of RF in couples coping with 
cancer. In addition, the dyadic intervention studies send an important message that encourages 
to further examine the potential benefit of such interventions in the future. However, more 
consensus in the conceptualization and assessment of the dyadic coping styles is needed in 
order to increase the comparability of the reported findings. 
Introduction
There is a growing awareness that a cancer diagnosis and its subsequent treatment not only 
affects the patient, but also the partner. Patients with cancer and their partners experience 
great levels of psychosocial distress4, which are higher than the levels of psychosocial distress 
in the general population.5-8 Having to incorporate ongoing cancer-related experiences may 
also influence the quality of life of patients and partners.9
Cancer and other chronic illnesses were for a long time viewed as individual stress 
experiences demanding individual coping efforts. However, since the 1990’s researchers 
started to consider stress and coping as interpersonal processes10-12 Consequently, the partner’s 
burden caused by the patient’s illness started to be considered.13,14 The interdependence 
between patients and partners was further supported by a meta-analysis indicating a relevant 
intercorrelation between the psychological distress of patients and partners.15 Therefore, a 
solely individualistic view, where patient and partner experience cancer separately and deal 
with it in a role-related perspective (as patient and caregiver), seems outdated. Instead, cancer 
or other severe chronic illnesses may be best considered as stressors concerning both partners 
simultaneously (cancer as a “we-disease”16,17).
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In 2005, Bodenmann defined ‘dyadic stress’ implying that a stressful event or encounter 
always concerns both partners either directly, if both partners are confronted by the same 
stressor or when the stress originates inside the relationship, or indirectly when the stress 
of one partner spills over to the relationship and in that way affects both partners.18 Cancer 
represents such a dyadic stressor; cancer not only threatens the patients’ life, which demands 
restoring his/her physical, psychological, and social homeostasis, but is also stressful for the 
other partner. The partner has to adapt to the patients’ illness, has worries about the patient, is 
burdened by taking over the patient’s tasks and by providing support and caring, experiences 
important restrictions in his/her social life, might suffer from economic consequences, and/or 
is threatened by an insecure future.
Beyond and above individual coping, dyadic coping is an additional form of (dyadic) stress 
management.19,20 Dyadic coping can be defined as the attempt of one member of the dyad to 
help reduce the stress perceived by the other member of the dyad and as a common endeavor 
to cope with stress that originates inside the relationship.10 This coping process is regarded as 
a circular bidirectional sequence that is influenced by interdependence of partners.21,22 There is 
empirical evidence that dyadic coping involves stress communication and support exchange, 
but is more than social support.23 Dyadic coping entails that both partners are mutually 
involved in the stress coping process; providing and receiving support from each other and 
engaging in joint problem-solving activities and shared emotion regulation.10,23 Therefore, 
couples may react as a unit rather than as individuals in the face of cancer.15,24,25 
Different dyadic coping theories have emerged, which all recognize interdependence 
between both members of the dyad.10,11,25-28 Most dyadic coping theories emphasize that 
dyadic coping does not only entail congruence in the individual coping of both members of 
the dyad, but represents an interpersonal form of coping that goes beyond individual coping 
congruence or discrepancy.10,11,21,25 According to the Systemic-Transactional Model10,28 (STM), 
the dyadic coping process is an interplay between (non) verbal stress signals of one or both 
members of the dyad (e.g., stress communication), the perception and decoding of these 
signals by the other partner and his/her reactions (e.g., (un)supportive behaviors), and joint 
dyadic coping efforts. Joint (or common) dyadic coping will be likely when both partners are 
similarly concerned by the stressor and perceive it as a ‘we-stress’. Hereby, the level of distress 
and Relationship Function (RF) not only depends on the extent to which both partners cope 
together but also on the quality and effectiveness of their coping attempts.29
As mentioned above, dyadic coping has two primary objectives: the reduction of distress 
for both members of the dyad and the preservation or enhancement of RF.21 In this review, we 
chose to focus on the latter objective of dyadic coping (i.e., RF). Conceptually RF refers to an 
ever-changing process with a qualitative dimension which can be evaluated in any point in time 
on a dimension ranging for adjusted to maladjusted.30 Deterioration of RF is often presumed 
to be related with chronic everyday stress or major stress events, such as cancer, that have 
an important impact on the couple or are poorly handled.31 However, maintaining a satisfying 
RF during and after the treatment of cancer is important, because RF is a key predictor of a 
person’s well-being.32,33 Dyadic coping may reduce stress in both partners ‘a sorrow shared is 
a sorrow halved’ but, and even more importantly, increases mutual confidence, intimacy, and 
cohesion.18,34
In sum, couples may react as a unit rather than as individuals when coping with cancer, which 
influences the distress experienced by both members of the couple and might impact their 
RF. The importance of adopting a couple-based perspective to coping with cancer has been 
acknowledged by several systematic reviews and meta-analyses.1-3,15 These reviews reported 
on the benefits of couple-based interventions to improve quality of life.1-3 In addition, they 
reported potential beneficial effects of this dyadic coping on the psychosocial adjustment and 
RF of patients and partners.1-3 However, even though we know that couple-based intervention 
might be useful, no systematic review has been conducted that focuses specifically on dyadic 
coping itself. 
Therefore, the primary aim of the current systematic review was to examine which forms of 
dyadic coping are related with RF in couples coping with cancer. In order to provide a complete 
view we additionally described if intervention studies aimed at improving dyadic coping were 
able to enhance the RF of these couples. 
Methods
Search strategy
A systematic computerized search was performed in Pubmed, EMBASE, PsycINFO, and the 
Cochrane Library. All searches were performed on 3 September 2012. The databases were 
searched with combinations of (i) neoplasms [Mesh], neoplasm* OR tumor* OR tumour* 
OR cancer* OR lymphoma* OR malignan* OR oncolog* OR carcinom* OR melanom*, (ii) 
partners [Mesh] OR couple* OR partner* OR marit* OR dyad*, (iii) intimacy OR distress 
OR communication [Mesh] OR support* OR sexuality [Mesh] OR adjustment, and (iv) 
psychological OR psychosocial OR “quality of life” [Mesh]. The search was restricted to studies 
published between January 1990 and September 2012 because the concept of dyadic coping 
has been evaluated in couples coping with cancer since the early 1990’s. The reference lists 
of the retrieved studies and other key reviews1-3,25,35 were checked in order to capture other 
relevant publications, which were not found in the computerized database searches. 
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Selection criteria
All studies that met the following criteria were included: (i) the primary or secondary 
objective of the article was to evaluate the relationship between dyadic coping and RF, (ii) the 
population studied consisted of both patients and their partners (studies including children 
or other family members, without separate partner analyses, were excluded), (iii) the cancer 
was diagnosed in adulthood, (iv) the article was a full report published in English or Dutch, (v) 
the article presented an original report with either a quantitative or a qualitative design (e.g., 
reviews and letters to the editor were excluded), and (vi) the studies were published in peer-
reviewed journals.
Data extraction
First, the search results from the separate databases were combined. Next, duplicates 
were removed. After removing duplicates one author (MJT) applied the described inclusion 
criteria in a standardized manner. First, the titles of the manuscripts were evaluated to assess 
suitability. For the studies that were not excluded based on the title, the abstract was screened 
to evaluate if the manuscript might fit the inclusion criteria. If suitability was expected, hard 
copies of the manuscripts were obtained. If during each of these steps there was doubt about 
the suitability of the manuscript, then the manuscript was included in the next, more specific, 
step. For the remaining studies, the manuscripts were read to examine if the article fitted the 
inclusion criteria. If there was doubt about the suitability of the manuscripts during this phase 
then this article was discussed with another author (BLDO). Finally, the reference lists of the 
retrieved studies and other key reviews were checked. If there were multiple reports of the 
same study with a similar study objective, only the most recent study was included. For the 
selected articles (n=33), the results regarding the association between one or more aspects of 
dyadic coping and RF were included in this review.
Data synthesis
The included studies relied on different study designs to examine the relationship between one 
or more aspects of dyadic coping and RF in various cancer populations. In addition, the studies 
differed with regard to the theory/model used to evaluate dyadic coping (for an overview of 
the different theories and models we refer to Revenson & Lepore, 201222). The different dyadic 
coping approaches led to heterogeneity in the operationalization of (aspects of) dyadic coping, 
which, however, reflects the current status quo in this field. Due to this heterogeneity, it was 
not possible to perform a meta-analysis. Furthermore, various definitions of RF and different 
measures assessing this variable complicated the analysis further (e.g., relationship (mal)
adjustment, relationship satisfaction, and/or relationship quality). Because the definitions all 
reflect the subjective evaluation of the relationship at a certain point in time, we reframed 
these different definitions into RF to have a more comprehensible outcome measure. 
The results of the prospective and intervention studies will be described in more detail, 
while the results of cross-sectional and qualitative studies will only be used to evaluate if 
they confirm the findings of the prospective and intervention studies. These descriptions 
will be brief. The results of the observational studies are for clarity purposes presented in 
three separate paragraphs based on the STM model10,21: (i) communication patterns related 
with RF, (ii) (un)supportive behaviors or (dys)functional behaviors related with RF, and (iii) the 
relationship between common/joint dyadic coping and RF. 
Data allocation was performed based on the constructs examined in the studies: studies 
focussing solely on communication patterns are described in the first paragraph, studies that 
examined a broader perspective (e.g., communication patterns in combination with support 
exchange) are listed in the second paragraph, and studies focussing on dyadic coping are 
presented in the third paragraph. However, an important note is that the paragraphs are 
interconnected as most (un)supportive behaviors can be seen as communicative since they 
symbolize the extent of commitment to the relationship and to their partner.36,37 In addition, 
the reversed direction can be applied as well: negative communication behaviors can also be 
viewed as unsupportive behaviors. 
Additionally, different checklists were used to evaluate the included studies: (i) a checklist 
for observational studies (STROBE: STrengthening the Reporting of OBservational studies 
in Epidemiology38), (ii) a checklist for qualitative studies (COREQ: COnsolidated criteria for 
REporting Qualitative research39), and (iii) a checklist for experimental studies (CONSORT: 
CONsolidated Standards Of Reporting Trials40). In case of disagreements between raters, the 
authors discussed the differences in opinions and carefully selected the most appropriate one.
An overview of the dyadic coping strategies analyzed and the association of these strategies 
with RF is presented in Table 1 (page 150) for the observational studies and Table 2 (page 162) 
for the intervention studies. An overview of the checklist items for each study is available as 
Supporting Information.




Combining the search results resulted in 3135 hits. After removing duplicates 2016 hits 
remained out of which 1875 articles were excluded, based on the evaluation of titles and 
abstracts. Hard copies were obtained of 121 articles, of which 34 met the inclusion criteria. The 
excluded studies did not focus on the association between dyadic coping and RF, focused only 
on the (psychological) functioning of the patient or partner, or included other family members 
without separate partner analyses. Three articles were excluded based on the multiple reports 
criterion. Two additional articles were found by means of cross-referencing. Thus, a total of 33 
studies were included in this review (see Figure 1).
Study characteristics 
Based on the checklists, improvements in the reporting quality of the studies are needed in 
order to be able to assess the risk of bias more adequately (see Supporting Information). All 
in all, studies varied considerably with regard to their study characteristics (see Tables 1 and 
2). In total, there were 14 (43%) cross-sectional studies of which six were (18%) qualitative 
studies. In addition, there were 10 (30%) observational prospective studies, and nine (27%) 
intervention studies. For the prospective studies, the study duration ranged from seven 
days up to 12 months. Fifteen studies (46%) examined couples coping with breast cancer, 6 
(18%) studies concerned prostate cancer, 3 (9%) studies concerned lung cancer, three (9%) 
studies examined couples coping with gastrointestinal cancer, one study (3%) evaluated 
coping after a hematopoietic stem cell transplantation, and five studies (15%) investigated 
a range of cancer types. Sample sizes varied greatly in the different studies and ranged from 
10 to 282 participants. Nevertheless, most studies included a sufficient number of patients 
and partners to answer their research questions. Especially the more recent studies included 
analyses comparing responders with non-responders and/or study completers with study non-
completers (if applicable). 
However, the way researchers handled missing data and loss to follow-up (if applicable) 
was often unclear. In most studies, the majority of the participants were middle-aged, while 
elderly patients (i.e., >75 years) were included and/or participated to a lesser extent. Not all 
studies yielded information on the ethnic background of the participants. However, the studies 
that did provide this information reported that more than 70% of the included participants 
were Caucasian, with exception of one study. In this study only 62% of the participants were 
Caucasian, however, this study had a low sample size (n=36, Ptacek et al., 199441). All studies 
Figure 1  Study selection process
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were conducted with heterosexual couples. Thus, the generalizability of most studies was 
limited. Based on the objectives of the studies, adequate study designs were chosen. The 
studies used psychometrically sound questionnaires or used adequate qualitative techniques. 
Overall, adequate techniques were used to analyze the data. The Dyadic Adjustment Scale 
(DAS) was most frequently used to assess dyadic adjustment (n=12; 36%). Moreover, in the 
last few years statistical techniques designed to measure the interdependence between 
both members of the couple, such as the Actor-Partner Interdependence Model, have been 
frequently applied.24,37,42-44 Study findings were generally well summarized. However, many 
studies could benefit from a more deepened discussion of sources for potential bias and/
or imprecision and a better integration of the work in the existing literature (not limited to 
studies that support the results of the conducted study).
The possible bonding effect of cancer
Facing cancer as a ‘we-disease’ may result in a strengthening of the relationship between 
partners. For instance, 42% of couples facing non-metastatic breast cancer reported that 
illness experience and its treatment had increased cohesion among partners, up to one year 
after diagnosis.45 Occasionally, only the patient or the partner reported getting closer, with no 
effect found in the other partner (14% and 20%, respectively). Finally, 6% of the couples had 
one partner reporting emotional distance, and in <1% of couples this was the case for both 
partners. An increased cohesion was also reported in the majority of qualitative studies16,46-51, 
except for one study in which no such effect was found52.
The association between communication patterns and RF
How both partners communicate with each other has important implications for RF. Manne et 
al. (2006)53 reported that for both members of the dyad, mutual constructive communication 
about breast cancer-related issues was related with higher RF, while demand-withdraw 
communication was related with lower RF. Mutual avoidance of discussing problems was 
not related with RF at all.53 Breast cancer-related relationship communication was stable 
within a nine month follow-up period.53 These results were expanded by Badr et al. (2008)42 
who examined if communication about the relationship, instead of talking about cancer-
related concerns, influenced relationship satisfaction. They found that patients and partners 
who reported more frequent discussions about their relationship reported higher RF over 
a 6-month period after diagnosis and/or treatment, regardless of gender.42 The positive 
relationship between constructive communication and RF was consistently supported by 
cross-sectional43,46,54-57 and qualitative studies47,49,51,52. 
The association between (un)supportive  
or (dys)functional behaviors and RF
Badr and Taylor (2008)37 examined relationship maintenance behaviors (i.e., positivity, 
openness, assurances, social networks, and shared tasks) in couples coping with lung cancer. 
Their results showed that if both partners were more engaged in relationship maintenance 
behaviors they both reported better RF up to six months after treatment.37 
The importance of adequate spousal support was further established by Langer, Brown, 
and Syrjala (2009)58 and Pasipanodya et al. (2012)59. Langer et al. (2009) showed that protective 
buffering (i.e., hiding concerns, denying worries, and avoiding discussions) reduced RF in a 
50-days follow-up study among couples coping with a stem cell transplantation.58 The more 
participants buffered their partner (and felt buffered by their partner), the lower their RF 
was.58 In addition, the partners buffered patients more than vice versa .58 The 7-day diary study 
of Pasipanodya, et al., (2012) focused on couples coping with breast cancer and showed that 
greater patient-reported and partner-reported social constrains to a reciprocal disclosure of 
thoughts, feeling, and concerns was related with lower levels of each partner’s own reports of 
average daily intimacy and RF.59 
Two studies focused more explicitly on support exchange.44,60 One of these studies, a 
12-month prospective study among various cancer types, showed that both the provision 
of adequate support and support concordance between patients and partners were related 
with higher RF.60 In the second study, the role of past spousal supportiveness (i.e., the degree 
to which the spouse was generally responsive to the individual’s needs before the couple 
was confronted with cancer) has been evaluated.44 Three months after treatment RF was 
maintained if past spousal supportiveness was high, even if the partner was currently not very 
responsive to the individual’s needs.44 However, at nine months follow-up, hiding concerns 
and minimizing the other partner’s concerns was negatively related with future RF.44 Again, 
the cross-sectional47,50,54,57,61 and qualitative studies16,48,51 confirmed the prospectively obtained 
results. 
The association between joint dyadic coping and RF
Finally, one prospective study included behaviors beyond support exchange (i.e., stress 
communication and/or (un)supportive coping).24 This study, among couples coping with 
metastatic breast cancer, examined the degree to which both partners worked together to 
manage dyadic stress and restore or maintain the balance in their relationship.24 They found 
that the couples that were using joint positive dyadic coping (i.e., joint problem solving, 
joint information seeking, sharing of feelings, mutual commitment, and relaxing together) 
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experienced higher RF than patients and partners who used joint negative dyadic coping 
(i.e., hiding concerns from each other, mutual denying of worries, and avoidance of shared 
discussion).24 Furthermore, individuals who perceived their partners as more supportive and 
less unsupportive had better RF up to six months after breast cancer treatment, regardless of 
their role.24 Joint dyadic coping was also examined in three qualitiative studies who all found 
that this form of coping was benificial for RF.16,48,50 
Intervention studies aimed at improving RF
In the past 10 years, several intervention studies aimed at improving the dyadic coping and 
RF of couples coping with cancer have been conducted (see Table 2, page 162). At 1-year 
follow-up an increase in RF was reported after couple therapy.62 Another intervention study 
aimed at restoring perceptions of equity reduced the levels of perceived underinvestment and 
overbenefit and improved RF.63 In addition, partner-assisted emotional disclosure, instead of 
a couples’ education/support condition, yielded improvements in RF and intimacy for couples 
in which the patient initially reported high levels of holding back.64 Furthermore, comparing 
a couple-skills intervention (Side by Side) with a psycho-education program (Couples Control 
Program) showed that women in the couple skills intervention scored higher on RF after 
treatment.65 Finally, couples in a psychosexual intervention group reported higher RF three 
months after mastectomy compared with baseline and compared with the control group.66 
However, in another study no differences were found between a telephone-intervention and a 
face-to-face intervention, perhaps due to a limited sample size. Compared with care as usual, 
a trend towards higher RF was noted in favor of both interventions.67 A sexual rehabilitation 
program found improvements in male distress and male and female global sexual functioning, 
in both the counseling together and the men-attend alone group.68 However, RF did not 
improve, most likely because the couples already reported high RF at baseline.68 Moreover, 
pre-intervention psychological and relationship factors largely moderated the effects of 
intimacy-enhancing therapy.69 Intimacy-enhancing therapy was only effective in couples with 
fewer personal relationship resources.69
Discussion
This review shows the importance of stress communication, supportive behaviors, and adequate 
dyadic coping for the maintenance or even enhancement of RF. More specifically, couples 
who were able to express their worries, feelings, and needs regarding cancer-related issues 
or their relationship reported higher RF. There are several reasons why stress communication 
might be beneficial. First, talking about one’s worries and needs allows couples to share the 
experience more adequately, building the basis for a definition of cancer as a ‘we-disease’16 
and allowing joint coping efforts24. Second, according to the optimal matching model of social 
support, sharing experiences by mutual emotional stress communication (self-disclosure of 
both partners) allows a better matching of needs and mutual support70, which covaries with 
higher relationship satisfaction71. Third, adequate self-disclosure of both partners may also 
indicate that the couples’ relationship is characterized by mutual trust and intimacy and that 
partners are used to rely on each other. Even though cancer may affect both partners’ lives 
significantly, they can build on previous experiences of mutual support and investment in the 
relationship.44 Fourth, it seems relevant that open and constructive dyadic communication not 
only concerns cancer-related issues but also the couple’s life in general (e.g., Badr et al., 200842). 
Therefore, enlarging the scope of communication and framing it in the general context of 
ongoing daily experiences of both partners is important.42,49 Since (stress) communication was 
found to be beneficial, it is not suprising that demand-withdraw communication or avoiding 
communication revealed to be dysfuntional.24,53,58,59 Not only communication strategies, but 
also supportive or dysfunctional behaviors and dyadic coping itself have been identified as 
highly relevant for relationship outcome in couples dealing with cancer. Couples’ coping 
characterized by supportive behaviors, active engagement, joint positive dyadic coping, and 
joint problem solving was related with higher RF, whereas unsupportive or dysfunctional 
behaviors (e.g., overprotection) were related with lower RF. These findings make sense. For 
the patient both protective buffering as well as overprotection do not reflect a thoughtful, 
respectful, and esteeming attitude towards the patient but attribute him/her the role of 
the impaired, deficient subject in need, ignoring or not valuing the patient’s self-efficacy, 
resources, and strengths. The findings emphasize the importance of addressing unsupportive 
behaviors and dysfunctional dyadic coping in both cancer research and treatment since these 
aspects coexists regularly with lower RF. Our results corroborate the findings of previous non-
systematic overviews which also noted that high RF during or after the treatment for cancer 
may, from a dyadic perspective, depend on how well the couple integrated cancer into their 
lives.25,35 Finally, our review indicates that couple-based interventions may have beneficial 
effects on RF. 
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Dyadic coping research is a relatively new field of expertise (i.e., the majority of studies has been 
conducted since 2000). Therefore, some additional notes regarding the progress and current-
status of the field are important. The earlier studies were mainly addressing the patient and the 
partner as separate entities while the more recent ones were able to apply statistical techniques 
equipped to focus on the dyad as the unit of analysis (i.e., Actor-Partner Interdependence 
Model72). In addition, the earlier, mostly cross-sectional, studies often reported RF as a state 
condition. In the more recent studies mostly prospective designs were applied, sometimes 
combined with an intervention. In these prospective studies, stress communication, supportive 
behaviors, and dyadic coping in couples dealing with cancer are no longer evaluated solely as 
a ‘snapshot’ of the continuum of (mal)adjustment at one point in time, but more accurately 
as a dynamic process. However, the studies included in this review differed with regard to the 
underlying theory/model. This theoretical heterogeneity reflected two lines of research (dyadic 
coping research originating from coping literature and social support research rooted in social 
support approaches). The different theoretical grounding inspired researchers in defining and 
selecting instruments and the design of the studies. This heterogeneity made it difficult to 
clearly summarize and categorize the results. For each outcome variable there was often an 
insufficient number of studies which did not allow meta-analysis or subgroup analyses. One of 
the main challenges for future research will, therefore, be to more uniformly conceptualize the 
couples’ role in the context of cancer and how both partners are concerned and enrolled in the 
process of dealing with the disease. For this purpose a meta theory linking the dyadic coping 
approaches with the social support models is needed. This would require that researchers 
conducting dyadic coping research and social spousal support research are more aware of 
the work of each other and form collaborations in order to overcome gaps and discrepancies 
in theory and methods. The dyadic coping field has recently turned their attention to the 
potential benefits of interventions to increase dyadic coping. Future research is warranted to 
more specifically evaluate which couples may benefit from such interventions and whether or 
not these interventions can be more cost-effective. Furthermore, most studies focused on the 
association between dyadic coping and cancer-related stress. However, as cancer-related stress 
adds to general life stress and daily hassles, researchers should be more aware of this pile-up of 
stress and the role of contextual variables. Couples dealing with cancer are not only exposed to 
the challenges of the illness but to all requirements of everyday life. Dyadic coping is, therefore, 
needed for both demands. The outcomes (e.g., psychosocial adjustment, RF) probably covary 
with the quality of handling the disease as well as daily life and the interplay between disease 
and daily life. This aspect also requires further attention.With regard to the generalizability of 
findings, it is unfortunate that the majority of the included studies consisted of middle-aged, 
heterosexual, and Caucasian participants. Therefore, future studies should also include same-
sex couples, elderly participants, and ethnic minorities in order to increase the external validity 
of the current findings. Finally, based on the checklists, improvements in the reporting quality of 
the studies is needed in order to be able to assess the risk of bias (e.g., handling of missing data, 
lack of flow charts, imprecise description of sample, recruitment, methods) more adequately. 
With regard to our review, an important limitation lies in the fact that we did not consider non-
published studies (e.g., grey-literature, dissertations, master thesis); therefore, some relevant 
but not published studies may potentially be missed. In addition, as stated above we were not 
able to perform a meta-analysis due to the theoretical and methodological heterogeneity of 
studies. Another challenge lied in the fact that not a single checklist could be used. Therefore, 
a variety of different lists had to be applied according to the study design. The checklists 
incorporated in this review evaluate the extent to which the studies report important aspects 
of the research process. Even though scoring negatively on many items might be indicative for 
presumed (or evidence of) association with susceptibility of bias it does not justify classifying 
studies into low/medium/high quality since reporting quality can differ from study quality.73 
Conclusion
There is an increasing awareness of viewing cancer as a dyadic affair (we-disease). This review 
showed the importance of adequate dyadic coping in order to maintain or even improve RF in 
couples dealing with severe illness such as cancer. However, a more uniformly conceptualized 
perspective on dyadic coping is needed in order to adequately compare the results and formulate 
general conclusions. Future research is needed to more specifically examine benefits of common 
dyadic coping compared with spousal support and under which conditions (individual-, dyadic-, 
and contextual variables) and for whom this approach is beneficial or harmful. Based on these 
more detailed findings, future more personalized psychological interventions for couples 
dealing with cancer can be developed which can emphasize best practice for defined types of 
couples, individuals, and types of cancer. Thus thorough basic research on dyadic coping and 
dynamics in couples with cancer is still needed to stimulate new theoretical insights that allow 
the development of specific interventions for these couples with the aim of improving quality of 
life for both partners as well as a more favorable dealing with cancer, in the best case resulting 
in better (relational) adjustment and recovery from the disease.
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Table 1 Overview of the cross-sectional and prospective studies assessing dyadic coping  
in couples coping with cancer 
Author Couples coping 
with
No. Of dyads Design Measurement 
intervals
Independent variables Dependent 
variables
Main conclusions
Pasipanodya et al., 
201259








Greater patient-reported and spouse-reported 
social constrains were associated with lower 
levels of each partner’s own reports of average 
daily intimacy and RF. 
Walker & 
Robinson, 201251
Prostate cancer 18 Cross-sectional; 
Unstructured 
interview




Strategies couples used when trying 
to adapt sexually to the side effects 




Some couples did find ways to have a satisfying 
sexual relationship despite the man’s castrate 
level of testosterone. 
Hagedoorn et al., 
201144
Colorectal cancer 88 Prospective; 
Questionnaires
3 and 9 months 
after diagnosis
Spousal active engagement and 





Three months after treatment, spousal active 
engagement was positively associated with RF 
in patients and partners. Spousal protective 
buffering was negatively associated with RF in 
patients. However these results only applied 
when past spousal support was relatively low. 
If past spousal support was high, participants 
rated their RF relatively high, regardless of their 
partner’s current support behavior. Over time, 
past spousal supportiveness did not mitigate the 






Breast cancer 191 Prospective; 
Questionnaires
At the start of 
treatment and 
3 and 6 months 
after treatment
Stress communication, support 
responses, mutual or common 
dyadic coping (FDCT-N); Cancer-
related stress communication, 
supportive coping, unsupportive 
coping, common positive dyadic 
coping, common negative dyadic 
coping (NVQ’s)
RF (DAS) Couples using common positive dyadic coping 
experienced better RF than patients and partners 
who used common negative dyadic coping. 
Individuals who perceived their partners as more 
supportive and less unsupportive had better RF 
up to 6 months after breast cancer treatment, 
regardless of role (i.e., patient or partner).
Badr & Taylor, 
200943




Male sexual function (IIEF); 
Female sexual function (FSFI); 
Communication patterns (CPQ)
RF (DAS) When patients had poor erectile function, their 
partners were more likely to report that the 
couple avoided open spousal discussions; this 
was associated with partners’ lower RF. Patients 
and partners who reported high levels of mutual 
constructive communication reported greater 
RF, regardless of their own sexual satisfaction. 
In contrast, greater sexual dissatisfaction was 
associated with poorer RF in patients and 
partners who reported low levels of mutual 
constructive communication. Mutual constructive 
communication and mutual avoidance partially 
mediated the association between patients’ 
erectile function and their partners’ RF.
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Author Couples coping 
with
No. Of dyads Design Measurement 
intervals
Independent variables Dependent 
variables
Main conclusions
Fergus & Gray, 
200947









The relationship dynamics were divided into 
pitfalls (i.e., communication barriers, withholding-
withdrawing, under-burdening, and conflictual 
intentions) and challenges (i.e., negotiating 
support, accommodating changes in other, coping 
with sexual disruption, and incorporating death 
and separation) associated with coping with 
breast cancer as a couple. 







50 days post 
transplantation
Protective buffering (NVQ) RF (DAS) Partners buffered patients more than vice versa, 
especially at 50 days post transplantation. The 
more participants buffered their partners at 50 
days post transplantation and the more they 
felt buffered, the lower their RF. Patients who 
buffered primarily to protect their partner before 
transplantation reported increases in RF over 
time; however, when they did so at 50 days post 
transplantation, their partner reported decreases 
in RF.
Badr, Acitelli, & 
Carmack Taylor, 
200842
Lung cancer 169 Prospective; 
Questionnaires
Within 1 month 
of treatment and 
3 and 6 months 
later
Relationship talk (NVQ) RF (DAS) Patients and partners who reported more 
frequent discussions of their relationships 
reported greater RF over the six month period 
after diagnosis and/or treatment, regardless of 
gender.
Badr & Taylor, 
200837
Lung cancer 158 Prospective; 
Questionnaires
Within 1 month 
of treatment and 
3 and 6 months 
later
Relationship maintenance strategies 
(RMSM)
RF (DAS) Regardless of gender or role (i.e., patient or 
partner) it was reported that own and partner 
engagement in each of the five maintenance 
strategies (i.e., Positivity, Openness, Assurances, 
Social networks, and Shared tasks) helped to 
enhance patient and partner reported RF at 
baseline and over time.
Kayser, Watson, & 
Andrade, 200716
Breast cancer 10 Cross-sectional; 
Couples 
interviews
Within 3 months 
after diagnosis




The mutual responsive couples had the relational 
qualities of relationship awareness, authenticity, 
and mutuality. These factors were identified 
as important ingredients for a good RF and 
facilitated the participation of both partners in 
the coping process. Through mutually response 
coping there was relationship growth. Couples 
who used a disengaged avoidant style of coping 
seemed to have developed a mutual respect for 
each other’s individual response to the cancer.
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Author Couples coping 
with
No. Of dyads Design Measurement 
intervals
Independent variables Dependent 
variables
Main conclusions
Norton & Manne, 
200760




 Baseline ( ±12 
months, SD = 27) 
and 3 months 
later 
Support concordance (CSI); 
Psychologicaldistress (MHI); 
Affiliative need (IOS); Patient 
physicalimpairment (CARES)
RF (DAS) Couples had high agreement and showed greater 
concordance on unsupportive behaviors than 
supportive behaviors. Both partners’ reports 
on RF were associated with greater support 
concordance and spouses’ need for attention 
was related with lower support concordance. 
Neither length of marriage nor psychological 
distress was related with support concordance. 
Greater patient physical impairment was not 
significantly related with concordance for 
supportive behaviors but was related with lower 
concordance for unsupportive behaviors.
Badr & Taylor, 
200646






Spousal communication; denial, 
avoidance/ protective buffering, and 
conflict
RF The couples experienced a wide variety of 
social constraints; including denial, avoidance, 
and conflict that can hinder open spousal 
communication. These factors can negatively 
affect RF. Participants who reported talking with 
their partners about their relationships reported 
fewer constraints and better communication 
about cancer. Participants talked about how 
relationship talk was beneficial for their RF.
Manne et al., 
200653
Breast cancer 127 Prospective; 
Questionnaires
±4.5 months 
(SD=2.2) and at 9 
months
Mutual constructive communication, 
mutual avoidance, demand-withdraw 
communication (CPQ)
RF (DAS) For both members of the dyad, mutual 
constructive communication about breast 
cancer-related issues was associated with better 
RF, while demand-withdraw communication was 
associated with worse RF. A mutual avoidance 
of discussing problems was not associated with 
relationship quality. Patients’ perceptions of 
mutual constructive and demand/withdraw 
communication were associated with partners’ 
marital satisfaction, but not vice versa. The 
cancer-related relationship communication did 
not change over nine months follow-up.
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Author Couples coping 
with
No. Of dyads Design Measurement 
intervals
Independent variables Dependent 
variables
Main conclusions
Dorval et al., 
200545
Breast cancer 282 Prospective; 
Individual 
interviews
 2 weeks and 3 
and 12 months 
after treatment 
start




Overall, 42% said breast cancer brought them 
closer. In some cases only the patient or the 
spouse reported getting closer, with no effect 
found in the other partner (14% and 20%, 
respectively). 6% of couples had one or other 
partner reporting feeling distanced and <1% 
of couples had both partners reporting feeling 
distanced. After taking into account partners’ 
pre-diagnosis characteristics and the patient’s 
treatment, the spouse reporting the patient 
as confidant, getting advice from her in the 
first 2 weeks about coping with breast cancer, 
accompanying her to surgery, the patient’s 
reporting more affection from her spouse at 3 
months since diagnosis predicted both partners 




Breast cancer 16 Cross-sectional; 
Semi-structured 
couple interviews
Between the 10th 
and 12th month 
after diagnosis
Couple adjustment processes RF The couples’ adjustment processes seemed to 
be structured around 5 major axes: building 
up shared knowledge, mutuality, intimacy, 
constructing meaning, and solidarity with the 
social network.
Porter, Keefe, 






 ? Caregiver strain (CSI*); Perception 
of empathy (RBLRI); Disclosure and 
holding back (NVQ)
RF (MSIS) Patients and spouses reported moderately high 
levels of disclosure and low levels of holding back, 
with patients reporting higher levels of disclosure 
than spouses. Patient and spouse disclosure was 
positively associated with RF (e.g., intimacy and 











±4.2 (SD=4.8) Stress communication (CSI**) RF (MMQ) The communication style of the couples was 
characterized by a high degree of intimacy and 
in a lesser degree by successively avoidance, 
destructive, and discongruent communication. 
The negative correlation between destructive 
communication and RF appeared to be stronger 
for women than for men, irrespective of their role 
(i.e., patient or partner). The negative relationship 
between discongruent communication and RF 
was found to be stronger for healthy female 
partners than for male partners. 
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Author Couples coping 
with
No. Of dyads Design Measurement 
intervals
Independent variables Dependent 
variables
Main conclusions
Manne et al., 
200456
Breast cancer 85 Cross-sectional; 
Questionnaires
? Cancer-related issues (CII); Perceived 
self disclosure, partner disclosure, 




For patients, perceived responsiveness partially 
mediated the association between partner 
disclosure and intimacy, but self-disclosure was 
not significantly associated with responsiveness 
or intimacy. For partners, perceived 
responsiveness mediated the association 
between self-disclosure and perceived partner 
disclosure and intimacy. Partner disclosure 
predicted patient feelings of intimacy; because 
this type of disclosure was associated with 
greater feelings of acceptance, understanding, 
and caring.
Kuĳer, Buunk, 
Ybema, & Wobbes, 
200261








Perceived equity and emotions 
(NVQ’s)
RF (MMQ) On average, only male patients felt overbenefited 
in their relationship, whereas female patients felt 
equally treated. The partners of these patients 
did not feel underbenefited in their relationship. 
In general patients seemed most sensitive to 
underbenefit (i.e., reported the lowest RF) and 
experienced on average least positive and most 
negative affect when they felt underbenefited. 
Particularly, patients who were physically 
impaired felt dissatisfied and angry when 
underbenefited. The partners of these patients 
were in general equally sensitive to inequity in 











surgery, and 11-13 
months post-
surgery
Facing illness as a team, reassuring 
that things will be OK, letting people 




Keeping relationships working was one of the 
main themes. Important issues were facing illness 
as a team, reassuring that things will be OK, 
letting people help, and keeping relationships 
normal. The couples not only had to deal with 
their individual reactions, but also with each 
other’s reaction and the mutual reaction. 
Hagedoorn et al., 
200054






Active engagement, protective 
buffering, and overprotection 
(NVQ’s); Depression (CES-D); Health 
Status (RAND-36)
RF (MMQ) The positive association between active 
engagement and the patient’s RF was stronger 
for patients with a rather poor psychological 
and physical condition than for those with a 
rather good condition. Protective buffering and 
overprotection were negatively associated with 
RF, only when patients experienced relatively 
high levels of psychological distress or physical 
limitations.
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Author Couples coping 
with
No. Of dyads Design Measurement 
intervals
Independent variables Dependent 
variables
Main conclusions
Lavery & Clarke, 
199949







Active engagement, protective 
buffering
RF The partners were more actively engaged in 
meeting the demands of the illness than the 
patients. Patients employed more protective 
buffering than partners by avoiding discussions 
about their cancer or by denying their cancer-
related anxieties and concerns. The majority of 
patients reported that their RF had remained 
the same or had improved since their diagnoses, 
although a few men reported negative changes. 










Balancinglives (MDI) RF (DAS) The couples were actively working to balance two 
realities: their life as couple and their cancer-
related life. Even when the couples were jointly 
discussing aspects of the cancer, they appeared 
to avoid potentially sensitive areas related with 
the cancer recurrence. 
Ptacek, Ptacek, & 
Dodge, 199441




Self-reported coping and other-
reported coping i.e., problem-
focused coping, social support, 
self-blame, wishful thinking and 
avoidance (WCCL)
RF (DAS) The patients’ self reported coping related 
significantly to the RF of their partners, 
particularly the use of problem-focused coping 
and avoidance. Partners whose wife reported 
using more problem focused coping and less 
avoidance while undergoing radiation therapy 
reported a better RF.
Abbreviations: CARES = Cancer Rehabilitation Evaluation System, CES-D = Center for Epidemiological 
Studies – Depression Scale, CII = Cancer Issue Inventory, CPQ = Communications Pattern Questionnaire, 
CSI = Cancer Support Inventory, CSI* = Caregiver Strain Index, CSI** = Communication Skill Inventory, DAS= 
Dyadic Adjustment Scale, FDCT-N = Dyadic coping questionnaire, FSFI = Female Sexual Function Index, IIEF 
= International Index of Erectile Function, IOS = Interpersonal Orientation Scale, MCBS = Mutual Communal 
Behaviors Scale, MDI = Marital Dyad Interview, MHI= Mental Health Inventory, MMQ = Maudsley Marital 
Questionnaire, MSIS = Miller Social Intimacy Scale, NVQ = non-validated questionnaire, RAND-36 = Health 
Related Quality of Life, RBLRI = Revised Barett-Lennard Relationship Inventory, RMSM = Relationship 
Maintenance Strategies Measure, SD= Standard Deviation, SF-36 = Medical Outcomes Study General Health 
Survey, PCI = Prostate Cancer Index, WCCL = Ways of Coping Checklist Revised.
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Table 2  Overview of the intervention studies aimed at improving dyadic coping and RF in couples coping 
with cancer
Author Couples coping 
with






Miller, Goulet, & 
Fifea, 201267
Breast cancer 65 Prospective; 
Questionnaires
Prior to the 
intervention, at 
the end of the 
intervention, 6 
months after the 
intervention
Care as usual, a face-to-face 
intervention, or the intervention by 
telephone
RF (DAS) There was an equal level of RF among those in the 
telephone and face-to-face groups. Interesting 
trends in differences between the intervention 
and comparison groups on the relationship 
variables of intimacy and RF were obtained; 
however, given the sample size, power was not 
sufficient to reach statistical significance.











at the end of 
intervention, 
and 6 and 12 
months after the 
intervention
Four bi-weekly face-to-face sessions RF (QMI) Comparing a couple-skills intervention (Side by 
Side) with education (Couples Control Program) 
showed that women in the side by side 
intervention reported better relationship skills 
However, all differences favoring Side by Side 
disappeared by 16 months after the diagnosis.
Manne et al., 
201169




At baseline and 8 
weeks follow-up
Five 90 minute couples’ sessions of 
intimacy enhancing therapy (IET) or 
care as usual (no treatment)
RF (DAS) IET effects were largely moderated by pre-
intervention psychosocial and relationship 
factors. Those who had higher levels of cancer 
concerns at pretreatment had significantly 
reduced concerns following IET. Similar 
moderating effects for pre-intervention levels 
were reported for the effects of IET on self-
disclosure, perceived partner disclosure, and 
perceived partner responsiveness. Among 
partners beginning the intervention with higher 
cancer-specific distress, lower RF, lower intimacy, 
and poorer communication, IET improved these 
outcomes.
Baucom et al., 
200962






and 12 months 
follow-up
Couple-based relationship 
enhancement (RE) condintion (6 
bi-weekly face-to-face sessions) or or 
treatment-as-usual.
RF (QMI) Compared with couples receiving treatment-
as-usual, both patients and partners in the RE 
condition experienced improved RF at posttest 
and 1-year follow-up. In addition, women in RE 
showed fewer medical symptoms at both time 
periods.










and at the end of 
the intervention 
sessions
4 face-to-face sessions of either 
partner-assisted emotional 





Compared with an education/support condition, 
the partner-assisted emotional disclosure 
intervention led to improved RF and intimacy for 
couples in which the patient initially reported 
higher levels of holding back from discussing 
cancer-related concerns.
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Author Couples coping 
with





Kalaitzi et al., 
200766
Breast cancer 40 Prospective 
intervention study
2 days before 
mastectomy 
and after the 
intervention (3 
months later)
6 sessions of a combined brief 
psychosexual intervention and a 
control group
RF (NVQ) Couples in the intervention study reported better 
RF 3 months after mastectomy compared with 












1.5-2 hour home intervention 
consisting of 3 parts: (i) the couple 
was asked about the impact of 
cancer on them as a couple and 
cancer-related concerns they had 
as a couple (ii) individual session 
about how the illness impacted both 
members individually; (iii) the couple 
further elaborated on their primary 
concerns together
RF Sixty-six percent of the couples wanted to work 
in a single case occasion intensive session on 
resolving the tension in their relationship or to 
find better ways to be together as a couple. Four 
core concerns were reported: dealing with tension 
in the relationship; needing to be together as 
a couple; wondering about the children; and 
managing the threat of breast cancer.
Canada, Neese, 
Sui, & Schover, 
200568




At baseline, post 
treatment and 
at 3-month and 
6-month follow-
up
4 sessions of counseling together or 
a man attend alone (i.e., education 
on prostate carcinoma and sexual 
function and options to treat 
erectile dysfunction as well as sexual 
communication and stimulation 
skills, psychological distress, and 
utilization of treatments for erectile 
dysfunction)
RF (DAS) The sexual rehabilitation program reported no 
improvements in RF, most likely because the 
couples reported good RF at baseline.
Kuĳer, Buunk, 











week, and three 
months post 
intervention
5 bi-weekly sessions by a 
psychologist designed to stimulate 
the provision of adequate support 
and help by the partner to the 
patient and vice versa in order to 
reduce feelings of inequity
RF (NVQ) After the intervention, both patients and their 
partners reported higher levels of RF. 
Abbreviations: DAS = Dyadic Adjustment Scale, MSIS = Miller Social Intimacy Scale, NVQ = Non validated 
questionnaire, QMI = Quality of Marriage Index
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Supplementary Table 1  Scores of the observational studies on the STROBE checklist 
STROBE Checklist Items
Author 1a 1b 2 3 4 5 6a 6b 7 8 9 10 11 12a 12b 12c 12d 12e 13a 13b 13c 14a 14b 14c 15 16a 16b 16c 17 18 19 20 21 22
Pasipanodya et al., 201259 - - + + + - - NA - + - - - - NA - NA NA - - - + - NA + + NA NA NA + - - + -
Hagedoorn et al., 201144 - - + + + - - NA - + + - - - - - NA NA - - - + - NA + - NA NA + + - - - -
Badr, Carmack, Kashy, Cristofanilli, & 
Revenson, 201024
+ - + + + - + NA + + + - + - - - NA NA - - - + - NA + - NA NA + + - - + -
Badr & Taylor, 200943 + - + + - - + NA + + + - - - - - NA NA - - - + - NA + - NA NA + + - - + -
Langer, Brown, & Syrjala, 200958 - - + + + - + NA -  + + + - - - - NA NA - - - + - NA + - NA NA + + - - - -
Badr, Acitelli, & Carmack Taylor, 
200842
+ + + + + - + NA - + + - - - - - NA NA - - - + - NA + - NA NA + + - - + -
Badr & Taylor, 200837 + - + + + - + NA - + + - - - - - NA NA - - - + - NA + - NA NA + + - - + -
Norton & Manne, 200760 - - + + + - - NA + + - - - - NA - NA NA - - - + - NA + - NA NA NA + - - + -
Manne et al., 200653 + - + + + - - NA + + + - + - - - NA NA - - - + - NA + - NA NA + + - - + -
Porter, Keefe, Hurwitz, & Faber, 200557 - + + + - - - NA - + - - - - NA - NA NA - - - + - NA + - NA NA NA + - - + -
Henselmans, Hagedoorn, Buunk, & 
Sanderman, 200455
- - + + - - + NA - - - - - - - NA NA - - - + - NA + - NA NA + + - - - -
Manne et al., 200456 - - + + - - - NA - - + - + - - - NA NA - - - + - NA + - NA NA + + - - + -
Kuĳer, Buunk, Ybema, & Wobbes, 
200261
- + + + - - - NA + - - - - - - - NA NA - - - + - NA + - NA NA + + - - - -
Hagedoorn et al., 200054 + - + + - - - NA + + - - - - - - NA NA - - - + - NA + - NA NA + + - - + -
Lewis & Deal, 199552 + - + - - - - NA - + - - - - NA - NA NA - - - + - NA + - NA NA NA + - - + -
Ptacek, Ptacek, & Dodge, 199441 + - + + - - + NA - + - - - - NA - NA NA - - - + - NA + - NA NA NA + - - + -
Note: + = The criteria of the item were sufficiently reported, - = The criteria of the item were not/insufficiently 
reported, NA = Not Applicable.
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Supplementary Table 2  Scores of the qualitative studies on the COREQ checklist
COREQ Checklist Items
Author 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
Walker & Robinson, 201251 + + + + - - - + - - + - - - + - - + - + + - - + + + + + + + -
Fergus & Gray, 200947 + - - + - - - - + + + + + - - + + - + - - - - + + + + - + + + -
Kayser, Watson, & Andrade, 200716 + + - + - - - - + + + + - - - + - - + - + - - + + + + - + + + -
Badr & Taylor, 200646 - - - + - - - - + + + + + - - + - - + - + - - + + + - - + + + +
Dorval et al., 200545 - - - + - - - - - + + + + - + + + - - - - NA - + + + NA NA + NA NA
Picard, Dumont, Gagnon, & Lessard, 
200550
- + + + + - - - + + + + - - - + - - + - + - - - - - - + - + + -
Gray, Fitch, Phillips, Labrecque, & 
Fergus, 200048
- - - + - - - - + - + + + + - + - + + + + + - - + + + - + + -
Lavery & Clarke, 199949 + - - - - - - - - - + + - + - + - - + - + - - + + + - - + + + -
Note: + = The criteria of the item were sufficiently reported, - = The criteria of the item were not/insufficiently 
reported, NA = Not Applicable.
Supplementary Table 3  Scores of the intervention studies on the CONSORT checklist
CONSORT Checklist Items
Author 1a 1b 2a 2b 3a 3b 4a 4b 5 6a 6b 7a 7b 8a 8b 9 10 11a 11b 12a 12b 13a 13b 14a 14b 15 16 17a 17b 18 19 20 21 22 23 24 25
Decker, Pais, Miller, Goulet, & Fifea, 
201267
- - + + - NA + + + - NA - NA NA NA NA NA NA NA + + + - - - + - - - - - - - - - NA -
Heinrichs et al., 201265 + - + + + NA + - + - NA - NA + + + + NA NA + NA + + + + + - - NA NA + - + - + + -
Manne et al., 201169 - - + + - NA + - + - NA - NA - - - - NA NA + NA + - - - + - - NA NA + - + + - - -
Baucom et al., 200962 - - + + - NA + - + - NA - NA + - - - NA NA + NA + - - - + - - NA NA - - + + - - -
Porter et al., 200964 + - + + - + + - + - NA - NA - + - - NA NA + + + - - - + - - - + + - + + - - -
Kalaitzi et al., 200766 - - - + - NA + - + - NA - NA - - - - NA NA + NA - - + - - - - NA NA - - + - - - -
Shands, Lewis, Sinsheimer, & Cochrane, 
200674
- - + - - NA + + - - NA - NA - - - - NA NA - NA - - - - + - - NA NA - - - - - - -
Canada, Neese, Sui, & Schover, 200568 - - + + + NA + - + - NA - NA + + - - NA NA + NA + + - - + - - NA NA - - - - - - -
Kuĳer, Buunk, De Jong, Ybema, & 
Sanderman, 200463
- - + + + NA + - + - NA - NA - - - - NA NA + NA + - - - + - - NA NA - - - + - - -
Note: + = The criteria of the item were sufficiently reported, - = The criteria of the item were not/insufficiently 
reported, NA = Not Applicable.
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chapter 7
Sexual, marital, and 
general life adjustment 
in couples coping with 
colorectal cancer: 














This study evaluated: (i) levels of sexual, marital, and general life (mal)adjustment for patients 
with colorectal cancer and partners, (ii) stress-spillover between the three domains for 
patients and partners separately, (iii) interdependence between patients and partners, and 
(iv) longitudinal change in (mal)adjustment and longitudinal stress-spillover from a dyadic 
perspective.
Methods
Couples coping with colorectal cancer (n=102) completed the Maudsley Marital Questionnaire 
(MMQ) preoperatively and three and six months postoperatively. Mean scores were compared 
with mean norm scores. A multivariate general linear model and a multivariate latent difference 
score model (LDS-SEM), which took into account Actor- en Partner effects, were evaluated.
Results
Patients and partners reported more sexual maladjustment, similar marital maladjustment 
(except patients’ higher maladjustment at six months), and more general life adjustment 
compared with norm scores. Moderate to high within-dyad associations were found. The LDS-
SEM model mostly showed Actor effects. A partner effect was reported for the longitudinal 
change in the partners’ sexual maladjustment. Sexual maladjustment did not spill over to the 
other domains, while the patients’ preoperative general life maladjustment influenced the 
postoperative marital and sexual domains. 
Conclusion
Patients and partners report sexual maladjustment. Therefore, clinicians should examine 
potential sexual maladjustment. But, they have to be aware that this (mal)adjustment may 
not spill over to the marital and general life domains. However, maladjustment in the general 
life domain may spill over to the marital and sexual domains. The interdependence between 
patients and partners supports the notion that a couple-based perspective (e.g., couple-based 
interventions/therapies) to coping with cancer is needed. 
Introduction
Having cancer and undergoing cancer treatment can influence sexual (mal)adjustment1,2, 
marital (mal)adjustment3, and general life (mal)adjustment4. Furthermore, since these domains 
are interconnected, maladjustment in one of these domains may spill over to the other domains 
(i.e., stress-spillover). However, for patients with cancer, this form of stress-spillover has only 
been examined to some extent for the general life domain. One study reported that having 
a well-adjusted relationship is important as it influences general life (mal)adjustment5, which 
may indicate that a spillover effect from a less broadly defined domain to a more broadly 
defined domain is present. However, another study found that the experienced general life 
(mal)adjustment influenced sexual (mal)adjustment, which may suggest stress-spillover 
from a broad domain to a less broadly defined domain.6 Therefore, there may be a complex 
bidirectional influence of the domains on one another. However, these cross-sectional studies 
do not allow drawing causal interferences. 
Furthermore, several reviews established emotional interdependence between both 
members of a couple when coping with cancer.7-9 Therefore, it is important to evaluate the 
interplay between sexual, marital, and general life (mal)adjustment from a dyadic perspective. 
This perspective postulates an Actor–Partner interdependence in which the dyad is the unit of 
analysis and each person’s score is an independent variable that can influence not only his/her 
own score on the outcome variable (Actor effect) but also the partner’s score (Partner effect).10 
Although the number of studies that have taken a couple-based perspective to coping with 
cancer is increasing, most studies focused on distress or relationship functioning in patients 
with breast, prostate, or gynecological cancers.7-9 To our knowledge, only a few studies focused 
on patients with colorectal cancer.11-14 While these studies focused on dyadic aspects of the 
(mal)adjustment domains separately11,13,14 or on stress-spillover between two (mal)adjustment 
domains12, no study has yet analyzed both objectives in an integrative, prospective, and dyadic 
model. 
Therefore, this study evaluated the (i) preoperative (Time-0) and three (Time-1) and six 
months (Time-2) postoperative levels of sexual, marital, and general life (mal)adjustment for 
both patients and partners, (ii) stress-spillover between the three (mal)adjustment domains 
for patients and partners separately, (iii) interdependence between both members of the 
couple, and (iv) longitudinal change in sexual, marital, and general life (mal)adjustment and 
longitudinal stress-spillover effects in these three domains, from a dyadic perspective.




Data were drawn from a larger study examining the (sexual) consequences of colorectal cancer 
for patients and their partners (NCT01234246). Before surgical treatment, patients diagnosed 
with colorectal cancer and their partners were asked to participate in this study. Patients were 
recruited from six Dutch hospitals: St. Elisabeth hospital (Tilburg), TweeSteden Hospital (Tilburg 
and Waalwĳk), Catharina Hospital (Eindhoven), Jeroen Bosch Hospital (‘s Hertogenbosch), 
Amphia Hospital (Breda), and Maxima Medical Centre (Eindhoven and Veldhoven). Patients 
and partners older than 18 years were eligible for participation. The following exclusion criteria 
were applied: (i) elderly age (older than 75 years), (ii) non-curatively treated metastases at 
baseline, (iii) poor expression of the Dutch language, (iv) dementia, and/or (v) a history of 
psychiatric illness. When patients declined participation, the partners were still invited to 
participate (and vice versa) in order to prevent selection bias. During a preoperative visit 
patients and partners were asked, by their treating physician, if they could be approached by a 
member of the research team who would explain the study design and purpose. Subsequently, 
this member (MJT) contacted the potential participants and explained the study details. If 
patients and/or their partners agreed to participate they were asked to complete a set of 
standardized questionnaires at home at each time point (i.e., Time-0, Time-1, and Time-2). 
The Dutch guidelines recommend that all rectal cancer patients, except those with a clinical 
T1 stage without positive lymph nodes, receive neoadjuvant treatments (i.e., radio(chemo)
therapy; www.oncoline.nl). Therefore, a subset of patients in this study completed the first set 
of questionnaires before surgery, but potentially while already receiving or after neoadjuvant 
therapy. Participants returned the surveys in sealed postage-paid envelopes. Participants who 
consented but who did not return the surveys within two weeks after consenting received 
a reminder (phone call(s) or a reminder letter). This study was approved by the institutional 
review board. All participants gave written informed consent. 
Measures 
Participants completed items on sociodemographic factors (age, sex, marital status, length 
of the relationship with their partner, and educational level) and the Maudsley Marital 
Questionnaire (MMQ)15,16. The MMQ evaluates three domains of (mal)adjustment: Sexual (Mal)
adjustment (5 items), Marital (Mal)adjustment (10 items), and General Life (Mal)adjustment (5 
items). The 20 items of the MMQ are answered on a 9-point response scale (0–8). The items in 
each domain were summed. Scores on the Marital (Mal)adjustment domain could range from 
0 to 80, while the Sexual (Mal)adjustment and General Life (Mal)adjustment domains could 
range from 0 to 40. For all domains, a higher score indicates more maladjustment. A cutoff 
score of ≥20 on the Marital (Mal)adjustment subscale was used to identify individuals who 
experienced marital maladjustment.17,18 The psychometric qualities of the Dutch version of the 
MMQ were found to be satisfactory. 15,16
Statistical analysis
A multivariate General Linear Model (GLM) was conducted using an unstructured covariance 
matrix for the outcome variables (i.e., three (mal)adjustment domains × three time points) 
with role (i.e., patient/partner) as within-subjects factor. The term ‘subjects’ refers here to 
dyads, as the patient-partner dyad is the unit of analysis.10 Type of tumor (i.e., colon/rectum) 
and the patients’ gender were included as covariates. The GLM analysis allows characterizing 
the level of (mal)adjustment in the sample (i.e., descriptive statistics) and assessing within-
dyad differences between patients and partners through the use of planned pairwise 
contrasts. Furthermore, the estimated covariance-matrix evaluates the association within 
dyads (i.e., patient-partner interdependence) as well as the inter-correlation between the 
three (mal)adjustment domains for both patients and partners (i.e., stress-spillover). Across 
time, stability of the MMQ domains was assessed with the IntraClass Correlation coefficient. 
For all correlations, a correlation of .5 was defined as strong, a correlation of .30 as moderate, 
and a correlation of .10 as weak.19 One-sample t-tests were used to compare the mean scores 
obtained in the present study with the mean scores of norm populations as described in 
the MMQ questionnaire manual.20 Finally, Structural Equation Modeling (SEM) was used to 
evaluate the longitudinal change in sexual, marital, and general life (mal)adjustment and 
longitudinal stress-spillover between these three domains, from a dyadic perspective. A 
multivariate Latent Difference Score Model (LDS-SEM)21,22 was conducted in which the change 
in (mal)adjustment from preoperative to postoperative was explicitly formalized as a latent 
outcome variable. These latent difference scores were defined as implicit contrasts between 
(i) Time-1 and Time-0 and (ii) Time-2 and Time-0. On these contrasts a common factor was 
superimposed that captured the common preoperative to postoperative transition. Thus, 
it is the latter common change factor that is being predicted based upon the preoperative 
maladjustment levels of both patients and their partners. This model takes into account the 
dyadic data structure by allowing both Actor- and Partner effects and by allowing the outcome 
residuals to be correlated.23 Again, type of tumor and the patients’ gender were included as 
covariates. In order to use all available information for each individual under the missing at 
random assumption, the GLM and the LDS-SEM were estimated by means of full-information 
Maximum Likelihood.24 Model fit was evaluated using the following fit indices24,25: (i) The chi-
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square with the associated p-value, (ii) The Root Mean Square Error of Approximation (RMSEA; 
<.08 = acceptable; <.05 = good fit), and (iii) The Comparative Fit Index (CFI; .90-.95 = acceptable; 
≥.95 = good fit).
Results
Sample characteristics 
In total, 374 eligible patients agreed to be contacted by a member of the research group, who 
informed them about the study. Of this group, 182 (49%) patients agreed to participate. Of 
these patients, 160 (87%) had a partner of which 123 (77%) participated. The non-responders 
had a higher age and were more often female compared with the responders (p<.05). In 
addition, three partners participated even though the patient did not. This resulted in a total 
of 182 participating patients and 126 participating partners. However, due to the dyadic nature 
of the study, the patients without a (participating) partner were excluded, resulting in 123 
couples. In addition, to be included in the analyses, patients and partners had to complete 
at least two assessments. Based on this criterion, 21 (17%) couples were excluded. Therefore, 
the studied population consisted of 102 couples. Various reasons for declining or terminating 
participation were reported. The most reported reasons for non-participation were (i) the 
intimate nature of the questionnaires, (ii) the length of the questionnaires, and (iii) the 
amount of experienced stress at that time. The average age of patients and partners was 63.2 
years (standard deviation=7.7) and 61.7 years (standard deviation=9.0), respectively. The male 
to female ratio of patients was 72 (70.6%) to 30 (29.4%). Thirty-nine (38%) patients had a colon 
tumor and 63 (62%) patients had a rectum tumor. The average length of the partner relationship 
was 36 years (standard deviation = 11.1; range 4 – 51 years). Although not a prerequisite, all 
couples were in a heterosexual relationship.
(Mal)adjustment levels for the sexual,  
marital, and general life domains
The levels of (mal)adjustment, differences between patients and partner on these 
(mal)adjustment scores, and a comparison with norm scores are presented in Table 1. In 
general, no significant differences were reported between patients, partners, and norm scores 
with regard to marital (mal)adjustment. Only at Time-2, partners reported more marital 
maladjustment compared with the norm. Moreover, at each time point both patients and 
partners reported more sexual maladjustment but better general life adjustment compared 
with norm scores. However, for all domains, large standard deviations and a broad range in 
(mal)adjustment scores were reported, especially for the sexual (mal)adjustment domain. No 
significant differences were found between the patients’ and partners’ adjusted mean scores 
on the MMQ. When the scores on marital (mal)adjustment were dichotomized, it was noted 
that 17 (20%) patients and 17 (20%) partners reported marital maladjustment at Time-0. 
Postoperatively these results remained relatively stable: 16 (18%) patients and 18 (21%) partners 
reported marital maladjustment at Time-1 and 19 (24%) patients and 19 (24%) partners reported 
marital maladjustment at Time-2. In three (Time-0), two (Time-1), and seven (Time-2) cases both 
members of the dyad reported marital maladjustment. Thus, in most cases only the patient 
or the partner reported marital maladjustment. In addition, different participants reported 
marital maladjustment across the assessment points. 
Stress-spillover between sexual,  
marital, and general life (mal)adjustment 
Table 2 presents, for patients and partners separately, the association between the (mal)
adjustment domains at each time point (i.e., Time-0, Time-1, Time-2). For patients, strong 
correlations are observed between the Marital (Mal)adjustment domain and the Sexual and 
General Life (Mal)adjustment domains at Time-0, but the strength of the correlations decreases 
over time. However, the reversed pattern is observed for the across time correlations between 
the Sexual and General Life (Mal)adjustment domains. The correlation is moderate at Time-
0 and Time-1, while a strong correlation is observed at Time-2. For partners, the correlation 
between the Sexual and Marital (Mal)adjustment domains are moderate to weak at Time-0 and 
Time-1 and even non-significant at Time-2. The correlation between the Sexual and General 
Life (Mal)adjustment domains is moderate at Time-0, but also becomes insignificant at the 
subsequent time points. However, a moderate correlation between the Marital and General 
Life (Mal)adjustment domains is observed at Time-0, which even increases slightly over time. 
Interdependence between patients and partners
Across time, the within-dyad associations are high for sexual (mal)adjustment and moderate 
for marital (mal)adjustment (see Table 3). For general life (mal)adjustment, the correlation 
decreases from high to insignificant across time. Thus, at each assessment point all three 
domains correlate within-dyads, with exception of general life (mal)adjustment at Time-2. 
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Table 1  Adjusted mean (mal)adjustment scores on the Maudsley Marital Questionnaire, differences in the 








Time-0 16.3±9.3 [1-36]** 17.2±8.2 [2-34]** .424
Time-1 19.2±9.4 [0-38]** 19.0±8.8 [2-40]** .847
Time-2 19.8±9.9 [0-40]** 20.1±8.9 [2-37]** .692
Marital (Mal)adjustment
Time-0 14.8±7.5 [0-44] 15.5±8.0 [2-52] .525
Time-1 14.8±10.0 [0-62] 15.9±8.4 [2-48] .362
Time-2 15.1±8.5 [0-38] 16.6±9.3 [0-47]** .213
General Life (Mal)adjustment 
Time-0 6.3±4.4 [0-24]* 7.1±4.4 [0-21]* .162
Time-1 8.0±4.9 [0-22]* 7.8±4.5 [0-22]* .692
Time-2 8.7±5.5 [0-24]* 8.6±4.8 [0-24]* .851
Note: Higher scores indicate more maladjustment. Scores on the Marital (Mal)adjustment subscale could 
range from 0 to 80, while the Sexual (Mal)adjustment subscale and General Life (Mal)adjustment could 
range from 0 to 40. Means ± standard deviations are reported adjusted for type of tumor and gender within 
a multivariate general linear model framework. The range in reported (mal)adjustment scores is reported 
between brackets. P-values based upon planned paired difference contrasts comparing patients with partners. 
Significantly less maladjustment compared with the norm scores is indicated with *, while ** indicates 
significantly more maladjustment compared with the norm scores. Time-0 = postoperative, Time-1 = three 
months postoperative, Time-2 = six months postoperative.
Table 2  Within-patient and within-partner correlation coefficients for the Maudsley Marital Questionnaire 
at each time point (i.e., stress-spillover between the three maladjustment domains)
Time-0 Time-1 Time-2
1. 2. 3. 1. 2. 3. 1. 2. 3.
Patient 1. Sexual  
(Mal)adjustment
1.0 .48*** .36*** 1.0 .36*** .37*** 1.0 .28** .48***
2. Marital  
(Mal)adjustment 
1.0 .49*** 1.0 .26** 1.0 .26*
3. General Life 
(Mal)adjustment
1.0 1.0 1.0
Partner 1. Sexual  
(Mal)adjustment
1.0 .26* .28* 1.0 .22* .16 1.0 .18 .17
2. Marital  
(Mal)adjustment 
1.0 .37*** 1.0 .39*** 1.0 .43***
3. General Life 
(Mal)adjustment
1.0 1.0 1.0
Note: *** p≤.001, ** p ≤.010, *** p ≤.050; Reported correlations are partialed for type of tumor and gender 
within a multivariate general linear model framework. Time-0 = postoperative, Time-1 = three months 
postoperative, Time-2 = six months postoperative.
Table 3  Within-dyad correlations for the Maudsley Marital Questionnaire (i.e., interdependence between 
patients and partners) 
(n=102) r 95% CI p-value
Sexual (Mal)adjustment
Time-0 .60 [ .44, .75] <.001
Time-1 .51 [ .35, .68] <.001
Time-2 .72 [ .61, .83] <.001
Marital (Mal)adjustment
Time-0 .46 [ .29, .63] <.001
Time-1 .34 [ .14, .54] .001
Time-2 .35 [ .16, .55] <.001
General Life (Mal)adjustment
Time-0 .50 [ .34, .66] <.001
Time-1 .23 [ .03, .44] .025
Time-2 .04 [-.18, .25] .733
Note: Reported correlations are partialed for type of tumor and gender within a multivariate general linear model 
framework. Time-0 = postoperative, Time-1 = three months postoperative, Time-2 = six months postoperative.
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Longitudinal change and longitudinal stress-spillover 
from a dyadic perspective
For both patients and partners scores on marital (mal)adjustment were stable across time, as 
indicated by the high intraclass correlations and the non-significant average level differences 
across the three time points (see Table 4). For patients, there is support for average level 
differences for the other two domains. This indicates that more sexual and more general life 
maladjustment is reported at Time-1 and Time-2 compared with Time-0. For partners there is 
a similar pattern, but the difference is only significant at Time-2. 
The LDS-SEM model evaluating the pre- to postoperative change had a good model fit 
(χ2(df=93) =127.42, p=.010; CFI=.944; RMSEA=.060, p=.252; Table 5), however, based on the 
R2 the model was better in predicting partner than patients’ scores. For both patients and 
partners autoregressive effects were reported for all domains, except for the partners’ marital 
(mal)adjustment. These autoregressive Actor effects entail that relatively more preoperative 
maladjustment in a certain domain lead to less worsening in the postoperative maladjustment 
of that domain. Furthermore, some pre- to postoperative cross-domain effects were found. 
Patients who were preoperatively relatively maladjusted in the general life domain showed 
a more steep increase in their postoperative sexual maladjustment, but a less steep increase 
in their postoperative marital maladjustment. For partners, their relatively high levels of 
preoperative marital maladjustment lead to a more steep increase in their postoperative 
general life maladjustment. Finally, the autoregressive effect of sexual (mal)adjustment was 
slightly compensated when their patients reported to be preoperatively sexually maladjusted 
(i.e., Partner effect). This effect indicated that if not only the partner but also the patient 
reported relatively high levels of preoperative sexual maladjustment, then the partner showed 
a steeper worsening of his/her postoperative sexual maladjustment even though he/she was 
already relatively maladjusted postoperatively. There was no significant influence of gender or 
type of tumor on the abovementioned results.
Table 4  Stability of scores on the Maudsley Marital Questionnaire over time and changes in the 







IntraClass Correlation .71 .47
Level differences across time
Time-0-> Time-1 2.9 .004 1.8 .167
Time-1-> Time-2 0.5 .526 1.1 .227
Time-2-> Time-0 3.4 .001 2.9 .023
Marital (Mal)adjustment
IntraClass Correlation .84 .78
Level differences across time
Time-0-> Time-1 -0.4 .966 0.4 .554
Time-1-> Time-2 0.3 .749 0.7 .450
Time-2-> Time-0 0.2 .761 1.1 .246
General Life (Mal)adjustment
IntraClass Correlation .54 .65
Level differences across time
Time-0-> Time-1 1.8 .005 0.7 .143
Time-1-> Time-2 0.7 .257 0.8 .163
Time-2-> Time-0 2.5 .001 1.5 .005
Note: P-values based upon planned paired difference contrasts between time points. Analyses adjusted 
for type of tumor and gender within a GLM framework. Time-0 = postoperative, Time-1 = three months 
postoperative, Time-2 = six months postoperative.
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Table 5  Latent Difference Score Model: longitudinal change in sexual, marital, and general life (mal)
adjustment and longitudinal stress-spillover between these three domains, from a dyadic 
perspective













Preoperative predictor ß S.E. p-value ß S.E. p-value ß S.E. p-value ß S.E. p-value ß S.E. p-value ß S.E. p-value
Patients’ Sexual 
(Mal)adjustment
–.29 .14 .031 .14 .12 .247 –.09 .09 .320 .48 .14 .001 .10 .10 .318 .02 .06 .742
Partners’ Sexual 
(Mal)adjustment
–.07 .14 .607 –.09 .12 .415 .04 .10 .701 –.92 .14 <.001 –.10 .11 .341 –.05 .06 .387
Patients’ Marital 
(Mal)adjustment
–.07 .15 .618 –.05 .11 .691 .12 .09 .160 –.17 .16 .274 .06 .11 .600 –.00 .06 .939
Partners’ Marital
 (Mal)adjustment
–.06 .12 .604 –.00 .10 .976 .01 .07 .918 .05 .12 .668 –.25 .08 .004 .16 .05 .001
Patients’ General Life 
(Mal)adjustment
.54 .23 .022 –.56 .20 .004 –.62 .14 <.001 .38 .27 .158 .13 .18 .453 .06 .09 .548
Partners’ General Life 
(Mal)adjustment
.00 .21 .989 .16 .17 .370 .07 .13 .618 .01 .23 .981 .03 .17 .883 –.45 .08 <.001
Patients’ gender .66 .81 .415 .35 .66 .599 .92 .49 .060 .30 .89 .734 .58 .63 .352 .21 .33 .523
Patients’ tumor -1.0 .74 .161 –.04 .61 .953 –.27 .46 .563 –.86 .81 .288 –.32 .63 .608 .10 .31 .760
Intercept T0 ->T2 7.51  2.07 4.07 9.97 2.59 1.73
Intercept T0 -> T3 8.47 3.08 4.71 10.09 3.42 2.67
R2 .34 .24 .42 .57 .31 .86
 Model fit: χ2(df=93) = 127.42, p = .010; CFI = .944; RMSEA = .060, p = .252.
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Discussion
Across time, patients with colorectal cancer and their partners reported more sexual 
maladjustment, similar marital maladjustment (with exception of patients’ higher 
maladjustment at Time-2), and even better general life adjustment compared with norm 
scores. These findings may indicate that even though the sexual maladjustment of patients 
and partners may be high, this stress does not necessarily spill over to the marital and general 
life domains. Moreover, the scores on marital (mal)adjustment were not only comparable 
with norm scores, but were also stable across time for both patients and partners. The fact 
that the studied population consisted mostly of couples in long-term relationships may have 
attributed to this. A U-shaped pattern of marital happiness across the life time has been 
previously reported.26 These high levels of marital adjustment found in couples in long-term 
relationships may be explained by their reported high quality of dyadic interaction (i.e., dyadic 
coping), which was found to be positively associated with marital satisfaction.27,28 
In line with previous studies, the within-dyad correlations were moderate to high.29,30 These 
within-dyad correlations and the lack of mean level differences between patient and partners 
are indicative for interdependence and congruence in the experienced (mal)adjustment 
between patients and partners. The within-dyad associations were the highest for the Sexual 
(Mal)adjustment domain and the lowest for the General Life (Mal)adjustment domain. 
Intuitively, this is what might be expected, since the domains are ordered from narrow to 
broad: general life (mal)adjustment can be influenced by a broader range of factors, with 
larger individual differences between both members of the dyad, than patients’ and partners’ 
sexual (mal)adjustment. 
The LDS-SEM model took into account actor-partner interdependence to examine the 
longitudinal change in sexual, marital, and general life (mal)adjustment and longitudinal stress-
spillover in these three domains. For both patients and partners, autoregressive effects were 
reported for all domains, except for the Marital (Mal)adjustment domain for partners. These 
Actor effects reflect the intuitive notion that when someone is already highly maladjusted 
preoperatively, he/she will have less relative space to worsen postoperatively compared with 
someone who is more adjusted preoperatively. Another important observation was that the 
patients’ preoperative general life maladjustment affected the postoperative change in all 
three domains, while sexual (mal)adjustment did not affect the postoperative change in the 
other two domains. This again shows that sexual maladjustment does not necessarily spill over 
to the other two domains. Moreover, the reversed direction may be applied. Maladjustment in 
the more broad general life domain may spill over to the smaller marital and sexual domains. 
Finally, both Actor- and Partner effects were reported for the longitudinal change in the 
partners’ sexual maladjustment. These effects implicate, in line with the high within-dyad 
associations for this domain, interdependence between patients and partners sexual (mal)
adjustment. 
The lack of gender effects in this study seems counterintuitive since the literature reports 
that women tend to experience more distress than men, regardless of their role.8,31,32 In 
our patient population, the ratio male to female patients was uneven (i.e., more male than 
female patients participated), which makes it difficult to formulate definitive conclusions. 
Nevertheless, Badr and Taylor (2008)33 were also unable to detect a gender effect for the 
relationship between dyadic coping behaviors and marital adjustment. Therefore, it may be 
that an effect of gender is less prominent when it concerns dyadic/relational processes as 
opposed to mood-related distress, such as anxiety and depressive symptoms. Type of tumor 
(colon versus rectum) was also a non-significant covariate. This non-significance may be 
due to the fact that both colon and rectal cancer patients report more sexual dysfunction 
compared with a normative population, regardless of treatment differences.34 In addition, both 
patient groups have to cope with cancer and incorporate the consequences of the disease and 
treatment in their life. 
While the interdependence between patients and partners reported in this study is 
consistent with the literature, our study has provided new insights regarding (longitudinal) 
stress-spillover in the sexual, marital, and general life domains. However, there is also a need 
for future research. First of all, our sample size did not allow us to incorporate more specific 
treatment-related or psychosocial variables. A larger cohort of patients and partners, including 
more equally divided numbers of participating men and women, is needed in order to test the 
influence of additional treatment-related and psychosocial covariates on (mal)adjustment. 
In addition, a longitudinal prospective study could examine the association between dyadic 
processes and the course of sexual, martial, and general life adjustment in (older) couples 
coping with cancer more extensively. Furthermore, our study consisted solely of heterosexual 
couples who were not older than 75 years. In order to increase the generalizability of our 
findings, future studies should also include same-sex and elderly couples. Finally, a response 
rate of 49% was obtained. Even though this is a fairly good result compared with previous 
research focusing (partly) on sexuality after colorectal cancer11, there still were considerable 
refusal rates. Some patients and partners felt reluctant to participate in a study that assesses 
relational and sexual aspects. Unfortunately, this may also entail that the patients and 
partners who experience the most maladjustment are the most likely to decline or terminate 
participation, which may have led to an underestimation of the experienced maladjustment. 
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Conclusion
Health care professionals have to be aware of potential sexual maladjustment after colorectal 
cancer surgery. However, they should evaluate if this sexual maladjustment influences the 
marital and general life adjustment of the couples and if patients and partners are bothered by 
sexual issues; there may not always be a need for help. Moreover, the reversed direction may 
be applied. Maladjustment in the more broad general life domain may spillover to the smaller 
marital and sexual domains. The moderate to high within-dyad associations and the similar 
levels of (mal)adjustment between patients and partners are indicative for interdependence 
between both partners. This supports the notion that a couple-based perspective to coping 
with cancer (e.g., couple-based interventions/therapy) is needed in both research and 
clinical practice. However, as mentioned above, future studies are needed to provide more 
specific insights in the course of the (dyadic) development of sexual, martial, and general life 
adjustment in older couples and to evaluate more specific treatment-related and psychosocial 
factors associated with this development.
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chapter 8
Evaluating quality of life 
and response shift from a 
couple-based perspective: 
a study among patients 














To examine (i) measurement invariance of Quality of Life (QoL) domains over time for patients 
with colorectal cancer and partners (i.e., response shift - recalibration, reprioritization, 
and reconceptualization); (ii) between dyad-members measurement invariance; (iii) QoL 
trajectories.
Methods
Participants completed the WHOQOL-Bref preoperative (Time-0) and three (Time-1) and six 
months (Time-2) postoperative. A stepwise procedure, using nested factor models, examined 
the viability of restricting specific model parameters to be equal across measurements and 
between dyad members.
Findings
No reconceptualization and reprioritization occurred, but indications for recalibration were 
present. Therefore, comparisons were restricted to group-level statistics at factor level. For 
patients, a decrease in the Physical Health domain occurred at Time-1 (p<.001), with partial 
recovery to baseline at Time-2 (p=.055). For partners, factor means in this domain remained 
constant (p‘s>.05) and were at each time point higher than patients’ factor means (p’s<.05). 
Patients’ and partners’ Psychological Health decreased at Time-1 (p’s<.05), with stabilization 
at Time-2 (p’s>.05). Patients and partners factor means were comparable (p’s>). Patients’ and 
partners’ Social Relationship factor means decreased at Time-1 (p’s<.05), which decreased 
further for patients (p =.011) but stabilized for partners (p =.214). Partners’ factor means were 
only lower than patients’ factor means at Time-1. A similar decrease in the Environmental 
Domain factor means occurred for both patients and partners at Time-1 (p’s<.05), with 
stabilization at Time-2 (p’s>.05). 
Conclusion
Since both patients and partners are affected by the patients’ disease and treatment we 
recommend that attention is paid to the couple instead of solely the patient. 
Introduction
There is an increasing awareness that not only oncological outcomes, but also patient-reported 
outcomes, such as Quality of Life (QoL), must be taken into account when evaluating the 
consequences of disease and treatment. However, QoL standards may change over the course 
of the disease trajectory.1-3 This may be inherent to the process of adapting to the disease.1,2 
Within chronic disease research, Sprangers and Schwartz were the first to theoretically and 
methodologically address changes in QoL standards.1,2 Theoretically, they operationalized 
the term response shift as a ‘meta-construct’ which includes three interrelated constructs: 
Response shift is a change in the meaning of one’s self-evaluation of QoL as a result of (i) 
recalibration: a change in the respondent’s internal standards, (ii) reprioritization: a change 
in the respondent’s values (i.e., the relative importance of an item on a QoL domain changed 
or the relative importance of the component domains constituting QoL changed), or (iii) 
reconceptualization: a redefinition of QoL.1,2 Response shift poses methodological challenges 
for QoL research: In order to adequately compare assessments completed over time, the 
questionnaire has to be measurement invariant.9 However, if response shift occurs, then 
this is not applicable. Therefore, evaluating response shift is necessary to allow adequate 
interpretation of QoL findings over time.
To our knowledge, only three studies examined response shift among patients with 
colorectal cancer4-6, even though colorectal cancer is among the most prevalent cancer types.7 
A qualitative study found recalibration and reconceptualization in patients with a temporary 
stoma.4 In addition, indications for recalibration were found in patients with colon cancer5 
and a definitive colostoma.6 However, the latter two studies used the Then Test to evaluate 
response shift.5,6 Unfortunately, this test is not without criticism due to its proven susceptibility 
to recall bias.8 Therefore, more insight in the occurrence of response shift in patients with 
colorectal cancer is needed.
Furthermore, it is interesting to evaluate whether response shift occurs in partners of 
patients with colorectal cancer. These partners also have to incorporate ongoing cancer-
related experiences into their lives, which may lead to changes in their QoL standards, values, 
and conceptualization. To our knowledge, this has not yet been evaluated. Incorporating both 
patients and partners in analyses can not only show if the QoL measurement is invariant over 
time for patients and partners separately, but also if measurement of QoL is invariant between 
both members of the couple. If this is true, then QoL findings of both patients and partners 
can be compared over time and between both dyad members.
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Therefore, the aim of the current study was to examine (i) measurement invariance of 
QoL domains over time for patients with colorectal cancer and their partners (i.e., response 
shift - recalibration, reprioritization, and reconceptualization), (ii) between dyad-members 
measurement invariance and (iii) QoL trajectories for patients and partners in which the 
measurement invariance is taken into account. 
Methods
Patients
Data were drawn from a larger study examining the (sexual) consequences of colorectal cancer 
for patients and their partners (NCT01234246). Before surgical treatment, patients diagnosed 
with colorectal cancer and their partners were asked to participate in this study. Patients were 
recruited from six Dutch hospitals: St. Elisabeth hospital (Tilburg), TweeSteden Hospital (Tilburg 
and Waalwĳk), Catharina Hospital (Eindhoven), Jeroen Bosch Hospital (‘s Hertogenbosch), 
Amphia Hospital (Breda), and Maxima Medical Centre (Eindhoven and Veldhoven). Patients 
and partners older than 18 years were eligible for participation. The following exclusion criteria 
were applied: (i) elderly age (older than 75 years), (ii) non-curatively treated metastases at 
baseline, (iii) poor expression of the Dutch language, (iv) dementia, and/or (v) a history of 
psychiatric illness. In order to prevent selection bias, partners were still invited to participate 
if the patients declined participation (and vice versa). During a preoperative visit patients and 
partners were asked, by their treating physician, if they gave permission to be approached by a 
member of the research team. This member would subsequently explain the study design and 
purpose. If patients and/or their partners agreed to participate they were asked to complete a 
set of standardized questionnaires at home at preoperatively (Time-0) and three (Time-1) and 
six months (Time-2) postoperative. However, the Dutch guidelines10 recommend that all rectal 
cancer patients, except those with a clinical T1 stage without positive lymph nodes, receive 
neoadjuvant treatments (i.e., radio(chemo)therapy). Therefore, a subset of patients completed 
the first set of questionnaires before surgery, but potentially while already receiving or after 
neoadjuvant therapy. Participants returned the surveys in sealed postage-paid envelopes. 
Participants who consented but who did not return the surveys within two weeks after 
consenting received reminders (phone call(s) or a reminder letter). The institutional review 
board approved this study. All participants gave written informed consent. 
Measures
Participants preoperatively completed questions assessing sociodemographic factors (age, 
sex, marital status, length of the relationship with the partner, and educational level) and an 
adapted Self-administered Comorbidity Questionnaire (SCQ)11, which evaluates comorbidity 
at the time of questionnaire completion. 
The cross-culturally developed World Health Organization Quality of Life assessment 
instrument-abbreviated version (WHOQOL-Bref) is a generic multi-dimensional QoL 
measure.12 The participants completed this questionnaire at each time point. The WHOQOL-
Bref consists of 26 items of which 24 cover four domains: Physical Health, Psychological 
Health, Social Relationships, and Environment (see Figure 1). Furthermore, two items 
constitute the facet Overall Quality Of Life and General Health. However, since this facet only 
consists of two items it was not included in the response shift analyses. The WHOQOL-Bref 
provides a valid and reliable alternative for the WHOQOL-100.12 Higher scores on a domain or 
the general facet indicate better QoL. Psychometric properties, such as discriminant validity, 
content validity, internal consistency, and test-retest reliability of the WHOQOL-Bref have 
been examined on multiple occasions and appeared to be good.13-15
The patient’s clinical information was retrieved from the Eindhoven Cancer Registry (ECR). 
The ECR routinely collects data on tumor characteristics including date of diagnosis, tumor 
grade according to the Tumor-Node-Metastasis clinical classification, clinical stage, and 
treatment. If the ECR had not yet registered all clinical information, then the missing clinical 
information was retrieved from the patient’s medical records.
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Figure 1  WHOQOL-Bref structure for patients and partners
Note: Variables within the gray box are allowed to intercorrelate.
Statistical analysis
Chi-square tests and independent student t-tests were used to compare participants who 
declined participation with the participants on age, sex, and tumor type (if applicable). For the 
participants, descriptive statistics of the sociodemographic and clinical data were calculated. 
Pairwise difference tests were used to determine whether differences in QoL were noted 
between colon and rectal cancer for (i) patients and (ii) partners. 
The equivalence of the QoL domains at different time points and between both members 
of the dyad (patients-partners) was evaluated. This so called factorial measurement invariance 
was examined by means of Structural Equation Modeling.16 An annotated path diagram of the 
factor model is given in Figure 2. To account for the dyadic data structure, there are different 
links (i.e., factor and residual correlations) between the patient- and partner-side of the 
model. For each domain, a stepwise procedure was followed that used nested factor models 
to examine the viability of restricting specific model parameters to be equal across time points 
and between dyad members (see Table 1 and Figure 2 and for an overview, see Millsap, 2011).17,18 
In the first step, a baseline model was established to check whether the theoretical domain 
specific factor structure holds across time points and between both dyad members (i.e., 
configural invariance). If this step does not hold, the same unidimensional factor structure, for 
the specific domain, is not applicable across time points and between patients and partners. 
This implies a form of reconceptualization of the specific QoL domain. In the second step, 
metric invariance (i.e., equal factor loadings) was assessed to verify whether the strength of 
relationship between each item and the underlying domain construct remains the same across 
time points and dyad members. If this step does not hold, a form of reprioritization is implied, 
with for instance one or more items becoming more relevant for the construct domain at a 
given time point. In the third step, scalar invariance (i.e., equal loadings and intercepts) was 
assessed to verify, whether specific items show a differential score pattern compared to the 
general trend across time and between dyad members. If this step does not hold, it implies 
that certain items get recalibrated across time points and/or are being scored higher/lower by 
patients or partners. In order to evaluate which items are the likely candidates for a specific 
response shift phenomenon, specific items that do not fit the common general pattern of 
results across time points and between dyad members (i.e., appear inconsistent with the 
imposed invariance restrictions) need to be located. 
To evaluate a configural invariance baseline model, we used the chi-square test of absolute 
fit; (ii) the Root Mean Square Error of Approximation to assess close fit (RMSEA; <.08= 
acceptable; <.05= good fit), and (iii) the Comparative Fit Index to assess deviations from the 
null model (CFI; .90-.95= acceptable; ≥.95= good fit). To allow for a clear interpretation of the 
208207 Quality of sexual life and colorectal cancer  Towards a dyadic approach Chapter 8   Evaluating quality of life and response shift from a couple-based perspective:  a study among patients with colorectal cancer  
and their partners
88
CFI we also fitted the null model (i.e., a model which restricts all correlations between items to 
be zero). If this null model already shows a reasonable goodness-of-fit (as shown in a relatively 
small RMSEA), this implies that the average correlation in the data is fairly low and that it will 
be unlikely to see very large CFI values for other models (as it is hard to greatly improve upon 
the null model). For the nested model comparisons between the different steps, we relied on 
chi-square difference tests and differences in the comparative fit index (∆CFI: a non-reduced 
CFI or a reduction smaller than or equal to .01 indicates that the null hypothesis of invariance 
should not be rejected)19, as well as relative model comparisons based on the sample-size-
adjusted Bayesian Information Criterion (saBIC; a lower value indicates a better trade-off 
between fit and complexity).20 When invariance restrictions did not hold, modification indices 
were used to locate the items showing potential response shift and, (if possible) partial 
invariance was established by relaxing the invariance restrictions for these items.21 All data-
analyses were done in the open-source statistical software R using the lavaan package for 
Structural Equation Modeling.22
Table 1  Stepwise procedure using nested factor models to examine the viability of restricting specific model 
parameters to be equal across time points and between patients and partners (see Figure 2 for the 
model used)
Invariance Restrictions
Configural means and variances for all factors are fixed, µ = 0 & σ2 = 1
Metric all α’s of the same item are equal (i.e., across time points and dyad)
variances of all factors are no longer fixed except for the reference factor F0a
Scalar all α’s of the same item are equal (i.e., across time points and dyad)
all β’s of the same item are equal (i.e., across time points and dyad)
means of all factors are no longer fixed except for the reference factor F0a
variances of all factors are no longer fixed except for the reference factor F0a
 Note: α: factorloading, β: item intercept, µ: factor mean, σ2: factor variance.
Figure 2  Factorial measurement invariance across time and between patients and partners
Note: Circles are latent variables, with the F’s representing common domain factors and the e’s unique 
residuals. Squares are observable variables representing the WHOQOL items. For reasons of clarity only one 
indicator per factor is shown, yet it represents the whole set of items for the domain. Numerical subscripts 
indicate the time point, subscript a/p are for patients (actors) and partners (partners), respectively. Variables 
within a gray box are allowed to intercorrelate. α: factorloading, β: item intercept, µ: factor mean, σ2: factor 
variance.
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Table 2  Number of participants at each assessment point
  Time-0 Time-1  Time-2 
  patients partners patients partners patients partners
Completed 164 166 148 141 123 114
Participated from Time-1 
onwards
42 40 - - - -
Missing - - 10 10 14 14
Drop-out at Time-1 - - 23 28 23 28
Drop-out at Time-2 - - - - 35 35
Not yet completed the 
questionnaire*
 -  - 25 27 35 35
Note: *Due to the ongoing nature of the study not all participants had already completed all time points.






Age at time of survey 62.0±8.6 6.6±9.9
Relationship in years 35.9±16.3 35.9±16.3
N (%) N(%)
Male gender 146 (71.2%) 59 (28.4%)
Educational level
Low 13 (6%) 10 (5%)
Medium 125 (61%) 142 (68%)
High 56 (27%) 47 (23%)
Missing 11 (6%) 9 (4%)
Type of cancer
Colon 125 (61%) - 
Rectum 80 (39%) - 
Type of surgery
Low anterior resection 84 (41%) -
Abdominoperineal resection 35 (17%) -
Hemicolectomy/ileocecal resection 29 (14%) -
Sigmoid resection 27 (13%) -
Other 27 (13%) -
Unknown type of surgery 3 (2%)
Type of radiotherapy (RT)
No RT 135 (66%) -
Preoperative RT 42 (21%) -
Intra-Operative RT 19 (9%) -
Other RT 5 (3%) -
Unknown 4 (1%) -
Results
Participants
In total, 672 eligible patients agreed to be contacted by a member of the research group, 
who informed them about the study. In total, 313 (47%) patients agreed to participate. Of 
these patients, 279 (89%) had a partner of which 205 (74%) participated. Due to the dyadic 
nature of the analyses, only these couples were included (n=205). An overview of the number 
of participants at each time point is presented in Table 2. To make use of all available data 
and account for missing data, the CFA approach was carried out using full information 
maximum likelihood under the missing at random assumption. Sociodemographic and clinical 
characteristics of patients and partners (if applicable) are presented in Table 3. Skewness and 
Kurtosis of the WHOQOL-Bref items did not pose problems for the use of normal maximum 
likelihood estimation procedures and was in line with recommendations for Structural 
Equation Modeling.23 For patients, skewness of the WHOQOL-Bref items ranged between -1.35 
to .21, while excess Kurtosis ranged from -1.15 to 3.51. For partners, these ranges were -1.42 to 
.28 and -1.30 to 6.01, respectively. No differences were seen in the mean QoL domains scores 
between colon and rectal cancer patients/partners (p>.05).









No 125 (61%) -
Yes 74 (36%) -
Unknown 5 (3%) -
Type of chemotherapy (CT)
No CT 145 (71%) -
Postoperative CT 50 (24%) -
Other CT 7 (3%) -
Unknown 3 (2%) -
Stoma
Yes 122 (60%) -
No 79 (38%) -
Unknown 4 (2%) -
Comorbidity 
Cardiovascular disease 21 (11%) 17 (9%)
Lung disease 8 (4%) 19 (10%)
Diabetes mellitus 11 (6%) 17 (9%)
Artrose 27 (14%) 44 (24%
Back pain 28 (15%) 37 (20%)
Note: Low = up to ten years of education, middle = 10-14 years of education, high = more than 14 years of 
education.
Table 4  Factorial invariance for patient-partner dyads and across time points and between dyad members
Invariance 
Model
x2 df p CFI RMSEA saBIC Δ x2 Δdf p ΔCFI
Physical Health
Null 4186 931 <.001 .000 .130 15690
Configural 1034 729 <.001 .900 .045 12974
Metric 1072 759 <.001 .897 .045 12947 37.67 30 .1583 .003
Scalar 1160 789 <.001 .878 .048 12971 88.45 30 <.001 .019
*Scalar 1115 885 <.001 .892 .045 12934 42.908 26 .0198 .005
Psychological Health
Null 3144 690 <.001 .000 .131 11716
Configural 793 510 <.001 .880 .052 9754
Metric 831 535 <.001 .874 .052 9737 37.35 25 .0534 .006
Scalar 882 560 <.001 .863 .053 9735 51.74 25 .0014 .011
*Scalar 865 558 <.001 .870 .052 9722 34.23 23 .0618 .004
Social Relationships
Null 968 183 <.001 .000 .144 5971
Configural 140 93 .001 .933 .050 5337
Metric 154 103 .001 .927 .049 5330 13.96 10 .1748 .006
Scalar 177 113 <.001 .909 .053 5331 23.00 10 .0108 .018
*Scalar 164 111 .001 .924 .048 5323 1.4 8 .238 .003
Environment
Null 3712 931 <.001 .000 .120 13965
Configural 1123 705 <.001 .843 .054 11863
Metric 1160 735 <.001 .840 .053 11836 37.46 30 .1642 .003
Scalar 1235 765 <.001 .824 .055 11845 73.97 30 <.001 .016
*Scalar 1185 760 <.001 .841 .052 11806 24.169 25 .5096 .001
Note:  * Scalar indicates partial invariance: freeing the intercepts of recalibrated items.
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Equivalence of the QoL domains at different time points 
and between patients and partners 
The null model showed a reasonable goodness-of-fit as can be seen from the relatively small 
RMSEA (see Table 4, page 211). The nested model comparisons showed that for each of the 
four QoL domains no support for reconceptualization and reprioritization was found. Hence, 
the QoL domains demonstrated configural and metric invariance as can be seen from the 
decreasing saBIC across subsequent models, negligible ∆CFI differences, and RMSEA’s of ≤.05 
(Table 4, page 211). 
Even though absolute fit indices for scalar invariance were still acceptable, relative 
comparisons pointed at some minor non-invariance issues at the item intercept level for the 
QoL domains (i.e., recalibration). Thus, for some items a higher or lower score at specific time 
points was reported than would be expected based upon the general trend at the domain 
level. For the Physical Health domain, item 10 “Do you have enough energy for everyday life” had 
a slightly higher intercept at Time-0 (∆=.28) while item 3 “To what extent do you feel that physical 
pain prevents you from doing what you need to do?” and item 4 “How much do you need any medical 
treatment to function in your daily life?” had slightly lower intercepts at Time-0 (∆=-.15 and ∆=-
.48, respectively). Thus, for item 10 surgery has a higher impact compared to the general trend. 
Surgery also had a substantial impact on item 3 and 4 resulting in lower preoperative scores 
on these items compared with the general trend. For partners, item 15 “How well are you able to 
get around” had a slightly lower intercept at Time-0 compared with the patients (∆=-.19), which 
indicates that the difference between patients and partners on this item was smaller before 
surgery. For the Psychological Health domain item 6 “To what extent do you feel your life to be 
meaningful?” had a slightly higher intercept at Time-1 (∆=.12), compared to Time-0 and Time-2 
for the patients. Thus, at the first assessment after surgery patients experienced a general 
decrease on the Psychological Health domain. However, patients showed less decrease on the 
extent to which they felt their life to be meaningful. For patients, item 7 “How well are you able 
to concentrate?” had a slightly higher intercept at baseline (∆=.21). Thus, surgery and adjuvant 
treatment (if applicable) have substantial impact on the patients’ concentration. For the Social 
Relationships domain, both patients and partners had a slightly higher intercept at Time-0 
for item 20 “How satisfied are you with your personal relationships?” compared with Time-1 
and Time-2 (∆=.20 and ∆=.29, respectively). This implies that, after surgery, the decrease in 
satisfaction with personal relations is even stronger than the general decreasing trend in the 
social relationships domain. Finally, the Environmental domain item 9 “How healthy is your 
physical environment?” had slightly lower intercept for partners than for patients (∆=-.43), 
which might be linked to the intrinsically worse physical condition of patients. The occurrence 
of recalibration indicates that the comparison of individual QoL domain scores may be biased. 
In total, 8 of the 24 items were affected to some extent by recalibration, yet the intercept 
deviations were relatively small and the majority of items for each separate domain could still 
be considered scalar invariant, hereby providing a broad enough base to warrant comparison 
of the domains at the factor level.20 Therefore, the results of the QoL domains over time and 
between dyad-members, based on group-level statistics of the partial scalar invariant factor 
model, are described below.
QoL domain trajectories 
The established partial scalar measurement invariance for the factor structure of the QoL 
domains allowed comparison of patients and partner over time and between both members 
of the dyad on these domains at the factor level. For patients and partners the results of these 
analyses are presented in Figure 3a and 3b. For patients, an initial decrease in the Physical 
Health domain occurred at Time-1 compared with Time-0 (p<.001), after which partial recovery 
to baseline was observed at Time-2 (p=.055). For partners, factor means in the Physical Health 
domain remained constant over time (p=.189, p=.679) and were at each time point higher than 
the patients’ factor means (p=.007, p<.001, and p=.001, respectively). Patients’ and partners’ 
factor means on the Psychological Health domain significantly decreased at Time-1 (p=.002 and 
p<.001) after which stabilization occurred at Time-2 (p=.471 and p=.362). Patients and partners 
factor means were at each time comparable (p=.844, p=.835, and p=.838, respectively). Patients’ 
and partners’ factor means on the Social Relationships domain significantly decreased at Time-1 
(p=.018 and p<.001), which decreased further on for patients (p=.011), but stabilized for partners 
(p=.214). Partners factor means were significantly lower than patients factor means at Time-1, 
but not at the other time points (p=.088, p<.001, p=.098, respectively). For the Environmental 
Domain a decrease in factor means was noted for both patients and partners at Time-1 (p<.001 
and p<.001), after which stabilization occurred at Time-2 (p=.952 and p=.830). For this domain, 
patients and partners factor means were at each time comparable (p=.459, p=.346, and p 
=.484, respectively). For each domain, significant correlations in the QoL construct domains 
were found across time points, for both groups (see Table 5). These relatively high over-time 
correlations indicate that the relative position of patients and partners stayed stable over time, 
however, their actual QoL-scores might still have changed. Between patients and partners, the 
QoL domain constructs correlated significantly at each time point (see Table 5). For the Social 
Relationship and Environmental domains between dyad-member correlations were relatively 
homogenous. However, for the Physical and Psychological Health domains an auto-regressive 
correlation structure was noted: correlations reduced over time. In addition, at each time 
point, the correlations between patients and partners for the Physical Health domain were 
low. Finally, the partners’ lower variances for the Physical Health and Psychological Health 
domains might indicate that, for these domains, the partners are a more homogeneous group 
than the patients. 
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Figure 3  Factor means across time for the QoL domains for patients and partners
Note: The factor mean at baseline for patients is set as reference (i.e., dashed line) and fixed at zero to identify 
the longitudinal Structural Equation Model.
Table 5  Correlations at different time points and between patients and partners and variances for patients 
and partners at each time point for the four QoL domain factors
Patients Partners




Time-3 .420* .692* 1.052
Partners Time-0 .281** .141** .152*** .882
Time-2 .366* .123** .321** .681* .702




Time-3 .668* .721* .939
Partners Time-0 .416* .282** .269*** .848
Time-2 .329** .340** .309** .269*** .888




Time-3 .890* .736* 1.059
Partners Time-0 .462* .435** .241 1.310
Time-2 .493** .410*** .426** .681* .816
Time-3 .507** .353*** .300*** .398* .808* 1.077
Environment
Patients Time-0 1.000
Time-2 .765* 1.074  
Time-3 .856* .738* .861
Partners Time-0 .496* .487* .501* .973
Time-2 .524* .596* .592* .789* 1.041
Time-3 .336** .376** .548* .661* .850* .998
Note: *p<.001, **p<.01, and ***p<.05; Variances on the diagonal and correlations on the off-diagonal.




For both patients with colorectal cancer and their partners no indication for reconceptualization 
(i.e., no dissimilarity in the conceptual frame of the construct domains across time points) and 
reprioritization (i.e., similar relative importance of one or more of the items relevant for the 
construct domain at a given time) was found. Furthermore, conceptualization and prioritization 
was similar between patients and partners. 
The lack of indications for reconceptualization and reprioritization might be surprising, 
since earlier studies did find these indications in other populations.24-30 The questionnaire used 
to assess response shift may in part explain the outcomes.31 Questionnaires routinely used 
to assess response shift are in fact questionnaires that assess health status (e.g., The Short 
Form (12/36) Health Survey; SF-12/36).3 The terms QoL, health status, and health-related quality 
of life are often used interchangeably, however, the distinction between these definitions is 
important.32 Health status evaluates the impact of disease on functioning.32 Questionnaires 
evaluating health status, such as the SF-12/36, therefore assess physical possibilities, social 
activities, and psychological function, but not the participants’ feelings concerning this 
functioning.32 QoL is defined by the World Health Organization Quality of Life Group as “an 
individual’s perception of his/her position in life in the context of the culture and value systems 
in which he/she lives and in relation to his/her goals, expectations, standards and concerns”.33 
This definition implies that QoL is always subjective in nature. Therefore, QoL entails 
participants’ subjective interpretation of their well-being. Thus, health status questionnaires 
measure the impact of disease on functioning whereas QoL questionnaires measure the extent 
to which a participant is bothered by these limitations.32 Therefore, questionnaires using the 
SF12/36 might assess response shift in health status as opposed to response shift in QoL. In 
addition, our study only examined within-domain reconceptualization. However, in order to 
detect reconceptualization between the several domains it is also necessary to evaluate the 
cross-loadings. Unfortunately, we were unable to conduct these multidimensional analyses 
due to a limited sample size. In addition, in both research and clinical practice the WHOQOL-
Bref is only used to evaluate each domain individually (i.e., no total score is computed), 
therefore, comparing the domains does also not fit within the established fixed framework. 
Thus, in this study the current within-domain analyses were justified, but future studies in this 
area are still needed. In line with earlier studies5,6, indications for recalibration were found. That 
is, some items showed a differential score pattern compared to the general trend over time 
and between dyad members. It is not surprising that patients preoperatively reported to have 
more energy (item 10), a better ability to concentrate (item 7), less prevented in their activities 
by physical pain (item 3), and in less need of medical treatment (item 4) compared with the 
general domain trend. Especially since surgery and adjuvant treatments (if applicable) can 
have a substantial impact on these aspects. It is also not surprising that the preoperatively 
difference between patients and partners was smaller on their ability to get around (item 15). 
However, it is noteworthy that the decrease in satisfaction with personal relations is stronger 
than the general decreasing trend in the Social Relationships domain. Potentially, the social 
support received after treatment did not live up to patients’ and partners’ expectations. In 
addition, even though patients experienced a general decrease on the Psychological Health 
domain at Time-1, patients showed less decrease on the extent to which the felt their life to be 
meaningful. In our opinion, this reflects what is in clinical practice often meant with response 
shift. Finally, for the Environmental domain partners reported their physical environment 
to be less healthy, which might be linked to the intrinsically worse physical condition of the 
patients. 
While the indications for recalibration prohibited straightforward comparison of individual 
QoL domain scores, the established (partial) scalar measurement invariance did allow 
comparison of patients and partners QoL domain factor means over time and between both 
members of the dyad. For both patients and partners these factor level analyses showed, for 
the domain Psychological Health and the Environmental domain (consisting of questions such 
as ‘To what extent do you have the opportunity for leisure activities?’), an initial significant 
decrease at Time-1 compared with Time-0, after which stabilization was observed at Time-
2. This makes sense, since patients and partners both need to recover psychologically from 
the diagnosis and impact of cancer treatment. Patients’ and partners’ factor means on the 
Social Relationships domain also decreased at Time-1. However, at Time-2 this dissatisfaction 
increased for patients, while a partial recovery occurred for partners. As can be expected, 
partners had higher scores on the Physical Health domain compared with patients and 
correlations between patients and partners for this domain were low. All in all, these results 
show that both patients and partners are affected by the patients’ illness. Therefore, it is 
recommended that health care professionals and researchers pay attention to the QoL of both 
patients and partners.
To our knowledge, this is the first study that examined measurement invariance and QoL 
over the first six months after colorectal cancer surgery from a dyadic perspective. The results of 
the factor level QoL domain analyses acknowledge the notion that a coupe-based perspective 
to coping with colorectal cancer is warranted. Using the WHOQOL-Bref was an important 
advantage, as it assesses the subjective evaluation of functioning instead of functioning alone. 
However, there are also some limitations that need to be noted. For instance; although the 
first questionnaire was completed prior to surgery (Time-0) it probably does not reflect the 
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patients’ and partners’ actual baseline QoL. The time after diagnosis but prior to surgery can 
be very distressing for patients, as the consequences and results of cancer treatment are still 
unknown. Furthermore, the patient population was quite heterogeneous. Within and between 
patients with colon and rectal cancer a wide variety of treatment schedules and possible 
consequences of treatment (e.g., a stoma) can occur. This might have influenced our results, 
even though no differences in QoL were found between patients with colon and rectal cancer. 
In addition, future studies are needed to evaluate multidimensional reconceptualization and 
how the QoL trajectories develop in the future. Finally, even though patients’ self-report is the 
most common and straightforward way to obtain QoL information, questionnaires may not 
completely capture the response shift experienced. In this regard, Rapkin and Schwartz rightly 
advice to incorporate direct measures of QoL appraisal and interviews in order to account for 
inter-individual and temporal differences in the meaning attributed to QOL scales.31
Conclusion
For patients with colorectal cancer and their partners no reconceptualization and 
reprioritization occurred within each of the QoL domains, but indications for recalibration 
of specific items were found. The reported partial scalar factorial invariance implied that 
straightforward comparison of individual QoL domain scores was not warranted, but that 
comparisons over time and between patients and partners were feasible if restricted to group-
level statistics at the factor level. The QoL domain trajectories showed that both patients and 
partners are affected by the patient’s disease and treatment. Therefore, it is recommended 
that health care professionals and researchers give attention to the couple as opposed to the 
patient alone. 
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Sexual dysfunction among patients with colorectal cancer is frequently reported. Studies 
examining patients’ sexual health care needs are rare. We examined the sexual health care 
needs after colorectal cancer treatment according to patients, partners, and health care 
professionals (HCPs). Factors that impede or facilitate the quality of this care were identified. 
Method
Participants were recruited from three Dutch hospitals: St. Elisabeth, TweeSteden, and 
Catharina hospital. Patients (n=21), partners (n=9), and 10 HCPs participated in eight focus 
groups. 
Results
It is important to regularly evaluate and manage sexual issues. This does not always occur. 
Almost all participants reported a lack of knowledge and feelings of embarrassment or 
inappropriateness as barriers to discuss sexuality. HCPs reported stereotypical assumptions 
regarding the need for care based on age, sex, and partner status. The HCPs debated on whose 
responsibility it is that sexuality is discussed with patients. Factors within the organization, 
such as insufficient re-discussion of sexuality during (long-term) follow-up and unsatisfactory 
(knowledge of the) referral system impeded sexual health care. The HCPs could facilitate 
adequate sexual health care by providing patient-tailored information and permission to 
discuss sex, normalizing sexual issues, and establishing an adequate referral system. It is up to 
patients and partners to demarcate the extent of sexual health care needed.
Conclusions
Our findings illustrate the need for patient-tailored sexual health care and the complexity of 
providing/receiving this care. An adequate referral system and training are needed to help 
HCPs engage in providing satisfactory sexual health care. 
Introduction
There is an increasing awareness that patients coping with cancer may have sexual health care 
needs.1 Previous studies have shown that patients with breast-, gynecological-, or prostate 
cancer may need informational support and treatment to optimize the patients’ sexual 
functioning and/or the quality of sexual life.1 However, these needs may not be adequately 
met.1 
Although sexual dysfunctions among patients with colorectal cancer are frequently 
reported2, studies examining the sexual health care needs of these patients are rare.3-5 One 
study investigated the informational needs of patients and reported that 55% of them did 
not remember receiving any information on how cancer or cancer treatment may affect their 
sexual functioning, while 58% rated this topic as important (somewhat – very important).3 In 
addition, patients’ unmet sexual health care needs were positively related to psychological 
symptom distress, but negatively related to age.4 To our knowledge, only one study noted an 
impact of surgery or a stoma on the sexual relationship.5 However, the two latter studies did 
not provide an in-depth view, since sexual health care needs were examined as a secondary 
objective. Furthermore, studies examining both patients and partners are lacking, even 
though coping with cancer is probably a dyadic affair.6,7 Finally, there may be a mismatch in 
expectations between patients and partners and health care professionals (HCPs) with regard 
to the necessity for sexual health care.8,9
Due to the abovementioned reasons it is important to ascertain the sexual health care 
needs of patients and partners coping with colorectal cancer and to explore when and by 
whom these sexual issues could be evaluated and managed.10,11 Knowledge of the barriers and 
facilitators associated with providing or receiving adequate sexual health care may enable 
patients, partners, and HCPs to overcome these issues. Therefore, the aim of the current focus 
group study was to examine (i) the sexual health care needs according to patients, partners, 
and HCPs and (ii) factors that impede or facilitate the sexual health care.
Method
Participants and procedure
Participants were recruited from the St. Elisabeth Hospital (Tilburg, the Netherlands), 
TweeSteden Hospital (Tilburg and Waalwĳk, the Netherlands), or Catharina Hospital 
(Eindhoven, the Netherlands). First, the patients’ medical records were reviewed in order to 
determine the patients’ eligibility. Eligible participants had to be (i) diagnosed with colorectal 
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cancer between January 2010 and February 2012 or be the partner of an eligible patient 
diagnosed with colorectal cancer within this time frame and (ii) aged between 18 and 75 
years. Persons were excluded if they (i) had metastatic colorectal cancer or their partner had 
metastatic colorectal cancer, (ii) were physically not fit enough to attend the focus group, 
(iii) had a history of mental disease or cognitive problems, or (iv) had insufficient knowledge 
of the Dutch language. One of the researchers (MJT) contacted the eligible participants to 
explain the purpose of the study and invited them to participate. In order to ensure a wide 
variety of experiences to be represented, potential participants were informed that having 
sexual health care needs and/or being sexually active was not a prerequisite to participate in 
this study. In addition, patients and partners were selected based on their sex, age, and tumor 
type (if applicable) in order to attain a fair representation of the colorectal cancer patient 
population and their partners. To rule out selection bias, the partners were still invited to 
participate when patients declined participation and vice versa. A purposive sampling method 
was applied. Purposive sampling implies that the recruitment of participants was stopped 
after the intended number of participants and sufficient diversity between the participants 
in the focus groups was achieved. The participating HCPs were invited by two members of 
the research team (JAR and HJTR). JAR and HJTR selected HCPs based on their expertise 
and experience working with the colorectal cancer patient population. The medical ethical 
committee approved the study. All participants gave written informed consent. Participation 
was voluntarily; no financial reward was given.
Focus group meetings
Conducting focus groups is one of the most used methods in qualitative research.12 Focus 
groups facilitate the in-depth exploration of a person’s perspective through group interaction.13 
Since sexual health care needs were the topic of the focus groups we thought that participants 
may share information more easily when not in the presence of their partner, someone of 
the opposite sex, or their HCP. Therefore, patients, partners, and HCPs were interviewed 
separately. In addition, the patient and partner groups were sex-specific. Usually, six to eight 
participants are invited per focus group.13 However, given the sensitive topic, we allowed 
fewer participants per group. After eight sessions data saturation was reached.14 Each focus 
group was guided by a focus group moderator (MJT). The moderator was assisted by a student 
who took notes. The moderator started each focus group by explaining the purpose of the 
study followed by an introductory round in which each of the participants briefly shared their 
experiences. During the focus groups two main questions were asked: “Which sexual health 
care needs did you have during the course of treatment or do you still have?” and “During which 
treatment phase did you need/receive this sexual health care?”. Follow-up questions were 
asked to capture the experiences of the participants and their view on how to improve sexual 
health care (if needed). The focus group structure was the same for each focus group. The 
focus groups took about 90 minutes and were audio taped with the participants’ permission.
Questionnaire
Patients and partners completed questions assessing socio-demographic factors (i.e., age, 
sex, marital status, and educational level). In addition, they rated on a 10-point scale: (i) the 
importance of sexuality, (ii) the severity of sexual problems, and (iii) the influence of sexual 
problems on their quality of life. For the item on the importance of sexuality a higher score 
indicated a higher importance. For the latter two questions a higher score indicated more 
severe sexual problems and a bigger influence of these problems on quality of life, respectively. 
Data analysis 
The focus group meetings were analyzed using a grounded theory approach.14,15 Data analysis 
proceeded stepwise. First, the focus groups were transcribed verbatim. Next, open coding 
was used in order to identify the needs and determinants for change. Subsequently, the 
determinants were grouped into barriers and facilitators. Next, these barriers and facilitators, 
could be grouped according to the model of Wensing et al., (2005)17,18 who described factors 
that impede or facilitate change in the care system: (i) individual factors (e.g., motivational, 
cognitive, or behavioral), (ii) social factors (e.g., professional teams, professional development, 
and professional networks), (iii) organizational factors (e.g., organizational processes, structure 
of the organization and work processes, and available resources), and (iv) societal factors 
(e.g., financial factors, law and regulations). Two authors (MJT and BLDO) independently 
reviewed and coded each of the transcripts and ensured data saturation. In addition, these 
authors discussed the different sets of coding. When coding disagreements arose, the authors 
discussed the responses and selected the most appropriate code for each response. After this 
discussion, the transcripts were re-read and re-coded. Analyses were done using color coding 
in Microsoft Word and Excel.
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Results
In total, 21 patients and nine partners participated (see Figure 1 and Table 1). For the patients 
and partners, the sociodemographic characteristics as well as the scores reflecting the 
importance of sexuality, the severity of sexual problems, and the influence of sexual problems 
on their quality of life are presented in Table 1. The clinical characteristics of the patients 
are also reported in Table 1. Ten HCPs participated: two surgeons, one gynecologist, one 
gynecologist/oncologist, an urologist, two sexologists/psychologists, a physician assistant, a 
nurse practitioner, and a stoma nurse. 
The sexual health care needs  
according to patients, partners, and HCPs
Survival seems to be the main priority for patients and partners, especially during treatment 
and the first months after treatment. However, sexuality may regain a more prominent 
position in the couples’ life after treatment. Patients and partners especially considered being 
intimate (e.g., hugging and kissing) and having a good relationship important. Moreover, they 
often rated intimacy as more important than being able to have sexual intercourse. 
Patients and partners both acknowledged the importance of receiving sexual health care. 
They reported having frank conversations about the possible consequences of colorectal 
cancer and its treatment on sexual function and/or the quality of sexual life as an important 
need. Since intimacy was often the main priority, they stated that these conversations should 
not focus solely on potential sexual dysfunctions, but also on psychosexual changes that may 
occur. Patients and partners also reported a need for (knowledge of) treatment options if a 
sexual dysfunction or sexual problem occurs. The HCPs acknowledged that sexual health care 
should be provided, both on an informational and treatment level. However, all participants 
also acknowledged a number of barriers to providing sexual health care. They reported similar 
individual and organizational factors that could impede or facilitate change. Therefore, the 
results are presented per factor. Within these factors few sex- or role-specific (patient-partner-
HCP) themes were reported. If a theme was only applicable for a subgroup of participants, 
then this is explicitly stated in the text.
Figure 1  Study Flow Chart
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Mean±SD Mean±SD Mean±SD Mean±SD
Age at time of focus group 63.1 ± 8.5 
[47-73]
63.4 ± 5.2 
[56-73] 




Months since surgery 6.6± 2.9 
[2-12]
7.6 ± 5.9 
[2-20]
- -
Importance of sexuality 6.6 ± 1.8 [3-8] 6.4 ± 1.4 [5-8] 6.0 ± 1.4 [5-7] 5.3 ± 2.9 [2-7]
Severity of sexual problems 4.8 ± 4.0 
[0-10]
5.0 ± 2.3 [2-8] 3.0 ± 0.0 [3-3] 2.3 ± 2.5 [0-5]
Influence of sexual problems on 
quality of life 
3.3 ± 3.0 [0-8] 2.0 ± 3.7 [0-7] 0.0 ± 0.0 [0.0] 1.3± 2.5 [0-5]
N (%) N (%) N (%) N (%)
Educational level
Low 3 (25%) 0 (0%) 1 (33%) 1 (7%)
Medium 6 (50%) 7 (78%) 1 (33%) 4 (79%)
High 3 (25%) 2 (22%) 1 (33%) 2 (14%)
Marital status
Partnered 12 (100%) 4 (44%) - -
Widowed/no partner 0 (0%) 5 (56%) - -
Type of cancer
Colon 7 (58%) 3 (33%) - -
Rectum 5 (42%) 6 (67%) - -
Type of stoma
No stoma 4 (33%) 4 (45%) - -
Temporary stoma 4 (33%) 2 (22%) - -
Definitive stoma 4 (33%) 3 (33%) - -
Note: Low = up to ten years of education, middle = 10-14 years of education, high = more than 14 years of 
education. *These questions were answered on a 1-10 scale. The demographical information of one male 
patient is missing. 
Individual factors
Patients and partners were not always able to recall if they received information on the 
potential sexual consequences of treatment. Especially, the potential consequences of (neo)
adjuvant therapy were reported as unknown. Knowledge on the available health care for 
sexual problems was also limited. Patients and partners reported this insufficient knowledge 
as a barrier to discuss their sexual health care needs with their HCP. Furthermore, the couples 
mentioned that sexuality is, in their opinion, still a taboo; therefore, they felt embarrassed 
to discuss their sexual problems. In addition, they considered it as inappropriate to discuss 
sexuality with their HCPs, since the main goal of treatment is survival. The partners felt that 
they had to be strong for the patient and that the patient’s needs were most important, so 
they discarded their own sexual needs (Table 2). 
The HCPs reported several barriers for providing sexual health care. Most HCPs felt that 
they are insufficiently equipped to have in-depth discussions about sexuality or felt that 
it is outside their purview of care. The HCPs also reported several beliefs that made them 
reluctant to discuss sexuality (i) a feeling of inappropriateness to discuss sexuality, since 
survival is the primary concern, (ii) a fear to cause discomfort, due to the private nature of 
the conversation, especially when other family members (e.g., children) are present, and (iii) 
sexuality was sometimes seen as irrelevant based on the patients’ age, gender, or relationship 
status (Table 2). 
The participants reported that discussing sexuality may become more easy if the HCPs 
(i) initiate and encourage the discussion without making any stereotypical assumptions, 
(ii) normalize concerns by providing straightforward information on the possible sexual 
consequences of treatment and treatment options in case sexual problems arise, (iii) give 
couples explicit permission to raise sexual issues at any time, (iv) possess an open-minded 
attitude, (v) maintain a personalized approach, (vi) be able to create a safe environment by 
placing the discussion not only into the context of the patient’s disease but also in the context 
of the couples’ lives, and (vii) pay attention to psychosexual changes instead of focusing 
solely on clinical outcomes. Subsequently, it is up to the couples to demarcate the depth of 
sexual health care needed. Thus, discussing sexuality was seen as a shared responsibility of all 
participants (Table 2). 
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Table 2  Barriers to and facilitators for change – Individual factors
Factors Themes Quotes
Consumer level (patients/partners)
Cognitive factors Knowledge of 
possible sexual 
dysfunction
!  ‘I am glad that they discussed it (potential sexual 
dysfunctions) (…), because otherwise you wouldn’t 







! ‘Hopefully you don’t experience it (a sexual 
dysfunction). However, if you do then the logical 
question is whether you were really prepared and 
if there is anything you can do?’ Male patient
Motivational factors Need for help ! ‘About 3-4 months after treatment, I finally 
started feeling that I wanted more than cuddling 
(..) I felt in better physical and emotional shape 
to do something more... And then, at one point, I 
realized that it was not working as it should.’ Male 
patient
Beliefs
3 Taboo ! ‘You feel exposed when you say “I do have a 
problem”. A lot of patients are embarrassed.” 
Male patient 
3 Appropriateness !  ‘The doctor said “Then (during chemotherapy) 
you can not have sex with your husband”. I did 
not know what she was talking about, that was 
difficult. However, I was doing chemotherapy, so I 
did not ask any further.’ Female patient








‘When the HCPs do not provide any attention to 
it (sexuality), then the patient will, nine out of 10 
times, not initiate the discussion.’ Male patient
 ‘Sexuality should be discussed with everybody. 
Then everybody can decide for themselves what 
is applicable to them.’ Female partner
Provider level (HCPs)
Cognitive factors Knowledge ! ‘I don’t do that (discuss sexuality extensively), since 
my knowledge about it is too limited. However, I 
do try to mention it.’ HCP
Competence ! ‘They (the couples) may experience premorbid 
relationship problems (..) Then I think “I am not 
qualified for this”.’ HCP
Factors Themes Quotes
Provider level (HCPs)
Motivational factors Improving 
sexual health 
care
√  ‘People often do not know what the possibilities 
are. I think that also applies to the HCPs.’
Beliefs
3 Appropriateness ! ‘I don’t believe sexuality is a subject you discuss 
in the diagnostic and treatment phase. (..) During 
that phase patients are mostly concerned with 
survival. (..) Sexuality is, in my opinion, a quality 
of life aspect, which is important in the long 
run, after treatment. If I discuss sexuality a lot 
with patients who are trying to survive, then the 
patients will think; “That doctor is crazy, he needs 
to get his priorities straight”.’ HCP
 ‘I have to admit that the situation in which the 
children are present works restraining.’ HCP
3 Gender ! ‘I think that with women you don’t discuss it 
(sexuality) that often. I mean, if you’re talking 








‘What is the point? A lot of patients, elderly 
patients, will say: “That is no longer an issue”.’ 
HCP
‘An increasing number of elderly people still 
undergo these kinds of surgeries and then, if 
there is someone sitting in front of me who is 
single, then I think oh well…’HCP
√  ‘You might unexpectedly get a partner, you never 
know. Then you should know which problems you 
might encounter and how you should deal with 
them.’ Widowed female partner
3 Need for help ! ‘There are physicians who literally said: “My 






√ ‘They should at least ask “Would it be helpful 
to discuss not only the medical but also 
psychological issues?”.’ Male patient
Attitude √  ‘Often it is normalizing concerns; the surgery, 
the disease, or permanent changes may alter 
sexuality. That should be open to discussion. HCP
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Social factors
Having a professional multidisciplinary team within the hospital may facilitate providing 
adequate sexual health care, especially when this team adopts a holistic patient approach. 
Amongst the HCPs, there was debate on whose responsibility it is to discuss sexuality. 
However, the patients and partners suggested that the HCPs of each discipline could 
discuss the possible consequences of their treatment modality and evaluate the patients’ 
sexual health during follow-up. In this way, the couples expected to receive patient-
tailored information. For instance, sexual issues accompanied with having a stoma only 
have to be discussed with patients with a stoma. Furthermore, the HCPs acknowledged 
that they could further improve their professional development by attending courses 
on how to provide (limited) information and how to evaluate sexual issues. In addition, 
learning to recognize the boundaries of the HCPs own profession and the possibilities of 
other HCPs may enable the HCPs to make a timely referral, if more extensive treatment 
is needed. The HCPs believed that the professional network as a whole could increase 
the awareness that providing sexual health care is an important aspect of cancer care 
(Table 3). 
Organizational factors
Establishing a primary contact person for the couples was seen as an organizational process 
that could advance the sexual health care. The structure of the organization could further 
benefit from sufficient time to discuss sexuality during the existing consults. However, it is 
important to carefully select the information given during these consults in order to avoid 
an information overdose. Therefore, a structural re-discussion of sexuality during (long-term) 
follow-up is essential. Furthermore, improving the (awareness of) available resources might 
enable HCPs to provide better sexual health care. Personalized information in writing could 
for instance complement the verbal information. In addition, the sexologists pointed out that 
the HCPs have to be able to identify existing problems; however, if psychosexual counseling 
(e.g., by a sexologist) or treatment for dysfunctions (e.g., by a gynecologist or urologist) is 
needed, then the HCPs should be aware of the possibilities for referral. Finally, patients and 
partners mentioned a potential role for their general practitioner in the management of their 
sexual health care needs. The general practitioner could play a key role in observing potential 





√ ´I think it helps if you place a story in the context 




√ He (the HCP) always asks: “Is there anything 
special”? Well, that not very inviting. However, if 
he would ask “How are things going sexually? Do 
you experience problems?” Then you can say yes 
or not to that.’ Male partner
Holistic view √
√
‘It (the MDT) is mostly a technical club (…) 
However, a sexual problem may not only 
be technical problem, but may also be a 
psychological problem’ HCP 
‘Surgeons often try the resolve it (sexual 
dysfunctions) with medication; however, I wonder 
if they should do that.’ HCP 
Note: In order to increase the readability of the table only one quote (either a barrier or facilitator) is provided 
by one of the participants. However, this does not reflect the total spectrum of quotes reported. * = these 
behavioral facilitators were reported by the participants (patient, partners, and HCPs) as the prerequisites to 
3 = Beliefs mentioned, ! = Barriers to change, √ = 
Facilitators for change.
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Table 3  Barriers to and facilitators for change – Social, organizational, and societal factors
Factors Themes Quotes
Social level




‘Sometimes it (sexual intercourse) is physically 
possible, but there may be a lack of arousal, lack 
of desire, or relationship problems. That is at least 
as interesting from a sexuological point of view.’ 
HCP
‘Patients mostly have issues concerning intimacy, 
these issues are often not even that erotically 
charged. Even if ‘it’ doesn’t work anymore, then 
you can still address that.’ HCP
Responsibility √ ‘I believe it is an ‘and and’ approach (…) During 






√ ‘I believe that it only takes one question: “Are 
there any sexual problems?” If that is the case 
we have a sexologist and it is very common that 
patients talk to him/her.’ HCP






√ ‘When I go to the bank, I have a person who 
handles all my affairs: a case manager. I really 
miss this in healthcare.’ Male patient
Structure of the 




! ‘I occasionally thought about discussing it (sexual 
problems) (..). However, 10 minutes later you are 
outside again (after an consult). While I walked 
through the corridor I thought I should have 




√ ‘It is always difficult; during the consult I have to 
do a physical exam, take a history, give education 
about the surgery. Some people I see don’t even 
know that they are getting a stoma. Then you 
have to discuss the complications that can occur 
postoperatively. And then I still have to tell them 
that there is also a possibility that (referring to 
potential sexual dysfunction). I mention it, but you 
can hear the couples think; “oh not that as well”.’ 
HCP
Follow up ! ‘But that is the problem; once it is needed (sexual 
health care) then I think they are often no longer 




Available resources Psycho/sexual 
referral
√ ‘I am no advocate of referring all patients with 
colorectal cancer to a sexologist, I am really not. 
Some aspects are part of the regular course of 
treatment. However, if they deviate from what is 
perceived as normal and this concentrates around 





‘I see patients with prostate cancer, but patients 
with colorectal cancer? That may only have 
happened once. So that is only seldom.’ Urologist
‘Every sexually active female patient who has had 
radiation on the pelvic area followed by surgery 
should be quickly referred to a gynecologist. (..) 
The first year after treatment patients barely have 
sexual needs. (..) However, later when the disease 
is well under control, then they start to believe 
and have an increasing sexual desire, however, 
then the vagina may be totally obstructed by 
tissue reaction due to radiation.’ HCP
General 
practitioner
√ ‘What about your general practitioner? He is 
there as well. I mean, in case you really want to 
discuss stuff.’ Female patient 
Information 
booklets
√ ‘But you do read it (the information booklets) and 
then, if you experience side-effects in the future, 
then you can at least think “Oh yes, I read about 
this somewhere”.’ Female patient
Societal level




‘That (providing separate care to the partners) 
is not possible according to the law. You have 
a relationship with the patient, not with the 
partner. However, you can easily address that in a 
conversation. Just say, it has been a rough period 
for you as a partner or as a family.’ HCP
‘Just prescribe the lubricants. (..) You get a lot of 
medications (at the pharmacy), if that includes 
them, well yes I would find that quite logical.’ 
Female patient
Financial factors Health care 
insurance
√ ‘For a lot of patent are the financial costs an 
argument. The advantage of a hospital is that the 
insurance is covered. ‘HCP
Note: In order to increase the readability of the table only one quote (either a barrier or facilitator) is provided 
described, 3 = Beliefs mentioned, ! = Barriers to change, √ = Facilitators for change.
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Societal factors
Societal factors were sporadically mentioned. For instance, one of the HCPs stated that the 
psychosexual care is largely covered by the health care insurance. However, another HCP 
mentioned that they can only provide limited care to the partner (i.e., Medical Treatment 
Agreements Act). Finally, some patients said that they could benefit from sexual aids (e.g., 
lubricants); however, buying these aids was considered difficult and embarrassing. Therefore, 
they wondered if the HCPs could prescribe sexual aids in order to increase the accessibility 
(Table 3). 
Discussion
Patients and partners coping with colorectal cancer have sexual health care needs that are not 
always adequately met. While all patients and partners stated that it was important to have 
their sexual health care needs evaluated and managed, some HCPs wrongfully assumed that 
elderly, widowed, or female patients might have a lower need for sexual health care. Therefore, 
there was a mismatch between patients, partners, and HCPs with regard to the importance of 
providing/receiving adequate sexual health care in these specific patient populations. Several 
barriers to and facilitators for change were identified. Almost all participants reported a lack 
of knowledge and unsatisfactory communication skills as important barriers, while the HCPs 
(except for the psychologist/sexologist) additionally reported a lack of knowledge with regard 
to the referral possibilities. In addition, as stated above, some beliefs made the HCPs decide 
that discussing sexuality was not important which impeded the probability that sexual issues 
were discussed. Finally, resources, such as a good referral and consultation system and training 
are needed to help the HCPs engage in providing satisfactory sexual health care. 
Even though we did not explicitly ask participants about factors that might impede or 
facilitate change, we were able to apply the theoretical framework of Wensing et al. (2005)18. 
Logically, the patients and partners were more concerned with the dynamics between the 
patient/couple and the HCP, while the HCPs were also more concerned with organizational 
and social, issues. Societal factors were only sporadically mentioned. Therefore, future studies 
should investigate these societal factors more explicitly.
Our findings corroborate previous studies among other types of cancer.8 For instance, the 
need for sexual health care has been found quite consistently in studies evaluating the sexual 
health care needs of primarily breast, gynecological, or prostate cancer patients (for an overview 
we refer to Park, Norris, and Bober; 20098). These studies also reported several aspects, such 
as insufficient knowledge about the potential sexual consequences of cancer treatment and 
beliefs about sexuality, as barriers to satisfactory sexual health communication.8 Furthermore, 
sufficient time during consults and adequate recourses (such as a good referral system) also 
are previously reported facilitators.8 These results suggest that the majority of sexual health 
care needs are applicable across cancer types and across (Western) countries. However, each 
cancer type may have additional disease-specific aspects that need to be taken into account. 
For instance, the participants in our study reported a need for information on how to have an 
intimate relationship while having a stoma (if applicable). In addition, individual barriers that 
may arise in the colorectal cancer patient population, such as assumptions based on age, sex, 
and partner status, were identified.
Overall, the patients and partners stated that it is important that they are adequately 
informed and that their sexual health care needs are carefully evaluated and managed; 
however, they also said that it is up to them to determine the extent of health care wanted. It 
is important to keep in mind that there may not always be a need for help. Based on the need 
for tailored sexual health care, the adoption of a stepped care program, such as the Extended 
PLISSIT (Ex-PLISSIT) model may improve the sexual health care.19 The traditional PLISSIT model 
developed by Annon (1976) follows a stepwise approach in which various levels of discussion 
or treatment are used.20 If a lower order level is insufficient, than a higher order level can be 
deployed (for examples see Katz, 200521). Although this model is widely used, the applicability 
for patients with colorectal cancer has only recently received attention.22,23 For instance, a 
recent intervention study reported that patients with a stoma who received more psycho-
education with regard to sexuality had better sexual satisfaction.22 The acronym PLISSIT 
signifies the four levels of intervention: Permission (P), Limited Information (LI), Specific 
Suggestions (SS), and Intensive Therapy (IT). The Ex-PLISSIT model extends the original model 
by emphasizing the role that Permission-giving plays at all stages by postulating that each 
stage is underpinned by Permission-giving.19 In addition, Intensive Therapy may be used at any 
stage. If the HCP is challenged with something they feel unable to deal with, it is important that 
they refer the patient/couple to a colleague who is better qualified, regardless of stage. Finally, 
the Ex-PLISSIT model enables practitioners to use reflection and review to develop their own 
practice. In current practice, the different levels of this model can be divided amongst several 
HCPs. In this way, providing sexual health care becomes a shared responsibility, which is also 
time effective. If needed, psychosexual counseling can be combined with medical treatment 
(e.g., phosphodiesterase type 5 inhibitor - PDE5-Is, vacuum erection devices, lubricants). 
Although the PLISSIT model provides a framework for discussing sexual issues, it does not 
provide the clinical knowledge and communication skills to exploit this dialogue in an effective 
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manner.23 Thus, providing training to HCPs could be beneficial, especially since the HCPs in 
our study stated that they could additionally benefit from education focused on improving 
their communication skills with regard to these domains (if needed). 
This study contributed to the current literature since it assessed an important, but still 
under evaluated, field of research namely the sexual health care needs of patients with 
colorectal cancer and their partners. Especially since we not only examined the patients’ 
perspective, but also that of the partners and HCPs. In addition, this study not only included 
partnered participants, regardless of their level of sexual activity, but also single and widowed 
patients. Another important strength lies in the study design: The semi-structured qualitative 
design of this study facilitated an in-depth exploration of the sexual health care needs. We 
noticed that participants felt free to share their experience, which facilitated frank in-depth 
conversations. We conducted the focus groups in a standardized manner in order to keep 
information gathered and style of questioning consistent (e.g., used the same moderators). 
Furthermore, our study strengthens the general believe that the majority of the sexual health 
care needs are applicable across cancer types and across (Western) countries. Hopefully, 
our study challenges HCP’s to begin to evaluate their own needs for information, education, 
and skill-training, along with affirmation from the patients and partners that sexuality is an 
important area of a quality of life that should be discussed during and after treatment. Finally, 
the results of this study allowed us to provide clear recommendations for both research and 
clinical practice (e.g., the use of the Ex-PLISSIT model) and questions for future research (e.g., 
the need to include ethnic minorities, see below).
However, there are also some limitations and still remaining questions that need to be 
addressed. With a response rate of 51% the possibility of response bias has to be recognized. 
Even after emphasizing that having sexual health care needs and/or being sexually active 
was not a prerequisite to participate, the majority of patients and/or partners that declined 
participation said that they were not interested in discussing sexual health care needs. It 
might be that these patients and partners felt embarrassed to talk about sexuality. In addition, 
our study population unfortunately consisted solely of Caucasian participants. The inclusion 
of ethnic minorities was impeded by the fact that sufficient knowledge of the Dutch language 
was an inclusion criterion. Therefore, future studies are needed to examine the sexual health 
care needs and the determinants for change of participants with other ethnic backgrounds. 
Finally, the primary aim of the focus groups was to address sexual health care needs in 
general as opposed to participants’ own private needs/functioning; therefore we obtained 
only limited quantitative information (i.e., the importance of sexuality, the severity of sexual 
problems, and the influence of sexual problems on their quality of life). Future research 
should evaluate the sexual functioning and quality of sexual life of this patient group more 
in-depth. In the future, it could be beneficial if sexual health is included as a theme in the 
national guidelines on (colorectal) cancer. Nowadays, sexuality is only represented in the 
Dutch Nursing guidelines.24 In that way, quality indicators can be developed which can be 
used to evaluate the quality of care at a national level. These quality indicators can be used to 
highlight potential quality concerns, while information on barriers and facilitators can guide 
the selection of implementation strategies to improve sexual health care.17,18
Conclusion
Our findings illustrate the need for patient-tailored sexual health care and the complexity of 
providing or receiving this care. An adequate referral and consultation system and training are 
needed to help HCPs engage in providing satisfactory sexual health care.
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In the 1950’s Bernstein and Long stated: “It is the feeling of the authors that the incidence 
of sexual dysfunction following operations for cancer of the rectum and sigmoid colon is a 
reliable index of the amount of lymphatic-bearing tissue which has been removed during 
the procedure.”1 This statement indicates that sexual dysfunction after (colo)rectal cancer 
surgery was considered unavoidable. While the current surgical procedures challenge 
the inevitable damage to the pelvic nerves necessary for an adequate physiological sexual 
response,2 prospective research focusing on Sexual Function (SF) and colorectal cancer is 
limited.3,4 Furthermore, patients’ subjective evaluation of the consequences of a colorectal 
cancer diagnosis and treatment on his/her sexual life (i.e., the quality of sexual life - QoSL) has 
not yet been evaluated in depth. Moreover, research incorporating the partner’s perspective 
and couple dynamics is, especially in the colorectal cancer population, scarce.5,6 Therefore, 
three major topics were examined in this dissertation. First, biopsychosocial consequences 
of colorectal cancer on SF and QoSL were identified (Chapter 2-5). Next, a dyadic-perspective 
was taken into account conceptually and methodologically (Chapter 6-8). Finally, patients’ 
and partners’ sexual health care needs were evaluated (Chapter 9). Based on these chapters, 
future research directions and implications for clinical practice are provided. 
SF and QoSL
The literature on SF and QoSL in patients with colorectal cancer was systematically reviewed 
in chapter 2. In the literature, erectile or ejaculatory dysfunction was reported for men, while 
women experienced dyspareunia and lubrication problems. Factors associated with sexual 
dysfunction were a higher age, neoadjuvant radio(chemo)therapy, a stoma, complications 
during or after surgery, having rectal cancer, having had an abdominoperineal resection 
(compared with an anterior resection), and a lower tumor location. Most studies (n=66, 81%) 
evaluated treatment-related sexual dysfunction in patients with rectal cancer.7-72 While this 
interest is not surprising, due to the potential nerve damage, psychosocial factors may still be 
missed. In addition, few studies focused on female sexual (dys)function38,52,54,68,73-75 and patients 
with colon cancer76,77 (n=7, 9% and n=2, 2%, respectively). Moreover, there was insufficient 
research into factors associated with QoSL to form clear conclusions. Broadening the scope to 
evaluate (i) women and patients with colon cancer and (ii) biopsychosocial predictors for both 
SF and QoSL was therefore warranted.
A higher age has been identified as a strong predictor of sexual dysfunction (see chapter 
2). However, there has been a debate if sexual dysfunction in a higher age is not only normal, 
but also not problematic.78,79 In order to address this issue, chapter 3 compared colorectal 
cancer survivors with an age-matched normative population. Compared with the normative 
population, male rectal cancer survivors reported lower erectile function and female 
colorectal cancer survivors reported more lubrication problems and pain during intercourse. 
Furthermore, sexual enjoyment for men was similar across groups, while women with 
colorectal cancer scored lower than the normative population. A higher age, being a woman, 
not having a partner, a low educational level, rectal cancer, depressive symptoms, and fatigue 
were negatively associated with SF, while a higher age, being a woman, depressive symptoms, 
and cardiovascular disease were negatively associated with sexual enjoyment. This study 
therefore shows that not all sexual dysfunction reported after surgery can be attributed to age. 
In addition, it raises awareness for sexual dysfunction also being a relevant topic in patients 
with colon cancer and women. Finally, this chapter showed a potential role for psychological 
variables. 
Chapter 2 also noted that preoperative SF and QoSL scores were often lacking. However, 
preoperative information on SF and QoSL is needed in order to determine the effects of 
treatment. In addition, at the time the review was conducted, only one study80 focused on 
the consequences of colorectal cancer for the family. Therefore, data obtained after diagnosis 
but prior to surgery were analyzed for patients and partners in chapter 4. Patients with colon 
and rectal cancer had comparable scores on SF and the QoSL. However, compared with 
normative data derived from the manuals of the questionnaires81-84, patients with colorectal 
cancer and partners reported a lower preoperative SF and QoSL. A partial explanation for the 
lower scores may be that neoadjuvant treatment may have already started for some patients 
with rectal cancer. Moreover, psychological factors may also contribute as high levels of 
psychological distress have been reported in patients awaiting a possible cancer diagnosis85-88 
and recently diagnosed cancer patients86,87,89-91. Thus, surgery may not be the sole cause of 
sexual dysfunction as low levels of SF and QoSL are already reported preoperatively. 
Psychological factors (e.g., mood92, body image93) have been previously related to SF. In 
addition, chapter 2, 3, and 4 suggest that psychological factors may contribute to the levels of 
SF and QoSL. Therefore, chapter 5 evaluated biopsychosocial predictors for both constructs 
with a one-year prospective study. Across time, correlations between SF and QoSL ranged 
from small to high, which indicates that SF and QoSL are distinctive but related constructs. 
This distinctiveness was further supported by the fact that SF did not change significantly 
over time, while QoSL decreased during the first year after surgery. Furthermore, different 
biopsychosocial predictors were identified for SF (i.e., a higher age, more fatigue, not being 
sexually active, and having a stoma) and QoSL (i.e., having rectal cancer, more depressive 
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symptoms, lower SF, and more relationship maladjustment). Moreover, partners’ SF and QoSL 
contributed to patients’ SF and QoSL, respectively. Interdependence between patients and 
partners has been reported before94 and may also be true in this chapter. Finally, a significant 
interaction effect between time and gender showed that SF and QoSL trajectories differ for 
men and women. All in all, this chapter showed that SF and QoSL are related but distinctive 
constructs and that attention for both SF and QoSL, from a biopsychosocial perspective, is 
needed. 
Towards a dyadic approach
The importance of viewing cancer as a we-disease95 is increasing rapidly.6,94,96,97 While chapter 
4 and 5 already incorporated the partners, the importance of adopting a couple-based 
perspective was highlighted in the systematic review on dyadic coping and relationship 
function (chapter 6). Dyadic coping entails that both partners are mutually involved in the 
stress coping process, providing and receiving support from each other and engaging in joint 
problem-solving activities and shared emotion regulation.98,99 This definition illustrates that 
couples may react as a unit rather than as individuals while coping with cancer.94,96,100 The 
review showed that stress communication is an important aspect of dyadic coping. Expressing 
worries, feelings, and needs regarding cancer-related issues or the relationship itself was 
associated with better relationship function, while demand-withdraw communication (i.e., one 
partner pressuring the other partner to discuss concerns while the other partner withdraws 
from the conversation) was related with lower relationship function. Furthermore, the review 
revealed that having a spouse that is generally responsive to the individual’s needs (i.e., 
supportive behaviors) is beneficial for relationship function, while unsupportive behaviors 
such as protective buffering (i.e., hiding concerns, denying worries, and avoiding discussion) 
and overprotection are not constructive. Finally, adequate dyadic coping (e.g., joint information 
seeking and problem solving, sharing of feelings, mutual commitment, and relaxing together) 
was found to be related to the maintenance or even enhancement of relationship function. 
Therefore, this review established the importance taking couple dynamics into account.
Chapter 7 evaluated the bidirectional influence of sexual, marital, and general life (mal)
adjustment on each other (i.e., stress-spillover) prospectively from a dyadic perspective. 
Compared with available norm data84, patients and partners reported longitudinal sexual 
maladjustment. The analyses, based on the Actor-Partner Interdependence Model (APIM; 
Figure 4, chapter 1)101, showed significant Actor- and Partner effects for the longitudinal 
change in the partners’ sexual (mal)adjustment. This result suggests interdependence 
between patients and partners. Sexual (mal)adjustment did not influence marital and general 
life (mal)adjustment. These results are in line with chapter 4 which showed that SF was lower 
in patients with colorectal cancer than in a norm population, while relationship function was 
comparable. Moreover, the reversed direction could be true since maladjustment in the more 
broad general life domain did spill over to the smaller marital and sexual domains. Therefore, 
in line with the literature102,103, this study shows that awareness for patients’ and partners’ 
Quality of Life (QoL) remains important. 
Based on the notion that QoL should be taken into consideration (Chapter 7), the goal of 
chapter 8 was to evaluate patients’ and partners’ QoL longitudinally. However, it is known 
that QoL standards may change over the course of the disease trajectory (i.e., response 
shift).104-106 If participants complete a questionnaire longitudinally, but with changing QoL 
standards, then the assessments cannot be adequately compared.107 Therefore, response shift 
was assessed first. For patients and partners no reconceptualization (i.e., a redefinition of 
QoL) and reprioritization (i.e., a change in the relative importance of the domains constituting 
QoL) occurred within each of the QoL domains. However, indications for the recalibration 
(i.e., a change in the respondent’s internal standards) of specific items were found. Therefore, 
comparisons over time and between patients and partners were only feasible if restricted to 
group-level statistics at the factor level. The QoL analyses showed that patients’ and partners’ 
Psychological Health and scores on the Environmental domain decreased at three months 
postoperative, with stabilization at six months postoperative. For both domains, patients and 
partners factor means were comparable across time. Patients’ and partners’ Social Relationship 
factor means both decreased a three months follow-up, which decreased further for patients 
but stabilized for partners. Partners’ factor means were only lower than patients’ factor means 
at three months follow-up. Finally, partners had relatively stable scores for the Physical Health 
domain which were, at each time point, higher than patients’ scores. The QoL trajectories 
reflect that both patients and partners are affected by the patient’s disease and treatment.
Sexual health care needs
Besides obtaining knowledge on the sexual consequences of colorectal cancer it is important 
to evaluate the sexual health care needs of patients and partners.108,109 The qualitative study 
described in chapter 9 showed that these needs are not always adequately met. All patients 
and partners stated that having their sexual health care needs evaluated and managed 
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was important. However, health care professionals sometimes wrongfully assumed that 
elderly, widowed, or female patients had a lower need for sexual health care. Therefore, a 
mismatch existed between patients, partners, and health care professionals with regard 
to the importance of providing/receiving sexual health care. Furthermore, almost all 
participants reported a lack of knowledge, feelings of embarrassment or inappropriateness, 
and unsatisfactory communication skills as important barriers. The health care professionals 
(except for the psychologist/sexologist) additionally reported a lack of knowledge regarding 
the referral possibilities. Factors within the organization, such as debate on who is responsible 
to discuss sexuality, insufficient re-discussion of sexuality during (long-term) follow-up, and 
unsatisfactory (knowledge of the) referral system also impeded providing sexual health care. 
Health care professionals could facilitate sexual health care by providing patient-tailored 
information, normalizing sexual issues, and establishing/using an adequate referral system. 
However, it is up to the patients and partners to demarcate the extent of sexual health care 
needed; there may not always be a need for help. Based on the established need for tailored 
sexual health care, the adoption of a stepped care program, such as the Extended PLISSIT (Ex-
PLISSIT)110,111 model may be helpful (see Chapter 9). 
Methodological considerations of the dissertation
Prospectively evaluating SF and QoSL from a biopsychosocial perspective allowed us to 
address the gaps in knowledge formulated in chapter 1. However, since all eligible patients 
with colon and rectal cancer were included in our study, a wide variety of treatment schedules 
are represented. Unfortunately, the combined treatment modalities, in combination with the 
observational nature of this study, prohibit the possibility to determine the unique contribution 
of a specific treatment modality on SF or QoSL. Furthermore, it would have been beneficial if a 
true baseline assessment was obtained. In our study, the preoperative assessment should not 
be mistaken for a baseline measurement as the time between diagnosis and surgical treatment 
can already be psychologically burdensome for patients and partners. In addition, some of the 
patients with rectal cancer may already started with neoadjuvant therapy. Moreover, chapter 
3, 4, 5, 7, and 8, relied on self-report questionnaires. While the importance of validated and 
reliable questionnaires is acknowledged, the current questionnaires may not capture SF and 
QoSL completely. Furthermore, in line with current best practice, statistical models were used 
that enable analyzing the couple as a unit (chapter 7 and 8). Moreover, analyses most suited to 
deal with missing data, such as linear mixed-effects models (chapter 5) and structural equation 
modeling (chapter 7 and 8) were deployed. Nonetheless, a substantial number of drop-outs 
and/or participants who had not yet completed all assessments should be noted. Finally, the 
results should be generalized with caution because: (i) the included sample predominantly 
consisted of male, heterosexual, Caucasian participants, (ii) our study did not recruit elderly 
patients (>75 years), and (iii) a response rate of approximately 45% was achieved. In this regard, 
it especially needs to be acknowledged that some patients and partners felt reluctant to 
participate in a study that evaluates SF and QoSL, which may further limit the generalizability.
Future research directions 
The field of research into patients’ and partners’ QoSL is still in its infancy; therefore further 
validation of the results is needed. Future research could, for instance, explore biopsychosocial 
mediators or moderators of QoSL. Furthermore, in chapter 3 patient’s SF, sexual enjoyment, 
and male/female sexual problems was compared with a recent age-matched normative 
population. This chapter is quite unique. For chapter 4, 7, and 8 normative data presented 
in the manuals of the questionnaires had to be used. However, this data was, unfortunately, 
very limited and perhaps even outdated. Currently, some normative data is available on SF 
in general.112,113 However, in order to adequately compare the same constructs/domains, it is 
desirable that (Dutch) normative data for the sexuality questionnaires is collected. In addition, 
the development of clear cutoff scores can allow stratification of scores in terms of severity. 
Finally, as stated above, the current questionnaires may not capture SF and QoSL completely. 
Therefore, we encourage the development of questionnaires that are applicable for both men 
and women and that incorporate not only important aspects of SF but also of the QoSL.
Furthermore, this dissertation showed that a couple-based perspective to coping with cancer 
is needed. However, no studies have specifically evaluated dyadic challenges associated with 
QoSL for couples coping with colorectal cancer. Moreover, chapter 6 showed that adequate 
dyadic coping is required in order to maintain or improve relationship function in general. It 
can be hypothesized that dyadic coping is also beneficial in maintaining or improving QoSL. 
In order to address this issue, it would be helpful if future research specifically explores (i) 
which dyadic challenges couples coping with colorectal cancer face with regard to their QoSL, 
(ii) to what extent and in which form dyadic coping is needed in order to maintain or retain 
a satisfactory QoSL. However, in order to achieve this, a more uniformly conceptualized 
perspective is needed on what dyadic coping is and how dyadic coping differs from individual 
spousal support, and (iii) ways to expand dyadic coping. Currently, there are already some 
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pilot studies that report promising results for couple-based interventions to improve QoSL.114-
117 However, future research is needed to evaluate this potential further and to determine 
specific benefits for defined types of couples, individuals, and types of cancer.
With regard to the sexual health care needs this dissertation addressed several barriers and 
facilitators for change. However, societal factors were only sporadically mentioned. Currently, 
this topic may be especially relevant since the Dutch health care insurance now only covers 
sexual health care by a sexologist if the sexual problem is accompanied by a psychological 
disorder, psychotropic medication, or sexual abuse or if patients have an additional insurance 
policy. A substantial number of patients with colorectal cancer will not meet these criteria. 
However, if patients have to pay for counseling themselves they may become more reluctant 
to seek adequate care. Future research on the influence of societal changes is therefore 
needed.
Implications for clinical practice
The perspective on sexual (dys)function after colorectal cancer surgery has changed since 
the 1950’s from being considered unavoidable into maximizing the possibilities to perform 
nerve sparing surgery. However, the levels of sexual dysfunction still postulate the need 
to further develop strategies that may enable (i) minimizing sexual dysfunction caused by 
the multidisciplinary treatment (e.g., laparoscopic surgery118) and (ii) providing adequate 
psychosexual care to patients and partners. Moreover, the future research directions show 
that no definitive clear-cut conclusions can be formed as to which patients/couples may 
benefit from psychosexual interventions. However, some implications for clinical practice can 
be made. This results from this dissertation may play a role in (i) increasing awareness for 
SF and QoSL as relevant topics during and after treatment, (ii) showing that psychosocial 
variables may also play a role in SF and QoSL, (iii) creating alertness for cancer as a ‘we-
disease’, (iv) inspiring health care professionals to include QoSL into their conversations with 
patients/couples, (v) encouraging health care professionals to optimize their knowledge of and 
collaboration with other health care professionals in order to lower the threshold for referral, 
and (vi) challenging health care professionals to evaluate their own needs for information, 
education, and skill-training. In order to achieve these goals we suggest incorporating QoSL 
as a theme in the national guidelines on (colorectal) cancer. 
In addition, chapter 9 described how providing sexual health care (ranging from 
information provision to intensive therapy) is important. In our opinion, providing sufficient 
evidence-based information is a basic premise. While this may seem like a small step, to 
date information on the potential sexual consequences of colorectal cancer may still not be 
adequately provided during and after treatment.108,109,119,120 The need for additional sexual health 
care is a collaborative decision between health care professional and the patient/couple (i.e., 
shared decision-making121). We do not suggest that each patient needs to be referred for sexual 
health care, but rather draw upon the flexibility of the current health care system to provide 
sexual health care to those who need it. However, since sexual (mal)adjustment did not seem 
to influence relationship function (chapter 4 and 7) and QoL (chapter 7), there may not 
always be a need for sexual health care. Providing sexual health care may be best considered 
as a multidisciplinary effort, demanding close collaboration between several health care 
professionals (e.g., surgeon, radiotherapist, oncologist, and psychologist/sexologist). The 
referral needed is largely based on the nature of the sexual problem. A biological problem, for 
instance, can be referred to an urologist/gynecologist, while a psychosexual problem can be 
referred to a psychologist/sexologist. A stepped care program, in which a higher order level of 
care is only deployed if a lower order level is insufficient, is recommended (see the Ex-PLISSIT 
model110,111,122, also described in chapter 9). 
If (intensive) therapy by a psychologist/sexologist is indicated, then adequate psychosexual 
diagnostics are important to determine which therapy may fit best. There are several evidence-
based treatments that can be deployed. For instance, Cognitive Behavioral Therapy (CBT)123 
addresses dysfunctional cognitions (e.g., ‘having sexual intercourse will hurt’) that lead to 
dysfunctional behaviors (e.g., avoidance of sexual intercourse). CBT is proven beneficial in 
treating psychosexual issues in patients with cancer.124-126 However, if dysfunctional relational 
dynamics are the main issue (e.g., if patient and partner have different expectations and 
feelings about their sexual life) then Emotionally-Focused Therapy (EFT)127 may be a suitable 
option. EFT enables couples to create synchrony of emotional responsiveness needed to build 
and maintain secure emotional bands.128,129 Hereby, EFT focuses on intrapersonal processes (i.e., 
how both partners process their emotional experiences) but also takes dyadic, interpersonal 
processes (i.e., how partners organize their interactions into patterns) into account.127 EFT 
is a well-established marital therapy.128 The potential for EFT to address sexual problems in 
couples coping with cancer will be evaluated in the near future.130
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